Yaya tsawon lokacin da waɗannan alamun suka kasance?
Kuma duk wani ciwon kirji dole ne a bi da shi ta wannan hanyar musamman a shekarunka
Kuma tare da zazzabi
Kuma ya kamata a yi gwajin hawan jini da kuma cholesterol.
Kuma kana da zazzabi yanzu?
Kuma kana jin wannan ciwon kirji yanzu?
kuma kuna da wahalar numfashi?
Kuma za ku iya gaya mana wasu alamun da kuka samu tare da waɗannan alamun?
Kuma ka taɓa samun zazzabi mai yawa kuwa?
Kuma ni ma na yi tari.
Kuma ina da ɗan sanyi da tari.
Kuma ina jin zafi sosai a cikin kirji yau.
kuma wannan shine lokacin rashin lafiyar rhinitis.
Kuma yana jin zafi a cikin kirji.
Kuma ina ganin ina da zazzabi.
kuma ina so ku bayyana inda kirjinku yake
Kuma suna da zazzabi.
da kuma tarihin ciwon sukari
Kuma kin san, ƙirjina na ji kamar zai karye
Kuma ka sani, mutane suna ta yin tari a kaina.
kuma kuna jin zafi a kirji
kuma ka ce akwai matsin lamba a kirjinka
kowa a cikin iyalin da ke da matsalar zuciya, ciwon zuciya, bugun zuciya, hawan cholesterol, hawan jini
Shin akwai wasu alamu ko matsaloli da kuka lura da su tare da ciwon tsoka?
Akwai wani da yake da ciwo kamar ku a gida da ke da irin wannan alamar?
Shin kuna jin wasu alamun?
Ka taɓa jin kamar ba ka da numfashi?
Har yanzu kana jin ciwon kirji?
Domin wannan shine lokacin mura.
Amma kuma ba za mu iya ƙin ciwon kirji da ke zuwa daga zuciya ba.
Amma abin da ya fi damuna yanzu shi ne ciwon kirji.
Kuma ina jin kamar ina da matsala na numfashi.
amma na san mutane da yawa coughing a gare ni
Amma dole ne mu ɗauki kowane ciwon kirji da muhimmanci.
Amma yanzu za ka iya numfashi da kyau?
Na manta da dalilin da ya sa nake jin wannan ciwon kirji.
Shin yana kama da wani yana damfarar kirjinka?
Har yanzu yana da kamar yana da numfashi.
Shin suna da irin wannan ciwo?
Shin kana da wata cuta mai tsanani kamar hawan jini ko wani abu makamancin haka?
Shin kana da wata cuta ko kuma wata cuta mai tsanani kamar ciwon sukari?
Shin kana jin kamar ka na shan iska tare da ciwon kirji?
Shin kana da hawan jini?
Shin kana jin kamar ba ka da numfashi tare da waɗannan alamun?
Ka san alamun da take nunawa?
Shin kun ga hoton?
Ka sha ruwa mai yawa yau
Amma na yi gwajin ciwon sukari.
Amma yana da wasu alamun da suka yi kama da nawa.
Yaya zafin zafin jikinka?
Yaya hawan jini?
idan zazzabin ya ci gaba
idan zafinka ya kai ɗari biyu ko sama da haka
Idan kana ganin kana da wata cuta ko kuma wata cuta kana bukatar ƙarin bincike
Ina da zazzabi jiya
Ni ma ina da zazzabi.
Ina da zazzabi jiya
Ina jin zafi sosai a nan, a cikin kirji
Ina da wahalar numfashi.
Zan aiko muku da hotuna.
Ina jin ciwon kirji a yau
Ina jin ciwon kai da zazzabi ne kawai yau
A ganina, wannan mura ce.
A ganina, wannan ɗan mura ne.
Shin yana kama da wani mai nauyi yana zaune a kirjinka?
Dukkanin sun fara ne da ciwon kai da zazzabi a kusan lokaci guda.
Ina jin zafi a tsakiya na kirji
Matsi kamar ciwon kirji
a cikin ƙirjina
a tsakiyar kirji na
a tsakiyar kirji
Ina da ciwo a kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ka bayyana wannan ciwon kirji
kamar hawan jini ko ciwon sukari.
kamar a tsakiyar kirji
Domin zazzabi, za ka iya shan tachipirina mai zaki
Mary, kwana nawa ne ka yi da irin waɗannan alamun?
Ka ce kana jin ciwon kirji
Wani lokaci ina jin ciwon kirji
To, akwai wasu alamun da ke tare da wannan bayyanar banda ciwo
Ko kuwa wani yana zaune a kirjinka?
kamar zazzabi, tari, ciwon kai, da kuma ciwon tsoka.
daidai a tsakiyar kirji na
Ka nuna a wannan hoton inda kake jin ciwo.
Domin kana da zazzabi
To, shin kuna ganin wasu daga cikin waɗannan alamun suna da nasaba da ciki?
To, yaranku suna da wasu daga cikin irin wannan cututtuka?
Ka gaya mini game da ciwon kirjinka
zazzabi ya tashi da dare
Na yi zazzabi na kwana biyu
Jinin da ya wuce ya fara tashi.
Wannan shi ne Dr. Porter a cibiyar triase ta ER.
Za ka iya gaya mana game da ciwon kirjinka?
Ina jin zafi a gaban jikina, a nan, a kirji.
Ina jin zafi sosai a kirjina
lokacin da na ji wannan ciwo a kirjina
Wace irin ciwo kake ji a kirjinka?
Yaushe ne wannan ciwon kirji ya fara?
A wane wuri ne kake jin ciwon kirji?
A wane sashe ne kake jin ciwon kirji?
Kana jin kamar ka matse a kirjinka
Ka san cewa ina da ciwon sukari da kuma wasu cututtuka
Ka ce cewa ka ji wannan ciwon kirji
Haɗuwa mai saurin ƙaruwa na cutar coronavirus (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya, 1 ga Janairu zuwa 15 ga Maris 2020
Cigaban kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin ƙasashen EU/EEA da Burtaniya wanda ya tabbatar da cewa, duk da cewa matakin ya bambanta daga ƙasa zuwa ƙasa, cutar ta COVID-19 tana ci gaba da sauri a duk ƙasashe.
Dangane da kwarewar Italiya, ya kamata jihohi, asibitoci, da rukunin kula da gaggawa su inganta shirye-shiryensu don karuwar marasa lafiya na COVID-19 waɗanda zasu buƙaci kulawa ta kiwon lafiya, musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an samu rahoton wani gungu na masu kamuwa da cutar huhu da ba a san asalin su ba a Wuhan, lardin Hubei, na kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton cewa, kwayar cutar coronavirus ce da ake kira SARS-CoV-2.
Tun daga wannan lokacin, cutar da SARS-CoV-2 ke haifarwa ana kiranta cutar coronavirus (COVID-19).
Shaida ta nuna cewa kusan kashi 80 cikin 100 na waɗanda ke fama da COVID-19 suna da ƙananan cututtukan numfashi tare da ko ba tare da ciwon huhu ba, kuma mafi yawan waɗannan marasa lafiya sun warke.
A cikin kusan kashi 14 cikin ɗari na cutar, COVID-19 ta zama mafi tsanani kuma tana buƙatar kulawar asibiti, yayin da kashi 6 cikin ɗari na sauran cutar ta zama mai tsanani wanda ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, mun bincika yanayin tarin cutar COVID-19 a cikin ƙasashen EU/EEA da United Kingdom sannan muka kwatanta shi da wanda ya faru a lardin Hubei na kasar Sin.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a EU/EEA da kuma Birtaniya da adadin waɗanda suka kamu da cutar a Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'amuran COVID-19 a ƙasashen EU/EEA da UK
Bayan China, COVID-19 ya sami ƙarin yaduwar ƙasa kuma yanayin annobar COVID-19 a sauran sassan duniya yanzu yana bin yanayin annobar a China.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon Turai tare da tabbatar da shari'ar COVID-19 bisa ga ma'anar yanayin WHO.
A EU/EEA, Faransa ta fara ba da rahoton mutane uku da suka kamu da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, na kasar Sin.
A ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU/EEA da Ingila (UK), tsakanin 31 ga Disamba, 2019 da 15 ga Maris, 2020 tare da waɗannan kwanakin, an sami shari'o'i 39,768 da mutuwar 1,727 da aka ruwaito, tare da shari'o'i 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun adadi da kuma adadin masu kamuwa da cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), adadin mutanen da suka kamu da cutar COVID-19 da aka sanar da kowace ƙasa a duniya ana sabunta su a kowace rana a karfe 8:00 na safe. Wannan adadi ana samun sa ne daga tushen hukuma kamar ma'aikatar kiwon lafiya ta ƙasar, hukumomin kiwon lafiya na ƙasa da na yanki, da WHO.
Ana amfani da wannan bayanan don kimanta yanayin COVID-19 a EU/EEA da UK, da kuma kwatanta shi da yanayin Italiya.
A matsayin wakilcin yaduwar cutar COVID-19 mai aiki, mun kirga abubuwan da suka faru na tsawon kwanaki 14, saboda haka muna la'akari da tafiyar COVID-19 ta al'ada, a kowace ƙasa ta EU/EEA da Burtaniya, a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gabatar da adadin adadin masu kamuwa da cutar da aka ruwaito a kowace kasa har zuwa 15 ga Maris 2020 da karfe 8:00 na safe idan aka kwatanta da na Italiya a lokacin 31 ga Janairu zuwa 15 ga Maris 2020.
Yanayin COVID-19 a EU/EEA da kuma Birtaniya
Yanayin abubuwan da suka faru na kwanaki 14 na COVID-19 a cikin EU/EEA da UK sun yi daidai da yanayin da ke faruwa a lardin Hubei (Thailand) (Hoto 1).
Ga EU/EEA da UK gaba ɗaya, adadin COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu, sannan ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (Abubuwan da aka ƙayyade).
Wannan yanayin ya samo asali ne daga saurin karuwar adadin wadanda aka ruwaito daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan yanayin karuwar adadin COVID-19 (Additional Material).
Shafi na 2 ya nuna adadin adadin COVID-19 a cikin EU/EEA da UK idan aka kwatanta da adadin da aka samu a Italiya a lokacin Janairu 31 zuwa Maris 15, 2020.
Bayanai sun nuna cewa, har zuwa 15 ga Maris, karfe 8:00, sauran ƙasashe 15 na EU/EEA da kuma Burtaniya sun ba da rahoton adadin adadin waɗanda suka yi daidai da adadin waɗanda suka yi daidai da Italiya makonni uku da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin rahoton COVID-19 na ƙaruwa cikin sauri a EU/EEA da kuma Birtaniya.
Yanayin da ake gani a cikin tarin abubuwan da suka faru na COVID-19 ya nuna cewa annobar ta karu a daidai saurin a dukkan ƙasashe.
Wannan duk da bambancin matakan da kasashe ke fuskanta, bambancin martani na kiwon lafiyar jama'a, da yiwuwar bambancin ma'anar shari'ar tsakanin ƙasashe da bambancin ladabi don zaɓar marasa lafiya da za a gwada don tabbatar da COVID-19, wanda ya haɗa da gwajin biyo baya.
A farkon watan Maris na 2020, likitoci a yankin Italiya da abin ya shafa sun bayyana halin da ake ciki game da kashi 10% na marasa lafiya na COVID-19 da ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa mai tsanani a yankin sun kai iyakar ƙarfin su.
A halin yanzu, ana samun bayanai game da karbar COVID-19 a asibitoci da/ko cibiyoyin kulawa mai tsanani a matakin EU/EAA na kashi 6% da 1% na shari'o'i (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara bayanai a cikin tsari don kammala bayanan sa ido na yanzu wanda ke mai da hankali kan adadin masu kamuwa da cutar da kuma mutuwar.
Bincike da aka yi a shekara ta 2010-2011 ya nuna bambancin da ke tsakanin wadatar gadajen jinya da na kula da lafiya a Turai, wanda ya kai daga 29.2 a Jamus zuwa 4.2 a kowace dubu 100 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu da yawa ko kaɗan fiye da Italiya (12.5 gadaje na kulawa mai mahimmanci da kulawa ta tsakiya a kowace 100,000 a cikin 2010-2011).
An samar da yanayin samfurin da ya danganci wadatar kulawar kiwon lafiya, tare da kimantawar yaduwar cutar COVID-19 a asibiti ga kowace EU/EEA da Burtaniya da ke da haɗarin >90% sama da ƙarfin gadajen kulawa mai tsanani, a cikin sabuntawa na shida na ECDC na saurin kimanta haɗarin COVID-19.
Tun da yake har zuwa yanzu an samu adadin mutane da suka kamu da cutar a wasu yankuna a cikin EU/EEA da kuma Birtaniya, kuma asibitoci da kuma cibiyoyin kula da gaggawa suna yawan yi wa jama'a hidima a wasu yankuna, ya kamata a samar da bayanai game da masu kamuwa da cutar da kuma wuraren kula da gaggawa a matakin Ƙididdigar Ƙungiyoyin Yanki na 2 (NUTS-2).
Kwarewar Italiya da yanayin da ake ciki a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ƙaruwa cikin sauri a EU/EEA da kuma Burtaniya.
Saboda haka, jihohi, asibitoci, da na'urorin kula da gaggawa ya kamata su shirya don yanayin watsa SARS-CoV-2 na al'umma da kuma karuwar adadin marasa lafiyar COVID-19 da ke buƙatar kulawa ta kiwon lafiya, musamman kulawa mai tsanani, kamar yadda ya faru a yankunan da abin ya shafa a Italiya.
Kamar yadda aka nuna a cikin rahoton ECDC na kwanan nan, hanzarin, hanzarin, da kuma cikakkiyar hanyar da za a bi na da muhimmanci wajen rage yaduwar SARS-CoV-2, tare da sauyawa daga tsarin hanawa zuwa tsarin ragewa, saboda karuwar yawan masu kamuwa da cutar, kamar yadda aka yi tsammani, na iya ba da isasshen lokaci ga masu yanke shawara da asibitoci don fahimtar, karɓa, da daidaitawa da amsa mai dacewa idan ba a aiwatar da shi ba.
Wannan saurin tantance hadarin ya kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai ɗan gajeren lokacin da za a iya ƙara inganta ƙoƙarin sarrafawa na SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan ya gaza, tsarin kiwon lafiya na wasu ƙasashen EU/EEA na iya fuskantar hauhawar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Barkewar cutar coronavirus ta 2019 (COVID-19), wadda ta samo asali daga cutar coronavirus mai saurin numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2), ya zuwa yanzu ta kashe mutane sama da 3,000 kuma ta kamu da mutane sama da 80,000 a China da sauran sassan duniya, wanda hakan ya haifar da bala'i ga bil'adama.
Kamar kwayar cutar ta SARS-CoV, wadda ta haifar da cutar SARS a dubban mutane a 2003, SARS-CoV-2 na iya yaduwa daga batutuwan kuma yana haifar da irin wannan bayyanar ta hanyar irin wannan hanyar.
Duk da haka, COVID-19 yana da ƙananan matakan tsanani da mutuwa fiye da SARS, amma yana da kamuwa da cuta kuma ya fi shafar tsofaffi fiye da matasa, kuma ya fi shafar maza fiye da mata.
Domin a amsa yawan littattafan da ake wallafawa game da wannan sabon ciwo, wannan talifin ya yi ƙoƙari ya ba da cikakken bayani game da wannan ci gaba da ake samu a bincike.
Za mu tattauna muhimman abubuwa game da cututtuka, da ilmin halitta, da kuma ƙwayoyin cuta, da yadda ake ganewa da kuma magance su, da yadda ake ganewa da kuma yadda za a hana su.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan binciken zai taimaka wajen fahimtar da kuma kawar da wannan cuta mai barazana.
Bikin bazara a ranar 25 ga Janairu 2020 ya kasance abin tunawa da ba a taɓa gani ba ga duk Sinawa waɗanda aka umarce su da su zauna a gida yayin hutu da makonni bayan haka saboda barkewar sabuwar cutar kwayar cutar.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) da ta haifar da barkewar cutar cutar sankarar hankula (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya mata sunan SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ta haifar an kira ta CoV Disease-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma ta bazu cikin sauri zuwa ko'ina cikin ƙasar da kusan ƙasashe 50 a duniya.
Har zuwa 2 ga Maris, 2020, cutar ta haifar da 80,000 na tabbatar da cutar COVID-19, tare da sama da 40,000 da aka mayar da su gida da kuma 3,000 da suka mutu.
WHO ta yi gargadin cewa COVID-19 shine "magabcin jama'a na 1" kuma yana da damar yin mummunan lalacewa fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu tun daga rahoton farko a ranar 7 ga Janairu 2020 wanda ya kafa jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa, an buga takardu sama da 200 game da COVID-19, wanda ya shafi kwayar cuta, annoba, ilimin halittu, ganewar asali, da magani.
Wannan bita ya yi ƙoƙari ya taƙaita ci gaban bincike a cikin wannan sabon batun da ke ci gaba da sauri.
A inda ya yiwu, za mu gwada COVID-19 da SARS da kuma sauran cututtukan da ke haifar da CoV, wato ciwon numfashi na Gabas ta Tsakiya (MERS, annobar cutar a shekarar 2012).
Za mu kuma tattauna abin da muka koya game da rigakafin cuta da kuma yadda ake gane ta, da kuma wasu tambayoyi da ba a amsa ba amma da suke da muhimmanci.
Bisa ga al'ada, CoVs ana ganin ba su da cutarwa ga mutane, musamman suna haifar da kusan kashi 15% na mura 4.
Duk da haka, a wannan karni, mun gano kwayar cutar ta Corona sau biyu, SARS-CoV da MERS-CoV, kowannensu ya haifar da barkewar cutar da ta fara a China a 2003 da Saudi Arabiya a 2012, kuma nan da nan ta bazu zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwa.
Saboda haka, COVID-19 a halin yanzu shine annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a Hoto 1.1, an fara bayar da rahoton cluster pneumonia da ba a san asalinsa ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin.
Kwana bakwai bayan haka, an fitar da jerin kwayar cutar.
A ranar 15 ga Janairu, 2020, an ba da rahoton farkon mutuwar mutum daga Wuhan.
A lokacin, annobar ta bazu cikin sauri zuwa birane, larduna, da kuma ƙasashe da ke makwabtaka da ita.
A ranar 20 ga Janairu, an bayar da rahoton kamuwa da cuta ta hanyar masu kula da lafiya, wanda ke nuna cewa yiwuwar kamuwa da mutum-zuwa-mutum na iya faruwa.
A ranar 23 ga watan Janairu, an kafa dokar keɓewa a birnin Wuhan kuma an dakatar da dukkan hanyoyin sufuri.
A ranar 24 ga watan Janairu, binciken farko na asibiti kan cutar ya ruwaito cewa, daga cikin marasa lafiya 41 da aka tabbatar da su, marasa lafiya 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan wanda ake ganin wuri ne na farko na kamuwa da cutar daga asalin dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana annobar a matsayin gaggawa ta duniya.
A lokacin rubuta wannan rahoto, cutar ta bazu ko'ina cikin kasar Sin da kuma kusan kasashe 50 a duniya (Fig. 2).
Saboda yanayin da ke tasowa cikin sauri, har yanzu ba a tantance ainihin yanayin annobar ba.
A ranar 11 ga Fabrairu, 2020, nazarin da aka yi a cibiyoyi da dama na marasa lafiya 8,866, wanda ya hada da 4,021 da aka tabbatar da cutar COVID-19, ya gabatar da wannan sabon tsarin annobar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na kamuwa da mutane a kowane zamani, amma musamman a tsakanin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne kawai shekarunsu ba su kai 20 ba, kuma mutane 14 ne kawai suka kamu da cutar ba su kai shekara 10 ba.
SARS-CoV-2 ya fi cutar maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 na yaduwa a cikin gidajen abinci, musamman a ciki da kewayen Hubei.
COVID-19 yana ɗaukar matsakaicin kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin incubation shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga haihuwa zuwa mutuwa shine kwanaki 9.5 (4,8-13).
Adadin haihuwa na asali (R0) shine 3.77 (95% CI: 3.51-4.05) kuma R0 daidai yake da 2.23-4.82.
Adadin mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin manyan sufuri kafin bikin bazara a China.
Mutuwar marasa lafiya tare da tabbatar da shari'ar ta kasance 1.44% (95% CI: 1.10-1.86%) da kuma mutuwar da aka yi daidai da shi ga dukkan marasa lafiya ta kasance 3.06% (95% CI: 2.02-4.59%).
Manyan abubuwan haɗari guda uku don COVID-19 su ne jinsi (maza), shekaru (≥60), da kuma ciwon huhu mai tsanani.
CoVs babban ƙaramin kwayar cutar kwayar cuta ne wanda ke ɗauke da zaren RNA guda ɗaya.
Ana iya rarraba CoVs zuwa jinsi huɗu, wato alpha, beta, gamma, da delta, tare da alfa- da beta-CoVs da aka sani suna cutar da mutane.
Glycoprotein na spike (S) na shinge yana haɗuwa da masu karɓar ƙwayoyin cuta, enzymes na canza angiotensin 2 (ACE 2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan membrane fusion ya faru.
An saki kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan kwayar cutar ta kwayar cutar, RNA ta kwayar halitta tare da glycoprotein da kuma kwayar nucleocapsid sun samar da wani kwayar cuta mai dauke da virion, wanda daga baya ya hade da membrane na plasma don sakin kwayar cutar.
An fara ba da rahoton jerin kwayoyin SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 sabon beta-CoV ne mai kamanceceniya da kwayoyin halitta sama da kashi 99.98% tsakanin samfuran 10 da aka gano; an samo samfurin ne daga wurin da cutar ta bulla, wato Kasuwar Abinci na Teku na Huanan a Wuhan.
A cikin kwayoyin halittar SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscopy na watsa electron, an gano SARS-CoV-2 a cikin wani yanki na epithelium na numfashin mutum mai kauri.
An gano ACE2 na ɗan adam a matsayin mai karɓa ga SARS-CoV-2 kamar yadda yake ga SARS-CoV.
Duk da haka, furotin S na SARS-CoV-2 ya fi rauni a danganta shi da ACE2 na ɗan adam fiye da yadda yake danganta shi da furotin S na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta wanda ba shi da tsanani kamar kamuwa da cutar SARS-CoV a cikin marasa lafiya.
SARS-CoV-2 kuma na iya samar da sabon gajeren furotin wanda aka sanya wa lambar orf3b da kuma furotin da aka sanya wa lambar orf8.
Kwayar SARS-CoV-2 orf3b na iya taka rawa a cikin kwayar cutar kwayar cutar da hana bayyana IFNβ; duk da haka, orf8 ba shi da wani yanki na aiki ko kuma sanannen dalili.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun ba da rahoton cikakken tsarin ACE2 na ɗan adam na cryo-EM a ƙuduri 2.9 Å a cikin hadaddun tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa hadaddun, wanda ke da bude da rufe, an tsara shi don samar da dimer kuma ACE2-B0AT1 hadaddun na iya ɗaure sunadarai biyu na S, wanda ke nuna alamar ganewa da kamuwa da cutar CoV.
B0AT1 na iya zama makasudin magani a cikin tacewar magani don hana kamuwa da cutar SARS-CoV-2.
Mai ba da labari da kuma mai shiga tsakani
SARS-CoV da MERS-CoV an san sun fito ne daga bat kuma an watsa su ga mutane ta hanyar fox da raƙumi.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, ana ganin bat ne ainihin mai watsa SARS-CoV-2 saboda wannan sabon kwayar cutar ta kasance kashi 96% daidai da CoVs biyu masu kama da SARS daga bat da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san ainihin mahaɗan da ke taimaka wa kwayar cutar ta ƙetare iyakar jinsin don ta iya kamuwa da mutane ba, kuma ba a bayyana hanyar watsa ba tukuna.
Ji, et al. sun ba da shawarar cewa macizai suna da ƙwayar cuta daga bat zuwa ɗan adam wanda ya ƙunshi sake haɗuwa da homologs a cikin S-proteins.
A cewar wani bincike, masu bincike a Guangzhou, China sun ba da shawarar cewa tururuwa, dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbobi dabbobi dabbobi dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da da dabbobi da dabbobi da da dabbobi da da da da dabbobi da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da
Duk da haka, bambancin 1% da ke rarraba a cikin dukkanin kwayoyin halitta har yanzu yana da bambanci; saboda haka, sakamakon da ya dace a matsayin hujja na gaskiya bai riga ya samu ba (Fig. 3).
Ba a san yanayin jiki da sinadarin SARS-CoV-2 ba.
A cikin in vitro, SARS-CoV da MERS-CoV na iya rayuwa na tsawon sa'o'i 48 a cikin bushewar yanayi da kuma har zuwa kwanaki 5 a 20 °C da zafi 40%-50%.
SARS-CoV-2 na iya samun irin wannan hali.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, disinfectant mai dauke da chlorine, acid acetate, chloroform, da sauran mai narkewa mai ƙanshi, amma ba chlorhexidine ba, sun yi tasiri wajen kashe kwayar cutar.
Gabaɗaya, dukkanin al'ummar ɗan adam ba su da rigakafin cutar SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da wannan sabon kwayar cutar.
A halin yanzu, babu cikakken bincike da ya ba da rahoton amsawar rigakafin cutar ga SARS-CoV-2.
Saboda haka, za mu iya komawa ga wasu binciken CoV da suka gabata, musamman SARS-CoV da MERS-CoV (Fig. 4).4).
Gabaɗaya, bayan mamayewar mai watsa shiri, kwayar cutar ta gano ta hanyar tsarin rigakafi ta hanyar masu karɓar tsarin ganewa (PRR), wanda ya haɗa da masu karɓar lectin-kamar C-type, masu karɓar Toll-like (TLR), masu karɓar NOD-like (NLR), da masu karɓar RIG-I-like (RLR).
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan kumburi, tsufa na kwayoyin dendritic, da kuma hadawar interferon nau'in I (IFN) wanda ke hana yaduwar kwayar cutar da kuma hanzarta maganin maganin kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar.
Duk da haka, furotin N a cikin SARS-CoV zai iya taimakawa kwayar cutar ta guje wa amsawar garkuwar jiki.
Ba da daɗewa ba, amsawar rigakafin ta shiga yaƙi da wannan ƙwayoyin cuta.
T lymphocytes, waɗanda suka haɗa da CD4+ da CD8+ suna da muhimmiyar rawa a wannan kāriya.
CD4+ T-cell tana motsa B-cell don samar da ƙwayoyin cuta da suka dace da cutar, kuma CD8+ T-cell tana kashe kwayoyin cutar kai tsaye.
T-cell mai taimako tana samar da cytokines masu hana kumburi don taimakawa kare sel.
Koyaya, CoVs na iya hana aikin T-cell ta hanyar haifar da apoptosis na T-cell.
Tsaron jiki, wanda ya ƙunshi abubuwan da ke cike da jini, kamar C3a da C5a, da kuma ƙwayoyin cuta ma suna da muhimmanci wajen yaƙi da kamuwa da ƙwayoyin cuta.
Alal misali, ƙwayoyin cuta da aka ware daga marasa lafiya da suka warke sun kawar da cutar MERS-CoV.
A wani ɓangare kuma, yawan halayen jikin mutum yana haifar da yawan 'yanci a gida, wanda zai iya sa a yi wa huhu da sauran gabobin jiki lahani mai tsanani, kuma a mafi munin yanayi, zai iya sa gabobin jiki su kasa aiki ko kuma su mutu.
Cutar SARS-CoV-2, wadda ke nuna cewa ta na da ciwon kwayar cuta, ta fi yawa a cikin tsofaffi da masu fama da cutar da kuma mata masu juna biyu.
A kullum, mutanen da suka kamu da cutar a yawancin ko kuma waɗanda suke da matsalar aikin garkuwar jiki suna da damar kamuwa da cutar fiye da sauran mutane.
Kimanin matsakaicin lokacin incubation na SARS-CoV-2 shine kwanaki 1-14, mafi yawan kwanaki 3-7 bisa nazarin shari'o'in farko 425 a Wuhan.
Amma, nazarin mutane 1,099 ya nuna cewa matsakaicin lokacin da ake yi wa mutum ciki kwana uku ne kuma ya kai kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka bayyana a sama, ya nuna cewa lokacin incubation na kwanaki 4.8 (3.0-7.2) bisa alƙaluma na mutane 8,866.
Yana da muhimmanci hukumomin kiwon lafiya su daidaita lokacin keɓewa bisa ga lokacin da aka fi dacewa na lokacin da ake kwantar da cutar domin hana mutane da ke da cutar, amma ba su da alamun cutar, su watsa cutar ga wasu.
A matsayin al'ada, ana bukatar a keɓe mutane na kwanaki 14 idan sun kamu da cutar ko kuma sun kamu da ita.
Ya kamata a ƙara tsawon lokacin keɓewa zuwa kwanaki 24?
Zazzabi sau da yawa shine farkon bayyanar COVID-19, tare ko ba tare da wasu alamun ba kamar su tari mai bushewa, numfashi mai wuya, ciwon tsoka, ciwon hanci, ciwon kai, ciwon makogwaro, rhinorea, ciwon kirji, diarrhea, nausea, da kuma amai.
Wasu marasa lafiya suna samun dyspnea da/ ko hypoxemia mako guda bayan farawar cutar.
A cikin mawuyacin hali, ciwon mai haƙuri yana ci gaba da sauri zuwa ciwon numfashi mai tsanani, tashin hankali, acidosis na metabolic, da kuma coagulopathy.
Marasa lafiya da ke da zazzabi da/ko alamun numfashi da kuma zazzabi mai tsanani, koda kuwa ba tare da cutar cutar ba, ya kamata a yi musu gwajin kwayar cutar don ganewar asali.
Nazarin alƙaluma a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar ya kai kashi 98% don zazzabi, 76% don tari mai bushe, 55% don dyspnea, da 3% don diarrhea; 8% na marasa lafiya suna buƙatar taimakon ventilator.
An kuma samu irin wannan binciken a wasu bincike biyu da aka yi kwanan nan, wato nazarin da aka yi a kan dangin da kuma wanda aka yi a kan mutanen da ba su da iyalinsu.
A kwatankwacin haka, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushe (47%), da dyspnea (55%) a matsayin manyan alamun.
Koyaya, kashi 80% na marasa lafiya suna buƙatar tallafin iska, fiye da marasa lafiya na COVID-19 kuma daidai da ƙimar mutuwar MERS fiye da COVID-19.
An kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), da ciwon makogwaro (13-25%) an nuna su a matsayin manyan alamun bayyanar kuma ana buƙatar tallafin iska don kusan 14%-20% na marasa lafiya.
Har zuwa 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2 cikin dari tare da tabbatar da cewa akwai mutane 66,576 a duniya.
A kwatankwacin haka, mutuwar SARS a watan Nuwamba na 2002 ya kai kashi 10 cikin 100 na 8,096 da aka tabbatar.
Don MERS, bisa ga binciken alƙaluma a watan Yunin 2012, mutuwar ta kai kashi 37% na 2,494 da aka tabbatar.
Nazarin da ya gabata ya ruwaito cewa R0 SARS-CoV-2 ya kai 6.47 tare da 95% confidence interval (CI) na 5.71-7.23, yayin da R0 SARS-CoV kawai ya kai 2 zuwa 4.
An ba da kwatancen SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da bayyanar cututtuka, mutuwa, da kuma R0 a cikin Table 1.
Wadannan lambobin sun nuna cewa SARS-CoV-2 yana da iyawar yadawa fiye da MERS-CoV da SARS-CoV, amma ba kamar MERS-CoV da SARS-CoV ba.
Saboda haka, kalubalen da ake fuskanta wajen shawo kan annobar SARS-CoV-2 ya fi na MERS-CoV da SARS-CoV.
Ana samun garkuwa a cikin iyali ɗaya ko kuma a cikin rukuni ɗaya ko kuma a cikin wani abin hawa kamar jirgin ruwa.
Marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da ke fama da cutar ko kuma sun yi hulɗa da mutane ko marasa lafiya a cikin makonni biyu da suka gabata kafin a fara cutar.
Amma, an bayar da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba fiye da makonni biyu kuma marasa lafiya da aka sallame daga asibiti na iya sake ɗaukar kwayar cutar, wanda ke haifar da faɗakarwa don ƙara lokacin keɓewa.
A farkon lokaci, marasa lafiya suna da ƙididdigar ƙwayoyin jini na jini (musamman lymphocytes) na al'ada ko raguwa.
Misali, lymphopenia tare da ƙididdigar ƙwayoyin jini < 4×109/L, wanda ya haɗa da ƙididdigar ƙwayoyin lymphocyte < 1×109/L, da ƙimar aspartate aminotransferase da haɓaka viremia an gano su a cikin marasa lafiya 1,099 na COVID-19.
An samu ƙaruwar ƙwayoyin hanta da ƙwayoyin tsoka da kuma ƙwayar myoglobin a cikin jinin wasu marasa lafiya, kuma an samu ƙaruwa a cikin ƙwayar C-reactive protein da kuma ƙarar jini a cikin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, yawan D-dimer, wanda shine samfurin fibrin a cikin jini, yana ƙaruwa, kuma ƙididdigar lymphocytes yana raguwa.
An gano rashin lafiyar hoto na kirji a cikin babban adadin marasa lafiyar COVID-19 kuma ana nuna shi ta hanyar haushi na biyu ko kuma ƙarancin gilashin ƙasa a cikin huhu.
Sau da yawa marasa lafiya suna fama da ciwon huhu, raunin huhu, da kuma ciwon numfashi mai tsanani (ARDS).
Sa'ad da ARDS ta faru, kumburi da ke ci gaba, da kuma yawan ruwa da ke tattare da ciwon tsoka suna daɗa sa yanayin ya yi muni sosai.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, sakamakon da ya fi muni a hoton kirji sau da yawa yana nuna cewa akwai ciwo mai tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna zubar da huhu, samuwar membrane na hyaline, da kuma infiltration na lymphocytes na interstitial, da kuma kwayoyin sinitial masu yawa a cikin huhu na marasa lafiya da suka mutu daga cutar, daidai da cutar cutar ta kwayar cutar da ARDS da kuma kwatankwacin binciken cutar na SARS da MERS.
Ana amfani da gano SARS-CoV-2 RNA ta hanyar halayen sarkar polymerase reverse transcriptase (RT-PCR) a matsayin babban sharadi don ganewar asali na COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarya, wanda zai iya hanzarta barkewar cutar, an fara amfani da bayyanar asibiti don ganewar asali (wanda ba ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Haka ma yake da cutar SARS.
Saboda haka, haɗuwa tsakanin tarihin cutar, bayyanar asibiti, gwajin gwaji, da binciken radiology suna da muhimmanci kuma dole ne a yi ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniyar amfani da fasahar SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin SARS-CoV-2 RNA na roba a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafi a kowace microliter shigarwa) ta amfani da sandar tsoma a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan cewa wannan sabuwar dabara zata iya inganta ƙwarewa da sauƙi idan aka tabbatar da ita a cikin samfuran asibiti.
Saboda rashin gogewa da sabon CoV, likitoci galibi suna ba da tallafi ga marasa lafiya na COVID-19, yayin da suke gwada magungunan da aka yi amfani da su ko aka ba da shawarar su a baya don kula da sauran CoV, kamar SARS-CoV, MERS-CoV, da sauran cututtukan ƙwayar cuta (Table 2).
Wannan magani ya haɗa da maganin da ake da shi yanzu da kuma maganin da ake so da maganin rigakafi, maganin hana rigakafi, maganin steroids, maganin plasma na marasa lafiya da suka warke, maganin gargajiya na kasar Sin, da kuma taimakon tunani.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke a yin maganin.
Kamfanonin harhada magunguna suna fafutukar samar da rigakafi da kuma maganin rigakafin cutar.
A farkon, SARS-CoV-2 ya fara kai hari ga huhu kuma yana iya kai hari ga sauran gabobin da ke bayyana ACE2 a ƙananan matakan, kamar tsarin gastrointestinal da na koda.
Duk da haka, rashin aiki da kuma rashin numfashi su ne manyan barazanar da ke damun marasa lafiya kuma su ne manyan sanadin mutuwa.
Saboda haka, tallafin numfashi yana da mahimmanci don sauƙaƙe bayyanar cututtuka da ceton rai, wanda ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai iska, da iska mai iska mai iska, dangane da tsananin cutar.
Dole ne a tallafa wa marasa lafiya da ke da alamun numfashi mai nauyi tare da oxygenation na membrane na waje (ECMO), wanda shine ingantaccen hanyar bugun zuciya da bugun jini wanda ake amfani dashi don kula da rashin lafiyar zuciya ko numfashi mai barazana.
Bugu da kari, kula da daidaiton electrolyte, rigakafi da kula da cututtukan sakandare da kuma cutar ta sarƙoƙi, da kuma kare ayyukan kwayoyin rayuwa ma suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa yawan halayen jikin mutum na hana cutar cutar cutar SARS da MERS.
Cytokine storm wani nau'i ne na amsawar kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines, wanda ya hada da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan sun sa ƙwayoyin cuta na rigakafi su saki ɗumbin ƙwayoyin cuta masu yawa da suke haddasa ARDS da kuma rashin ƙarfi na gabobin jiki.
Imunosuppression yana da muhimmanci wajen kula da guguwar cytokine, musamman ma a cikin marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroid da Tocilizumab, wani maganin rigakafin IL6 na monoclonal, don magance wannan guguwar cytokine.
Sauran maganin rigakafin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Ana amfani da steroids, a matsayin maganin hana rigakafi, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Koyaya, steroids a cikin manyan allurai ba su da amfani ga mummunan rauni na huhu a cikin marasa lafiya na SARS da COVID-19.
Akasin haka, steroids na iya haifar da mummunan sakamako, musamman osteonecrosis, wanda ke shafar yanayin ciwo.
Duk da haka, ana ba da shawarar a yi amfani da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A lokacin rubuta wannan bita, babu wani maganin rigakafi mai inganci da aka tabbatar.
Amma, an gano cewa maganin remdesivir, wanda yake kwatankwacin nucleotide, yana da tasiri a cikin wani mai cutar COVID-19 daga Amurka.
Remdesivir sabon maganin rigakafi ne da Gilead ta samar, da farko don maganin cututtukan da ke haifar da ƙwayoyin cutar Ebola da Marlburg.
Daga baya, remdesivir ya kuma nuna hanawa ga wasu ƙwayoyin cuta na RNA guda ɗaya, waɗanda suka haɗa da MERS da SARS.
Bisa ga wannan, Gilead ta samar da wannan fili ga kasar Sin don gudanar da jerin gwaje-gwaje a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana sa ran samun sakamako.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su a matsayin maganin da zai yiwu ga marasa lafiya da ke da alamun cututtukan numfashi.
Rashin jin daɗi, tashin zuciya, amai, lalacewar hanta, da sauran halayen illa na iya faruwa bayan maganin hadewa da lopinavir/ritonavir.
Ya kamata a lura da hulɗar wannan maganin tare da sauran magungunan da marasa lafiya ke amfani da su.
Plasma daga marasa lafiya da suka warke da kuma samar da ƙwayoyin cuta
Akwai dogon tarihi na tattara jinin marasa lafiya da suka warke daga cututtuka masu yaduwa don a kula da wasu marasa lafiya da ke fama da irin wannan cutar ko kuma a hana mutane masu lafiya kamuwa da cutar.
Hakika, marasa lafiya da suka warke sau da yawa suna da ƙwayoyin cuta masu yawa a cikin jininsu.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙi da kwayar cuta da sauran abubuwa na waje, gane kwayoyin da ke da alaƙa da kwayar cuta, kuma kai tsaye ya kawar da su.
Bisa ga wannan, an tattara jini daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi ga marasa lafiya 10 da suka kamu da cutar.
Alamar su ta fice cikin sa'o'i 24, tare da rage kumburi da nauyin kwayar cutar da kuma ƙaruwar iskar oxygen a cikin jini.
Duk da haka, ana bukatar a tabbatar da kuma bayyana yadda ake amfani da wannan hanyar a manyan wurare kafin a samar da takamaiman maganin.
Bugu da ƙari, ban da maganin, wasu ƙalubalen da suka shafi jini suna bukatar a mai da hankali sosai.
Alal misali, ƙwayoyin cuta suna iya sa rigakafin ya yi tsattsauran ra'ayi kuma su sa a samu ciwon cytokine, wanda zai iya sa mutum ya rasa ransa.
Yawan rigakafin a cikin jini ba shi da yawa kuma ana bukatar jini mai yawa don kula da marasa lafiya masu ciwo mai tsanani.
Ƙirƙirar ƙwayoyin cuta da ake bukata da sauri don yaƙi da annobar duniya yana da wuya.
Saboda haka, yana da muhimmanci kuma yana da amfani a ware kwayoyin B daga marasa lafiya da suka warke kuma a gano lambar kwayoyin da ke yin amfani da rigakafin da ya dace ko kuma yin amfani da rigakafin da ya dace don kawar da sunadarai da suka dace da kwayar cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da ƙwayoyin cuta.
An yi amfani da TCM wajen magance cututtuka a ƙasar Sin na dubban shekaru.
Amma, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban-daban a cikin ƙira. Wannan ƙirar ta bambanta dangane da ganewar cututtuka bisa ka'idar TCM.
Yawancin abubuwan da ke da tasiri har yanzu ba a san su ba ko kuma ba su da tabbas saboda yana da wahala a cire ko tabbatar da waɗannan abubuwan ko haɗuwa mafi kyau.
A halin yanzu, saboda babu ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya masu saurin ciwo ko kuma ga mutanen da ke murmurewa daga mummunan cuta.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun sami inganci wajen maganin COVID-19.
An lura da mafi girman adadin warkarwa a cikin maganin marasa lafiya na COVID-19 a lardunan Sin da ke amfani da TCM a kashi 87% na marasa lafiya, wanda ya hada da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM a cikin kusan kashi 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin adadin warkarwa (13%).
Duk da haka, wannan kwatancen har yanzu yana da matukar damuwa saboda yawancin abubuwan da ke haifar da tasiri, kamar yawan marasa lafiya da tsananin su, dole ne a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokansa sun buga wani bincike wanda ya kwatanta maganin gargajiya na yamma (WM) kawai da maganin WM da TCM.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki, kawar da alamun, da kuma asibiti ya fi na WM+TCM yawa fiye da na WM kawai.
Abin mamaki, yawan cutarwa (daga mai sauƙi zuwa mai tsanani) ya kasance mafi ƙasƙanci ga ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%) kuma ƙananan mutuwar a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Duk da haka, amfanin TCM da amincinsa suna jiran gwaji mai kyau a manyan sikelin da kuma cibiyoyin bincike da yawa.
Wani abu mai ban sha'awa shi ne bayyana tsarin aiki da kuma bayyana abubuwan da ke da tasiri a cikin maganin TCM ko kuma haɗuwa, idan ya yiwu.
Yawancin marasa lafiya da ake zargi ko kuma aka tabbatar da su da COVID-19 suna jin tsoron wannan cuta mai saurin yaduwa da kuma kisa, kuma mutanen da ke keɓewa suna jin haushi, kaɗaici, da fushi.
Ƙari ga haka, cututtuka kamar zazzabi, hypoxia, da kuma tari da kuma wasu cututtuka na magani kamar rashin barci da ake samu ta hanyar maganin corticosteroid suna iya sa mutum ya ƙara damuwa da kuma baƙin ciki.
A farkon fasalin annobar SARS, an ba da rahoton jerin cututtukan ƙwaƙwalwar ƙwaƙwalwa, waɗanda suka haɗa da baƙin ciki, damuwa, tashin hankali, rikicewar ƙwaƙwalwa, alamun psychotic, ɓacin rai, har ma da sauyawar tunani.
Binciken tarihin hulɗa da keɓewa na dole, a matsayin wani ɓangare na amsar lafiyar jama'a ga barkewar COVID-19, na iya sa mutane su ƙara damuwa da jin laifi game da tasirin kamuwa da cuta, keɓewa, da kuma wulakanci game da dangi da abokai.
Saboda haka, ya kamata a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi, da waɗanda suka yi hulɗa da su, da kuma jama'a da ke da bukata.
Tallafin halayyar dan adam ya kamata ya hada da kafa ƙungiyoyin kiwon lafiya na hankali na fannoni daban-daban, sadarwa mai ma'ana tare da sabuntawa na yau da kullun da kuma daidai game da barkewar SARS-CoV-2, da kuma shirin magani da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don guje wa kusanci da juna.
Alurar riga kafi mai inganci tana da mahimmanci wajen katse sarkar watsawa daga cikin kwayar cutar ta dabbobi da mutane zuwa ga masu karɓar cutar kuma sau da yawa tana dacewa da maganin rigakafi wajen sarrafa annobar da cutar ta haifar.
An yi ƙoƙari don haɓaka allurar rigakafin S-protein, wanda zai iya samar da maganin rigakafin SARS-CoV a cikin dogon lokaci da kuma tasiri.
Don SARS, an gwada rigakafin da ya rage rayuwa a kan dabbobi.
Duk da haka, ya kamata a ƙayyade ingancin in vivo na wannan rigakafin a cikin tsofaffi da kuma ƙirar ƙalubalen ƙwayoyin cuta da kariya daga kamuwa da kwayar cutar zoonotic kafin fara gwajin asibiti.
Wataƙila saboda SARS ya ragu shekaru 17 da suka gabata kuma babu wani sabon hali da aka ba da rahoto tun daga lokacin.
Akasin haka, an samu karuwar cututtuka da kuma tarin cututtuka na MERS a Gabas ta Tsakiya da kuma yaduwar su zuwa wasu yankuna saboda ci gaba da samun tushen kwayar cutar a yankunan da ke da ciwon.
An tsara dabarun allurar rigakafi don MERS ta amfani da kwayar cutar da aka kashe, plasma na DNA, mai ɗaukar kwayar cutar, nanoparticles, ƙwayoyin cuta masu kama da kwayar cutar, da kuma subunits na furotin da aka sake haɗawa kuma an kimanta su a cikin dabbobi.
Ci gaban rigakafin SARS-CoV-2 mai lafiya da tasiri ga mutanen da ba su da rigakafi aiki ne mai gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Duk da haka, wannan matsala ba ta da sauƙi saboda dogon lokaci don haɓaka allurar rigakafi (tazarar watanni 18) da kuma bambancin CoV mai ƙarfi.
A matsayin sabuwar cuta, COVID-19 ya fara nuna cikakken hanyar asibiti a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya samun sauƙi ba tare da wani ɓarna ba.
Duk da haka, kamar SARS da MERS, COVID-19 kuma an danganta shi da yawan kamuwa da cuta da mutuwa a cikin marasa lafiya da ke da manyan cututtuka.
Saboda haka, tsara tsarin ciwo yana da muhimmanci ga ma'aikatan kiwon lafiya don fifita ayyukan su, musamman a yankunan da ke da iyakantaccen albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan na iya shafar ko kuma danganta su da cutar COVID-19 (Table 3):
Shekara: Shekara ita ce muhimmiyar mahimmanci ga bayyanar cutar SARS, wanda kuma ya shafi COVID-19.
COVID-19 ya fi yawa a cikin shekaru 30-65 tare da kashi 47.7% na marasa lafiya sama da shekaru 50 a cikin binciken da ya ƙunshi shari'o'i 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai mahimmanci suna da haɗarin haɗuwa da rikice-rikice kuma suna da shekaru da yawa fiye da marasa lafiya da ba sa buƙatar kulawa mai mahimmanci (matsakaiciyar shekaru 66 da 51), wanda ke nuna shekaru a matsayin mai nuna alama ga ƙarshen ƙarshen COVID-19 na marasa lafiya.
Jima'i: SARS-CoV-2 ya fi cutar maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Haɗuwa da rikice-rikice: Marasa lafiya da ke da COVID-19 da ke bukatar kulawa mai tsanani suna da damar samun raunin zuciya mai tsanani da kuma rashin isasshen jini.
Cutar zuciya ita ce kuma sanadin mutuwar mutane da yawa a cikin marasa lafiya da cutar SARS.
SARS-CoV-2 kuma an bayar da rahoton cewa yana iya haɗuwa da cholangitis tare da ACE2-mai kyau, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa tsufa da ciwo suna da nasaba sosai kuma suna iya shafan juna.
Binciken dakin gwaje-gwaje: Matsakaicin kwayar C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an gabatar da shi azaman yiwuwar yanayin hangen nesa don cutar, amsawa ga magani, da dawowa na ƙarshe.
An kuma ba da shawarar daidaituwa tsakanin matakan CRP da tsananin cutar COVID-19 da kuma hangen nesa.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da kuma creatine kinase (CK) na iya taimakawa wajen hango ƙarshen sakamako.
Ana bayyana waɗannan enzyme sosai a cikin gaɓoɓin jiki, musamman a zuciya da hanta, kuma ana sake su yayin lalacewar nama.
Saboda haka, waɗannan sunadaran sun kasance alamun gargajiya na rashin aiki na zuciya da hanta.
Babban bayyanar cututtuka: Za a yi la'akari da hotunan kirji da ci gaban bayyanar cututtuka na lokaci tare da wasu abubuwa don hango ƙarshen sakamako da rikitarwa na COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids su ne maganin hana rigakafi da ake amfani da su sosai a matsayin maganin tallafi ga cututtukan cututtuka don rage tsananin lalacewar kumburi.
Saboda ana amfani da magungunan corticosteroid masu yawa a cikin marasa lafiya masu cutar SARS, mutane da yawa da suka tsira daga cutar sun ƙare da shan cutar osteonecrosis avascular tare da nakasa rayuwa da kuma rashin ingancin rayuwa.
Saboda haka, idan ya zama dole, ya kamata a yi amfani da steroids a ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19.
Damuwa ta hankali: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19, marasa lafiya da yawa sun sha wahala sosai saboda sun sami tsawan keɓewa da matsanancin rashin tabbas da kuma ganin mutuwar dangi na kusa da abokan su.
Ya kamata a ba da shawara ta ruhaniya da kuma tallafi na dogon lokaci don a taimaki wannan mai ciwo ya warke daga matsin kuma ya koma rayuwarsa ta yau da kullum.
Bisa ga binciken alƙaluma da aka yi, COVID-19 ya bayyana yana da hoto daban na annoba da SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi cikin inganci a cikin ƙananan hanyoyin numfashi kuma yana haifar da ƙananan ko babu alamun bayyanar cututtuka a farkon farkon kamuwa da cuta, kamar sauran CoVs da ke haifar da sanyi.
Saboda haka, a farkon lokaci ko lokacin da ake kwantar da cutar, marasa lafiya da suka kamu da cutar na iya samar da kwayar cutar a manyan adadi a lokacin ayyukan yau da kullun, wanda ke haifar da babbar wahala wajen sarrafa annobar.
Duk da haka, ana ganin SARS-CoV yana yaduwa ne a lokacin da mutum ya yi rashin lafiya mai tsanani kuma yawanci ba ya faruwa a farkon lokacin.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma ta fi wahalar sarrafawa.
A halin yanzu, ana yin gagarumar yunkuri a kasar Sin, wanda ya hada da killace yankin Wuhan da garuruwan da ke kewaye da shi da kuma ci gaba da killace kusan dukkan al'umma da fatan kawo karshen yaduwar SARS-CoV-2.
Duk da cewa wannan matakin ya yi matukar lahani ga tattalin arziki da sauran bangarori a kasar, adadin sabbin masu kamuwa da cutar ya ragu, wanda ke nuna raguwar annobar.
Kimanin kashi biyu cikin dari na cutar za ta ƙare a watan Maris kuma za ta yi ta raguwa na tsawon watanni uku zuwa huɗu.
Amma, wasu masana ba su da bege.
Paul Hunter et al. sun kimanta cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al. sun kirkiro wani tsari don hango sakamakon barkewar cutar kuma sun bayyana cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan jama'ar duniya.
Kungiyar masu binciken na Kanada sun ba da rahoton cewa an gano SARS-CoV-2 a cikin hanjin tsakiyar-hannu da kuma cikin hanci na marasa lafiya waɗanda suka warke kuma suka dawo daga asibiti makonni 2 da suka gabata.
Duk da haka, akwai alamun da ke nuna cewa akwai yiwuwar a kasar Sin, idan aka duba raguwar adadin sabbin cututtuka, wanda ke nuna cewa dabarun na yanzu na iya yin tasiri.
An yi hasashen cewa cutar Ebola za ta kai mutane miliyan daya, kuma za ta kashe mutane rabin adadin.
Amma, tare da tsauraran matakan killacewa da keɓewa, an sami nasarar sarrafa cutar.
Wataƙila kuma, kamar SARS-CoV, SARS-CoV-2 ya raunana ikonsa na kamuwa da cuta kuma daga ƙarshe ya ɓace ko kuma ya zama kwayar cuta mai ƙarancin cuta da za ta iya zama tare da mutane.
An ba da kwatancen cutar COVID-19 da cutar SARS da MERS a ƙasa (Fig. 5).
SARS-CoV-2 yana da sauƙin yaduwa ta hanyar tari ko tari, kuma mai yiwuwa ta hanyar hulɗa kai tsaye da kayan da cutar ta gurɓata.
An kuma gano wannan kwayar a cikin kwantena, kuma hakan ya haifar da yiwuwar sabon hanyar watsawa, wato, watsawa ta bakin kwantena.
Wani bincike na kwanan nan a kan mutane 138 ya ba da rahoton cewa kashi 41 cikin dari na cutar na iya kasancewa sanadiyyar kamuwa da cutar nosokomial, wanda ya hada da marasa lafiya 17 da suka riga sun kamu da wasu cututtuka da kuma masu kula da lafiyar 40.
Saboda haka, dole ne a ɗauki matakan kariya don kare mutane, musamman masu kula da lafiya, ma'aikatan zamantakewa, 'yan uwa, abokan aiki, har ma da waɗanda suka yi haɗari da marasa lafiya ko kuma waɗanda suka kamu da cutar.
Hanyar farko ta kariya da za a iya amfani da ita wajen rage hadarin kamuwa da cutar ita ce ta amfani da abin rufe fuska, ko dai abin rufe fuska na tiyata ko kuma abin rufe fuska na numfashi na N95 (lambar jerin 1860s) yana taimakawa wajen sarrafa yaduwar kwayar cutar.
Masks na tiyata suna hana hawan hawan mutum mai cutar daga shiga iska ko kuma ya tsaya a kan kayan aiki, inda za a iya watsa shi ga wasu.
Koyaya, kawai abin rufe fuska na N95 (lambar jerin 1860s) na iya karewa daga inhalation na virion mai girman 10 zuwa 80 nm, tare da kawai 5% na virion zai iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV dangane da girma, duka suna da girman kusan 85 nm.
Tun da ƙwayoyin suna iya shiga cikin masks biyar da aka ɗora a kan guda, masu kula da lafiyar da ke hulɗa kai tsaye da marasa lafiya dole ne su sanya N95 (lambar jerin 1860s) maimakon abin rufe fuska.
Baya ga abin rufe fuska, masu kula da lafiyar jama'a su sanya rigar keɓewa da ta dace don rage haɗuwa da kwayar cutar.
Ƙari ga haka, za a iya samun ƙwayoyin cuta ta idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; cutar ta iya shiga jikinsa ta hanyar kumburi na ido.
Saboda haka, masu kula da lafiyarsu suna bukatar su saka abin rufe fuska ko kuma tabarau sa'ad da suke aiki da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma za ta iya shafawa, an ba da shawarar sosai ga kowa ya wanke hannayensa da sabulu mai gurɓata fiye da yadda ya saba, ya yi ƙoƙarin zama a gida don keɓe kansa, kuma ya guji hulɗa da mutanen da ke da cutar.
An yi imani cewa tazarar ƙafa uku ya dace don nisantar marasa lafiya.
Waɗannan ayyuka hanya ce mai tasiri don rage haɗarin kamuwa da cuta da hana yaduwar cutar.
Kodayake SARS-CoV-2 sabon kwayar cuta ne ga duniyar ɗan adam, babban daidaituwa da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya zama babban gargadi ga China wacce ke da ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwal.
Duk da haka, a ranar 19 ga Janairu, 2020, daraktan Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankalin jama'a ta hanyar cewa sabon kwayar cutar tana da yanayin yaduwa da iyakantaccen damar haifuwa daga mutum zuwa mutum kuma rigakafin da kuma hana cutar ba matsala.
Wannan sakon ya kwantar da hankalin jama'a, musamman a lokacin da kasar ke shirin bikin bazara, don haka wannan lokaci mai mahimmanci ya wuce don hana cutar ta Wuhan.
Hukumar kula da cututtuka a China za ta yi koyi da wannan kuma ta yi gagarumin gyara a nan gaba.
Alal misali, ya kamata hukumar ta (1) kasance mai taka tsantsan wajen yin sanarwa ga jama'a domin kowane kalma tana sa mutane su kula kuma tana iya canza halinsu da shawarwarinsu; (2) ta kasance mai saukin kai da kuma amsawa ga bayanai da ba na al'ada ba daga asibitoci maimakon jiran rahoto na hukuma daga likitoci ko jami'ai masu iko; (3) ta kasance mai tsaurara don hana yiwuwar annoba a farkon matakai, maimakon ƙoƙarin kwantar da hankalin jama'a; kuma (4) ta fi yin atisaye masu manufa da tasiri don inganta wayar da kan jama'a game da annobar cutar da kuma gwadawa da inganta tsarin mayar da martani na jama'a a kai a kai.
Cutar COVID-19 ta samo asali ne daga sabon kwayar cutar SARS-CoV-2 wanda ya fara yaduwa a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, annobar ta bazu ko'ina cikin kasar Sin da kuma kasashe sama da 50 a duniya a lokacin da nake rubuta wannan bita.
Saboda kwayar cutar ta yi kama da SARS-CoV kuma alamun COVID-19 da SARS sun yi kama, barkewar COVID-19 na da alama kamar annobar SARS ta sake faruwa.
Duk da haka, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci wajen shawo kan annobar da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa kuma ya fi shafar maza fiye da mata, kuma yawan mutuwar tsofaffi ya fi na matasa.
Mutuwar SARS ta fi ta COVID-19 (10.91% vs. 1.44%).
Marasa lafiya COVID-19 suna watsa kwayar cutar koda kuwa ba su da alamun cutar, yayin da marasa lafiya SARS galibi suna watsa kwayar cutar lokacin da suke da mummunan rashin lafiya. Wannan yana haifar da babbar wahala wajen hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wani ɓangare na dalilin da yasa SARS-CoV-2 ke yaduwa cikin sauri da kuma yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don bincika SARS-CoV-2 na iya haifar da sakamako mara kyau a cikin wasu marasa lafiya na COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake nuna tabbatacce a gwajin cutar.
Wannan binciken ya kara hadarin yaduwar cutar.
Tare da saurin ci gaban binciken COVID-19, wasu mahimman batutuwa har yanzu suna buƙatar warwarewa, wato:
Daga ina SARS-CoV-2 ya fito?
Duk da cewa an gano daidaiton kwayoyin halittar kashi 96 cikin dari tsakanin SARS-CoV-2 da kuma wasu nau'in SARS-CoVs guda biyu na bat, har yanzu ba mu iya kammala cewa SARS-CoV-2 ya fito ne daga bat ba.
Waɗanne dabbobi ne suke aiki a matsayin matsakaici wajen watsa ƙwayoyin cuta daga mahaifinsu, kamar su bat, zuwa ga mutane?
Idan ba mu san amsoshin 1 da 2 ba, ba za mu iya kashe watsawar yadda ya kamata ba kuma annoba za ta iya sake yaduwa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da asalin kwayoyin halitta sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya ainihin kwayar cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na pathological?
Shin wannan kwayar cutar tana da alaka da kwayoyin dake bayyana ACE2 a wasu gabobin jiki?
Idan ba tare da amsoshin waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma magani mai kyau ba.
Har yaushe za a ci gaba da wannan annobar?
Ta yaya kwayar cutar take girma a cikin kwayoyin halittar mutum?
Shin za ta zama annoba ta duniya, ta ƙare kamar SARS, ko kuma za ta sake faruwa a kai a kai kamar mura?
Amsoshin waɗannan tambayoyin da kuma wasu da yawa suna da muhimmanci, amma suna iya ɗaukan lokaci kafin a samu.
Duk da haka, ko da menene farashin, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri don mu koma ga rayuwa ta yau da kullun.
Tushen cutar korona ta mutum
Shekaru dubbai, sauye-sauye da kuma daidaitawa sun motsa co-juyin halitta na kwayar cutar korona (CoV) da mai masaukin ta, gami da mutane.
Kafin 2003, an san cewa kwayar cutar mutum (HCoV) biyu tana haifar da cututtuka masu saurin kamuwa da cuta, kamar mura.
Annobar cutar sankarar numfashi (SARS) da cutar sankarar numfashi ta Gabas ta Tsakiya (MERS) sun juya al'amarin kuma sun nuna yadda kamuwa da kwayar HCoV za ta iya zama mai hallaka da barazana ga rai.
Yunƙurin SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake sanya CoV a cikin haske kuma ya ba mu mamaki tare da yawan watsawa, amma tare da ƙananan cututtukan cututtukan da ɗan'uwansa, SARS-CoV.
Cutar HCoVs cuta ce ta dabbobi, saboda haka fahimtar asalin HCoVs zai taimaka mana.
Yawancin kwayar cutar HCoVs sun fito ne daga bat. A cikin waɗannan dabbobi, kwayar cutar ba ta da cutar.
An kuma san cibiyar ajiyar wasu HCoVs.
Gano mahaifar dabba yana da tasiri kai tsaye a rigakafin cutar ɗan adam.
Binciken hulɗar CoV-guga a cikin dabbobi na iya ba da muhimmiyar fahimta game da cutar CoV a cikin mutane.
A cikin wannan bita, mun gabatar da cikakken bayani game da ilimin da ake da shi a yanzu game da kwayar cutar HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin su na dabbobi da kuma yaduwar su tsakanin jinsuna.
Abu mai mahimmanci, mun gwada kuma mun bambanta HCoVs daga ra'ayi na juyin halitta da kuma sake haɗuwa da kwayoyin halitta.
An tattauna game da annobar cutar CoV 2019 (COVID-19) a wannan mahallin.
Bugu da ƙari, an kuma ba da haske game da bukatun sauyawar mai watsa shiri da kuma tasirin juyin halitta na kwayar cutar akan tsananin cutar.
Kwayar cutar korona (CoV) ta fito ne daga dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ɓoye, masu kyau, da kuma RNA guda ɗaya.
Wannan kwayar tana da kwayar halitta mafi girma da girman 26 zuwa 32 kilobase a tsakanin kwayar RNA da ake kira "CoV", saboda yanayin jikinta da ke kama da kambi a ƙarƙashin allon lantarki.
Bisa ga tsarin, CoVs suna da kwayoyin halittar da ba su da rarrabuwa da ke da tsari iri ɗaya.
Kusan kashi biyu bisa uku na kwayoyin halitta sun ƙunshi manyan tsarin karatu guda biyu (ORF1a da ORF1b) waɗanda suka haɗu da juna.
Polyprotein yana fuskantar ƙarin sarrafawa don ƙirƙirar 16 ba tare da tsari ba, wanda ake kira nsp1~16.
Sauran genomes sun ƙunshi tsarin karantawa na buɗe (ORF) don sunadarai na tsari, wanda ya haɗa da spikes (S), sheqa (E), membrane (M), da nucleoprotein (N).
Wasu sunadarai masu amfani da keɓaɓɓun layin sun kuma ƙunsar da layin CoV daban-daban.
Dangane da bambance-bambance a jerin sunayen sunadarai, an rarraba CoVs zuwa jinsi huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV); daga cikin waɗannan nau'ikan huɗu, nau'in beta-CoV yana da mafi yawan HCoVs kuma an sake raba shi zuwa layi huɗu (A, B, C, da D).
Shaidar phylogenetic ta nuna cewa bat da rodents sune tushen yawancin kwayoyin alpha-CoV da beta-CoV, yayin da tsuntsaye sune babban ma'ajiyar gamma-CoV da delta-CoV.
Shekaru dubbai, CoVs suna ci gaba da ƙetare shingen jinsin kuma wasu CoVs sun zama muhimman cututtuka ga mutane.
Ya zuwa yanzu, an san mutane bakwai da ke dauke da kwayar cutar korona (HCoVs).
Daga cikin kwayar cutar guda bakwai, HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, kwayar cutar coronavirus na cututtukan numfashi mai tsanani (SARS-CoV), kwayar cutar coronavirus na cututtukan numfashi na Gabas ta Tsakiya (MERS-CoV), da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63 yawanci suna haifar da ƙananan alamun, kamar sanyi da/ko zawo.
Akasin haka, SARS-CoV, MERS-CoV, da SARS-CoV-2 suna da cututtuka sosai, suna haifar da kamuwa da cuta ta hanyar numfashi a cikin marasa lafiya da yawa kuma suna da damar da za su iya zama cututtukan cututtukan numfashi (ARDS) da bayyanar da ke bayan gabobin huhu.
An gano kwayar HCoV-229E ta farko, B814, daga cikin marasa lafiya da suka kamu da cutar sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar zurfin nazarin HCoV-229E da HCoV-OC43, waɗanda duka biyu ke haifar da bayyanar cututtuka da kansu.
A gaskiya, an yarda da cewa kamuwa da kwayar HCoV ba ta da haɗari, har sai da barkewar cutar SARS.
Barnar SARS da ta auku a 2003 tana ɗaya daga cikin munanan annobar cutar a tarihin zamani, ta cutar da mutane fiye da 8,000 da yawan mutuwar kusan 10%.
Shekaru goma bayan haka, annobar cutar MERS ta Gabas ta Tsakiya ta haifar da ci gaba da barkewar cutar a yankin Larabawa tare da yaduwar ta a wasu sassan duniya.
Sabuwar kwayar cutar HCoV ta 2019 (2019-nCoV), wanda aka sani da SARS-CoV-2, shine mai haddasa annobar cutar korona ta 2019 (COVID-19), wacce ta kashe mutane sama da 3,120 kuma ta kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi gargadin cewa duniya za ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin kwayar cutar HCoVs bakwai suna da asalin zoonotic daga bat, mice, ko dabbobi.
Akwai shaidar da ta nuna cewa dukkanin kwayar cutar HCoVs sun samo asali ne daga bat. A cikin bat, CoVs suna da kyau kuma ba su da cutar, amma suna nuna bambancin kwayoyin halitta.
Annobar COVID-19 ta haifar da ƙalubale na musamman na likita, kimiyya, zamantakewa, da ɗabi'a ga China da sauran duniya.
Binciken asalin kwayar cutar HCoV ya ba da tsari don fahimtar tarihin halitta, motsa jiki, da abubuwan da ke hana yiwuwar motsawa tsakanin jinsuna.
Wannan binciken kuma na iya jagorantar ko sauƙaƙa binciken mai watsa shiri na SARS-CoV-2 na tanadi, matsakaici, da kuma fadadawa, wanda ke da muhimmiyar ma'ana a cikin hana yaduwar nan gaba.
A cikin wannan bita, mun ba da cikakken bayani game da asalin zoonotic, watsawa tsakanin jinsuna, da kuma cutar HCoV.
Mun ba da haske musamman kuma mun tattauna batun gama gari cewa kwayar cutar HCoV ta saba zama ba kwayar cuta ba a cikin taskar halitta, amma ta zama kwayar cuta bayan watsawa tsakanin jinsuna zuwa sabon mai masaukin baki.
Mun kuma duba yanayin juyin HCoV cewa ƙaruwar iyawar watsawa sau da yawa yana tare da raguwar cutar.
An kuma tattauna sakamakon cutar SARS-CoV-2 a cikin wannan mahallin.
An san kwayar cutar dabbobi tun daga ƙarshen shekarun 1930.
Kafin warewar HCoV-229E na farko na B814 daga cikin mutanen da suka kamu da mura, an gano CoVs da yawa daga dabbobi da yawa da suka kamu da cutar, wadanda suka hada da turke, beraye, shanu, aladu, kuliyoyi, da karnuka.
A cikin shekarun baya-bayan nan, an gano kwayar cutar HCoV guda bakwai.
Takaitaccen tarihin gano HCoVs cikin tsari na lokaci (Table 1) yana da bayani.
An fara ware kwayar HCoV-229E daga cikin numfashi na marasa lafiya da ke fama da kamuwa da cutar numfashi a shekarar 1966, wanda daga baya aka tsara shi don girma a cikin layin kwayar cutar huhu WI-38.
Marasa lafiya da ke dauke da HCoV-229E suna nuna alamun sanyi, wanda ya hada da ciwon kai, tari, kumburi, da ciwon makogwaro, tare da zazzabi da tari wanda aka gani a cikin 10~20% na lokuta.
Daga baya a 1967, an ware HCoV-OC43 daga al'adun gabobin da kuma jerin hanyoyin da aka tsara a cikin kwakwalwar jariri mai shayarwa.
Bayanan asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da kamuwa da cutar da HCoV-229E ke haifarwa, wanda ba shi da bambanci da cututtukan cututtukan cututtukan numfashi kamar su kwayar cutar mura A da rhinovirus.
HCoV-229E da HCoV-OC43 sun yadu a duniya kuma suna iya yaduwa sosai a lokacin hunturu a yankunan da ke da yanayin zafi.
Yawancin lokaci, lokacin da kwayar cutar take kwance a cikin ƙasa da mako guda, sai kuma a yi rashin lafiya na tsawon makonni biyu.
Bisa ga binciken masu ba da kai na ɗan adam, mutane masu lafiya waɗanda ke kamuwa da HCoV-229E suna da ɗan sanyi.
Ƙananan marasa lafiya da suke da rauni a tsarin garkuwar jiki ne kawai suke nuna kamuwa da cutar numfashi.
SARS, wanda aka fi sani da "atypical pneumonia", shi ne farkon annobar cutar HCoV da aka rubuta a tarihin ɗan adam kuma kwayar cutar SARS-CoV ce, wanda shine HCoV na uku da aka gano.
Ana iya gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da kamuwa da cutar mutum 8,096 da mutuwar mutum 774, a kasashe da nahiyoyi da dama.
Baya ga superinfectious, kowane yanayi ana tsammanin zai iya haifar da kusan yanayi biyu na biyu, tare da lokacin incubation na kwanaki 4 zuwa 7 kuma ana iya ganin ƙaruwar ƙwayar cutar a ranar 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoV sun fara fuskantar rashin tausayi, ciwon kai, zazzabi, rashin motsi, da kuma jin ƙanƙantar jiki, wanda ya biyo bayan dyspnea, tari, da kuma rashin numfashi a matsayin alamun ci gaba.
Lymphopenia, rashin aikin hanta, da kuma ƙaruwar creatinine kinase su ne cututtukan da ake samu a cikin SARS.
An kuma lura da lalacewar yaduwar alveolar, yaduwar ƙwayoyin epithelial, da kuma ƙaruwa na macrophage a cikin marasa lafiya na SARS.
Bugu da ƙari, kusan kashi 20-30% na marasa lafiya suna bukatar kulawa mai tsanani da kuma na'ura mai sarrafa iska.
Ban da ƙananan hanyoyin numfashi, wasu gabobin da suka haɗa da gastrointestinal tract, hanta, da kuma ƙwayoyin cuta suna iya kamuwa da cuta a cikin matsanancin yanayi, yawanci tare da hadarin cytokines, wanda zai iya zama mai kisa, musamman a cikin marasa lafiya marasa ƙarfi.
An fara gano kwayar cutar ne daga wani dan uwan da aka yi masa kwayar cutar a cikin wani wuri da aka bude wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen binciken HCoV.
An ware HCoV-NL63 daga jariri mai wata 7 daga Netherlands a ƙarshen 2004.
A farko, wannan cuta ta fi yawa a cikin yara, tsofaffi, da marasa lafiya masu rauni da ke fama da cututtukan numfashi.
Bayani na choriitis, conjunctivitis, zazzabi, da bronchiolitis ana samun su a cikin cututtukan da HCoV-NL63 ke haifarwa.
Wani bincike na 'yanci ya bayyana cewa an ware irin wannan kwayar cutar daga kwayar hanci na wani yaro mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma a gaskiya ya yaɗu a duk duniya.
An kiyasta cewa HCoV-NL63 yana wakiltar kusan kashi 4.7% na cututtukan numfashi na yau da kullun kuma mafi girman abubuwan da ke faruwa suna faruwa a farkon bazara, bazara, da hunturu.
HCoV-NL63 yana da alaƙa da cutar laringitis ta hanawa, wanda kuma ake kira croup.
A wannan shekarar, an gano HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti saboda ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Baya ga cutar huhu da kuma cutar ta ƙwayar cuta, an ba da rahoton HCoV-HKU1 da ke da alaƙa da matsanancin cutar asma.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, ana samun HCoV-HKU1 a duk duniya, yana haifar da rashin lafiya na numfashi.
Duk da haka, ba a san dalilin da ya sa wasu cututtuka masu yawa ba su faru ba, kamar yadda aka yi a cikin cutar HCoV-NL63 mai cutarwa wanda aka ba da rahoton kwanan nan yana haifar da kamuwa da cutar numfashi a cikin kasar Sin.
Gabaɗaya, lokacin da aka sami damar motsawa cikin inganci da ci gaba da riƙe kansa a cikin ɗan adam, cutar da cutar HCoVs ɗin ma sun ragu.
An fara gano kwayar cutar MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da ke fama da ciwon huhu da kuma rashin aikin koda a Saudi Arabiya.
Kodayake yawancin lab-tabbatattun magungunan sun fito ne daga Gabas ta Tsakiya, an samu rahoton shigo da magungunan tare da wasu lokuta na watsawa zuwa wasu kasashen Turai da Tunisia.
Wani barkewar cutar ta biyu ya faru ne a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da kamuwa da cutar mutum 186.
Bayyanar asibiti na MERS yayi kama da bayyanar asibiti na SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin masu fama da cutar MERS suna fama da rashin ciwon koda, wanda ya zuwa yanzu ya kasance kawai a cikin cutar MERS tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna nuna alamun ciwon ciki, kamar su diarrhea da kuma amai.
Har zuwa 14 ga Fabrairu, 2020, an bayar da rahoton fiye da lambobi 2500 da aka tabbatar da su tare da mutuwar mutane da yawa, wato kashi 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi kowa tsoro da aka sani ga ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano wani gungun marasa lafiya na ciwon huhu wanda aka danganta da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa annobar cutar numfashi ta ƙasa da ke gudana da kuma SARS-CoV-2 a matsayin Matsalar Lafiya ta Duniya kuma ta sanya sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk duniya, tare da mutuwar marasa lafiya da kashi 3.4%.
A lura, mutuwar cutar a Hubei, China, ya kai kashi 4.2%, yayin da mutuwar cutar a wajen Hubei ya kai kashi 1.2%.
SARS-CoV-2 na haifar da kamuwa da cuta mai tsanani kamar SARS-CoV da MERS-CoV tare da bayyanar zazzabi, tari, da kuma numfashi mai wuya.
An kuma samu zawo a wasu marasa lafiya.
Ciwon huhu yana cikin alamun da suka fi tsanani kuma yana iya saurin zama ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban daidaiton tsarin nucleotide, na 82%, dukansu sun kasance cikin rassan bishiyar phylogenetic daban.
Pathogenicity na SARS-CoV-2 a bayyane yake ya fi ƙasa, amma ya fi yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An samu rahoton mutane da ke kamuwa da cutar SARS-CoV-2 ba tare da wata alama ba kuma wataƙila sun taka rawa wajen saurin yaduwar SARS-CoV-2 a duniya.
Kwatanta SARS-CoV-2 da kuma bambance-bambance da sauran HCoVs shida ya nuna kamance da bambance-bambance masu ban sha'awa.
Na farko, lokacin incubation da tsawon tafiya na cutar HCoV suna da kama sosai.
A wannan yanayin, SARS-CoV-2 ya bi sahun sauran HCoVs shida.
Na biyu, tsananin COVID-19 ya kasance tsakanin SARS-CoV da sauran HCoVs guda huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 ta nuna hoto mafi na kowa da ake gani a cikin kamuwa da cutar HCoV na al'umma, wanda ya haɗa da hoto na rashin bayyanar cututtuka ko kuma rashin bayyanar cututtuka.
A gefe guda, ƙananan ƙananan shari'o'in COVID-19 masu tsanani na iya zama kamar kamuwa da cutar SARS-CoV duk da cewa a ƙananan rabo.
Na uku, watsa SARS-CoV-2 ya kuma nuna halaye masu ban sha'awa, yana da kamanceceniya da HCoVs na al'umma da SARS-CoVs.
A gefe guda, yaduwar SARS-CoV-2 tana da iyaka kamar na HCoV na al'umma.
A gefe guda, raguwar yaduwar SARS-CoV-2 bayan wasu hanyoyi a cikin mutane har yanzu yana buƙatar tabbatarwa, kamar yadda lamarin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 daga samfurin stool.
"Ko watsa SARS-CoV-2 ta hanyar hanji yana da muhimmanci, kamar yadda yake a cikin watsa SARS-CoV, aƙalla a wasu yanayi, har yanzu binciken zai bayyana".
Abu mai mahimmanci kuma da za a sani shi ne ko SARS-CoV-2 na yanayi ne kamar yadda yake a cikin al'ummar HCoVs.
Ko ta yaya, fasalin SARS-CoV-2, wanda ya haɗa da iyawar watsawa, cutar, da ci gaba da yaduwa a cikin hanyoyi da yawa a cikin mutane, zai yi tasiri sosai kan ƙarshen annobar COVID-19 da ke gudana.
HCoVs hudu na al'umma da ke haifar da rashin ciwo sun daidaita da mutane.
Idan aka duba daga wani bangare, za a iya cewa mutane sun daidaita da wadannan HCoVs guda hudu.
A wasu kalmomi, ko dai HCoV ko kuma ɗan adam na iya zama nau'in mai tsira daga annobar HCoV na zamanin da.
An kawar da kwayar cutar HCoVs da ke haifar da mummunar cuta a cikin mutane da kuma mutane da ke fama da mummunar cuta ta HCoVs.
Don wannan ya faru, HCoVs dole ne su ninka a cikin mutane a cikin isassun adadi don ba da damar tarawa na juyin halittar da ke adawa da abubuwan da ke hana mai masaukin baki.
Saboda haka, tsawon lokacin da annobar SARS-CoV-2 ta daɗe kuma mutane da yawa sun kamu da ita, hakan zai sa cutar ta iya daidaitawa da mutane.
Idan kwayar cutar ta daidaita da kyau, zai yi wuya a dakatar da yaduwar ta ga mutane ta hanyar keɓewa ko wasu matakan sarrafa kamuwa da cuta.
A cikin shekaru, CoVs hudu na al'umma sun yadu a cikin yawan mutane kuma sun haifar da mura a cikin mutanen da ba su da kariya.
Wannan cuta ba ta bukatar tasoshin dabbobi.
Akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su daidaita da mutane ba kuma ba za a iya kiyaye su ba.
Dole ne su kare kansu kuma su yi kiwo a cikin tanadin zoonotic kuma su nemi damar yadawa ga maƙasudin ɗan adam mai rauni, mai yiwuwa ta hanyar ɗaya ko fiye da matsakaici da kuma haɓaka.
SARS-CoV-2 yana da kwatankwacin SARS-CoV/MERS-CoV da kuma HCoVs hudu na al'umma.
SARS-CoV-2 yana da sauƙin yaduwa kamar HCoV na al'umma, aƙalla a yanzu.
Koyaya, SARS-CoV-2 ya fi cutar HCoVs na al'umma kuma ba shi da cutar SARS-CoV ko MERS-CoV.
Har yanzu ana jiran ganin ko SARS-CoV-2 zai iya daidaitawa da mutum kuma ya yadu a cikin mutum ba tare da mai masaukin dabba ko matsakaici ba.
Kafin mu tattauna asalin dabbobi na HCoV, muna bukatar mu tattauna ma'anar da kuma halaye na masu karɓar baƙi na halitta, masu tanadi, masu matsakaici, da kuma masu haɓaka HCoV.
Dabbobi suna aiki a matsayin mai watsa labaran HCoV idan suna da kakannin da ke da dangantaka ta kusa kuma suna da babban daidaituwa a matakin jerin nucleotides.
Kwayar cutar ta saba daidaitawa sosai kuma ba ta haifar da cuta a cikin wannan mai masaukin.
Hakazalika, mai riƙe da ruwa yana ɗauke da HCoVs a kai a kai kuma a cikin dogon lokaci.
A cikin waɗannan lokuta biyu, mai watsa shiri ya kamu da cutar ta halitta kuma shine mai watsa shiri na halitta ga HCoVs ko kwayar cutar mahaifa.
Akasin haka, idan HCoV ya shiga cikin wani mai watsa shiri na tsaka-tsaki a daidai lokacin da ko kuma a lokacin da kwayar cutar ta shiga cikin mutane, kwayar ba ta daidaita da sabon mai watsa shiri ba kuma galibi tana da cutar.
Wannan mai watsa shiri na iya zama tushen kwayar cutar ɗan adam kuma yana aiki azaman mai watsawa ta hanyar ba da damar kwayar cutar ta ɗan lokaci, sannan ta watsa shi ga ɗan adam don haɓaka sikelin kamuwa da cutar ɗan adam.
HCoVs na iya kamuwa da kamuwa da cuta idan ba za su iya ci gaba da watsawa a cikin mahaɗan matsakaici ba.
Akasin haka, HCoVs na iya daidaitawa da mai watsa shiri na tsakiya har ma ya haifar da ƙarancin lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Bayanan da aka samu sun nuna cewa babu wani mutum da ya taɓa yin cutar SARS.
Binciken da aka yi na seroprevalence ya nuna cewa masu sayar da dabbobi suna da yawan IgG na anti-SARS-CoV fiye da sauran jama'a.
Tsuntsaye (Paguma larvata) da karnukan rakuna a kasuwar dabbobi masu rai sune farkon waɗanda aka gano suna ɗauke da kwayar cutar SARS-CoV-like wanda kusan iri ɗaya ne da SARS-CoV.
A kaikaice, wannan ya tabbata ne da cewa babu wani sabon yanayin SARS da aka ruwaito tun lokacin da aka kashe dukkan foxes a kasuwa.
Duk da haka, an bayar da rahoton cewa wasu tsuntsayen watan daga daji ko gonaki waɗanda ba a fallasa su zuwa kasuwannin dabbobin da ke raye ba sun ba da sakamako mara kyau ga SARS-CoV. Wannan yana nuna cewa tsuntsayen wata na iya zama kawai a matsayin mai watsa shiri na matsakaici, amma ba mai ba da izinin SARS-CoV ba.
Ya kamata a lura, saboda kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da rigakafin SARS-CoV, ba za a iya ware cewa wataƙila yawancin ƙananan nau'ikan dabbobi masu shayarwa suna aiki a matsayin masu watsa shirye-shiryen SARS-CoV na tsaka-tsaki ba.
Dukkanin waɗannan rundunonin sun zama kamar su ne masu kawo karshen SARS-CoV.
Binciken da aka yi na dabbobi masu kama da SARS-CoV ya bayyana wani CoV na bat mai dangantaka, wanda ake kira Rhinolopus bat CoV-SARS HKU3 (SARSr-Rh-BatCoV HKU3), wanda aka samo a cikin bat bat na China.
Wannan bat ya gwada tabbatacce don anti-SARS-CoV antibodies da SARSr-Rh-BatCoV HKU3 genomic sequence.
Wannan CoV da sauran CoVs na bat suna da kashi 88-92% na daidaiton jerin nucleotides tare da SARS-CoV.
Wannan binciken ya kafa tushen sabon ra'ayi cewa bat ne mai masaukin kamuwa da cututtukan mutum.
An kuma gano wasu CoVs masu kama da SARS (SL-CoV) daga bat, amma guda daya, wanda aka sanya wa suna WIV1, za a iya ware shi a matsayin kwayar cutar mai rai.
An san enzyme mai canza angiotensin 2 (ACE2) a matsayin mai karɓar SARS-CoV.
An nuna cewa WIV1 da aka samo daga kwayar bat ne ta yi amfani da ACE2 na bat, fox, da kuma mutum a matsayin masu karɓa don shiga cikin ƙwayoyin.
Abin sha'awa, ƙwayar cutar SARS mai warkewa ta iya kawar da cutar WIV1.
Ya zuwa yanzu, WIV1 na wakiltar mafi kusanci ga SARS-CoV a cikin bat, tare da daidaiton tsarin nucleotide na kashi 95%.
Duk da irin girman homology tsakanin kwayar cutar biyu, an yi imani da cewa WIV1 ba kwayar cutar SARS-CoV ce kai tsaye ba kuma bat ba mai masaukin SARS-CoV ba ne kai tsaye.
Binciken phylogenetic ya rarraba MERS-CoV zuwa rukuni ɗaya tare da CoV-HKU4 na bat da CoV-HKU5 na bat.
CoV-HKU4 na bat da MERS-CoV suna amfani da mai karɓar bakuncin daya, dipeptidyl peptidase 4 (DPP4), a matsayin hanyar shiga kwayar cutar.
Tsarin RNA mai dogara da RNA-polymerase na MERS-CoV yana da kusanci da tsarin halittar sa zuwa kwatankwacinsa a cikin beta-CoVs na bat da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a gano wani kwayar cutar MERS mai rai a cikin namomin kaza ba.
MERS-CoV da kuma danginsa na kusa CoV-HKU25 na bat sun raba kashi 87% na daidaiton jerin nucleotides.
Saboda haka, bat ba zai iya zama mai masaukin kai tsaye na MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Larabawa sun yi gwajin kwayar cutar MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya suka yi a wasu ƙasashen Afirka.
An gano kwayar cutar MERS-CoV mai rai wanda yake kama da wanda aka gano a cikin mutane daga hancin raƙuman Arabiya. Wannan ya kara nuna cewa raƙuman ne ainihin wurin ajiyar MERS-CoV.
Yana da mahimmanci a lura cewa an lura da lalata ƙwayar cuta mai yawa tare da alamun rashin ƙarfi a cikin raƙuman gwajin da ke kamuwa da MERS-CoV.
Ya kamata a lura cewa raƙuman da suka kamu da cutar ba su watsa cutar ta hanyar numfashi kawai ba, amma kuma ta hanyar faecal-oral, wanda kuma shine babban hanyar watsa cutar daga bat.
Duk da haka, tambayar ba ta amsa ba saboda yawancin waɗanda aka tabbatar da cutar MERS ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka, mai yiwuwa sakamakon yaduwar mutum-zuwa-mutum ko hanyar watsawa da ba a sani ba wanda ya shafi nau'in dabbobi da ba a sani ba wanda ke ɗauke da MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayar cutar nucleotide tare da bat CoV RaTG13 wanda aka ware daga bat Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin jerin abubuwa tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don kafa dangantakar mahaifa.
A wasu kalmomi, bat ba zai iya zama mai masaukin baki na SARS-CoV-2 kai tsaye ba, sai dai idan an gano CoV mai kama da bat a nan gaba.
Wataƙila, mai watsawa na dabbobi na SARS-CoV-2 yana cikin nau'ikan namun daji da aka sayar da kashe su a Kasuwar Kasuwancin Kayan Kifin na Huanan.
Wasu binciken da aka yi kwanan nan bisa jerin metagenomics sun nuna cewa wani rukuni na kananan dabbobi masu shayarwa da ke cikin hatsari, wanda aka sani da albasa (Manis javanica), na iya ɗaukar beta-CoVs na kakannin da ke da alaƙa da SARS-CoV-2.
Wannan sabon kwayar cutar CoV tana da kashi 85-92% na kwayar nucleotide da SARS-CoV-2.
Koyaya, CoVs suna da kusanci da RaTG13 tare da kusan kashi 90% na kamanceceniya a matakin jerin nucleotides.
An rarraba su cikin ƙananan layin-tsarin kwayar cutar SARS-CoV-2 guda biyu a cikin bishiyar phylogenetic, ɗayan yana raba yankin ɗaure mai karɓa (RBD) wanda ya fi kama da SARS-CoV-2, tare da kamanceceniya na jerin amino acid na 97.4%.
Abin mamaki, RBD na SARS-CoV-2 da RaTG13 sun bambanta sosai, kodayake yawan daidaiton jerin kwayoyin sun fi girma.
Binciken da aka yi a baya a kan tsuntsayen da ke fama da cutar ya kuma ba da rahoton gano kwayar cutar daga samfurin huhu, wanda kuma ya zama yana da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tsarawa da kuma sarrafawa ta hannu don samar da jerin kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar halittar kwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar hali hali halittar halittar hali hali halittar halittar hali hali hali hali hali hali hali hali hali hali halittar hali hali hali hali hali hali hali hali hali hali hali hali hali
Ba za mu iya ware yiwuwar tsuntsayen tsuntsaye a matsayin daya daga cikin masu daukar nauyin SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ta goyi bayan SARS-CoV-2 ya fito kai tsaye daga tururuwa saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoV dangi-SARS-CoV-2 na tururuwa.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi kusa da nesa tsakanin SARS-CoV-2 da beta-CoVs dangi-SARS-CoV-2.
Har yanzu ba a tantance hanyar juyin halittar SARS-CoV-2 a cikin bat, tsuntsaye, da sauran dabbobi masu shayarwa ba.
Duk da cewa an sami mafi girman daidaiton tsari a cikin RBD tsakanin SARS-CoV-2 da beta-CoV dangi-SARS-CoV-2 na tururuwa, SARS-CoV-2 da RaTG13 suna da mafi girman daidaito a cikin tsarin tsarin kwayoyin halitta.
Ya yi yawa a ce ana iya cewa irin wannan babban kamance tsakanin RBD beta-CoV dangi-SARS-CoV-2 na tururuwa da SARS-CoV-2 ne ta hanyar juyin halitta mai ma'ana wanda zaɓin sa ya daidaita.
Hujja ta kwatancen tana goyon bayan sake haɗuwa tsakanin beta-CoV dangi-SARS-CoV-2 na tururuwa da RaTG13 a cikin nau'in dabbobi na daji na uku.
A matsayin abin motsa juyin halitta, ana samun sauyi sosai tsakanin beta-CoVs.
Masu bincike ba su iya yanke hukunci game da asalin SARS-CoV-2 na dabbobi ba.
Baya ga HCoVs masu cutarwa, asalin zoonotic HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1 suma an bincika su.
Shaidar phylogenetic ta nuna cewa HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoV na bat, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An bayar da rahoton cewa CoV na bat mai suna ARCoV.2 (Appalachian Ridge CoV) wanda aka gano a cikin bat mai launin uku na Arewacin Amurka ya nuna kusanci da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da kwayar cutar bat CoV, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, tare da Camelidae da ake tsammanin kuma shine mai watsa shiri.
Don ƙarin haske, an taƙaita ilimin yanzu game da asalin dabbobi na HCoVs a cikin Hoto na 1 da Table 2.
Binciken phylogenetic ya ba da tabbacin cewa akwai yiwuwar watsa HCoVs tsakanin jinsuna a tarihi.
A kusan 1890, lokacin da HCoV-OC43 ya wuce wani nau'in daga dabbobi don ya cutar da mutane, an lura da annobar cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna bai bayyana ba.
An gano alpha-CoV na bat da ke da dangantaka da HCoV-229E.
Tsakanin su, akwai alpha-CoV na alpaca.
Akwai wasu shaidu da suka nuna cewa za a iya watsa kwayar cutar kai tsaye daga bat zuwa ga mutane.
Na farko, mutane, ba alpacas ba, da za su iya yin hulɗa da batutuwan a cikin yanayin yanayin da suke da shi.
Akasin haka, mutane suna da dangantaka ta kusa da alpaca.
Na biyu, alpha-CoV na bat da ke da alaƙa da HCoV-229E ya kasance mai yawa kuma ba shi da cutar a cikin bat, yayin da alpha-CoV na alpaca ya haifar da barkewar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano alpha-CoV na alpaca a cikin dabbobin daji ba.
Saboda haka, ba za a iya ware yiwuwar alpacas sun sami dangin HCoV-229E-alpha-CoV daga mutane ba.
A gaskiya, bat ne tushen cututtuka masu cutar mutum, da suka haɗa da kwayar cutar rabi, Ebola, Nipah, da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa batutuwan na iya kai tsaye watsa HCoV-229E ga mutane.
Wataƙila, yayin da alpha-CoV na bat yayi aiki a matsayin ɓoye na kwayar HCoV-229E, alpacas da Arabian camels na iya zama masu watsa shirye-shiryen watsa kwayar cutar ga mutane, daidai kamar yadda lamarin MERS-CoV yake.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga bat zuwa raƙuman Arabiya da kuma daga raƙuman Arabiya zuwa ga mutane.
An san asalin juyin halittar MERS-CoV daga bat ne a farkon gano kwayar cutar kuma an kuma karfafa shi da binciken da aka yi daga baya.
A bayyane yake cewa bat ne mai tarin nau'in kwayar cutar da ke da wadataccen musayar kwayoyin halittar tsakanin jinsuna da kuma watsawa tsakanin jinsuna.
Rayuwa mai tsawo, ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarƙarƙarƙarƙarƙarƙarƙun.
A gefe guda, MERS-CoV ya shiga cikin raƙuman Arabiya shekaru da yawa.
Kwayar cutar ta daidaita da raƙuman da suka canza daga matsakaiciyar mai watsa shiri zuwa mai riƙe da kwanciyar hankali da na halitta.
MERS-CoV na haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙarancin canjin canji a cikin waɗannan dabbobi.
Rarrabawar da ke faruwa a cikin mutane ba zato ba tsammani kuma mutane sun kasance masu masaukin karshe na MERS-CoV saboda ba za a iya ci gaba da watsawa ba.
Ba kamar rawar raƙuma a watsa MERS-CoV ba, rawar da albasa, idan akwai, a watsa SARS-CoV-2 ta bambanta.
Musamman, beta-CoV na tururuwa yana da matukar cutarwa a cikin tururuwa.
Moose na iya zama mai masaukin karshe ga beta-CoVs dangin SARS-CoV-2, kamar fox a cikin yanayin SARS-CoV.
A cikin nazarin da ke zuwa, wasu yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane dole ne a yi la'akari da su ko kuma a ware su.
Na farko, batutuwan na iya zama masaukin jirgi ga kwayar cutar SARS-CoV-2 wanda kusan yake kama da SARS-CoV-2.
Mutane za su iya raba wurin da suke da shi da namomin kaza ta wajen kashe su ko kuma hakar kwal.
Na biyu, tsuntsayen tsuntsaye na iya zama ɗaya daga cikin masu watsa shirye-shiryen watsa shirye-shiryen watsa shirye-shiryen SARS-CoV-2 da suka shigo.
Mutane sun kamu da cutar ta hanyar yanka da cin naman da aka kashe.
Wataƙila, dabbobi masu shayarwa da yawa, waɗanda suka haɗa da dabbobin gida, suna da saukin kamuwa da SARS-CoV-2.
Ana bukatar a yi gwajin rigakafi a kan dabbobin gida da kuma dabbobin daji.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'in na uku wanda ke hulɗa da duka bat da tsuntsaye.
Binciken asalin dabbobi na SARS-CoV-2 na ci gaba.
Baya ga nau'ikan dabbobi masu ba da izini, manyan abubuwa uku na ɓangarorin kwayar cutar suna da mahimmanci don sauƙaƙe wa CoVs su ƙetare shingen nau'in.
Na farko, saurin canjin da suke yi a kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar ƙimar canjin CoV za a iya ɗauka matsakaici zuwa high tare da matsakaicin sauyawar sau ~10-4 a kowace shekara a kowane wuri, dangane da matakin daidaitawar CoV zuwa sabon mai masaukin.
CoVs suna da exoribonuclease mai gyara, kawarwa wanda ke haifar da ƙaruwa mai yawa, attenuation, ko ma inviability.
Abin sha'awa, an san cewa analog na Remdesivir yana hana kwayar cutar CoV ta hanyar hana wannan exoribonuclease da RNA-dependent RNA polymerase.
Remdesivir yana ɗaya daga cikin magungunan anti-SARS-CoV-2 da suka fi ba da tabbaci da za a gwada a gwaji.
Duk da haka, canjin CoV ya ninka na mai shi sau miliyan.
Bugu da ƙari, yawan canjin sau da yawa yana da girma yayin da CoVs ba su daidaita da mahaifinsu ba.
Idan aka kwatanta da SARS-CoVs waɗanda ke da saurin canji, saurin canjin SARS-CoV-2 ya yi ƙasa, yana nuna cewa ya fi dacewa da ɗan adam.
Wataƙila, SARS-CoV-2 ya daidaita da wasu runduna da ke da kusanci da mutane.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV wanda ya daidaita da raƙuman Arabiya.
A ka'ida, akwai yiwuwar cewa canjin kwayoyin zai sa allurar rigakafi da kuma maganin rigakafin cutar SARS-CoV-2 su zama marasa tasiri.
Na biyu, babban kwayar RNA a cikin CoVs na ba da ƙarin sassauci a gyaran kwayar halitta, don canzawa da sake haɗawa, don haka yana ƙara yiwuwar co-juyin halitta tsakanin jinsuna, wanda ke da fa'ida ga bayyanar sabbin CoVs lokacin da yanayi ya dace.
Wannan yana da goyon baya ta hanyar yawan takamaiman tsarin karantawa da kuma aikin da aka tsara na furotin zuwa ƙarshen 3′ na genomes.
Na uku, CoVs suna sauya samfuri ba zato ba tsammani yayin kwafin RNA ta hanyar tsarin select-salin na musamman.
A cikin mai masaukin da ke aiki a matsayin mai hadawa, sauya zaren yana faruwa sau da yawa yayin fassarar RNA na CoV.
Cikakken RNA da kuma RNA mai yawan kama-da-wane na iya sake haɗuwa don samar da sabon CoV.
An sami tabbacin phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, haka kuma a cikin CoV na dabbobi kamar su SL-CoV na bat da CoV-HKU9 na bat.
Haɗin gwiwar kwayar cutar a cikin hulɗa da watsawa
Baya ga abubuwan da aka ambata a sama, hulɗar kwayar cutar da mai karɓar mai watsawa wani babban abu ne wanda ke shafar watsawa tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na musamman, wanda kuma ya nuna shaidar zaɓi mai kyau yayin faruwar watsawa tsakanin jinsuna.
Dangane da nazarin kwatancen tsakanin kwayar cutar SARS-CoV na ɗan adam da na fox, ana zargin SARS-CoV yana yin saurin daidaitawa a cikin yawancin mahalarta, musamman tare da maye gurbin RBD na furotin S.
A yadda aka saba, kwayar cutar S CoV mai suna RBD tana hulɗa da masu karɓar ƙwayoyin cuta kuma tana zama maƙasudin amsawar kwayar cutar.
A cikin SARS-CoV, RBD shine amino acid na 318 zuwa 510 a kan S1 fragment, wanda ke da alaƙa da ACE2 na ɗan adam da kuma masu karɓar sa a matsayin hanyar shiga kwayar cutar.
RBD SARS-CoV yana da ikon gane masu karɓar ACE2 na dabbobi daban-daban, waɗanda suka haɗa da bat, fox, mice, da raccoon, don haka yana ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya, kawai 6 amino acid residues aka lura daban-daban tsakanin mutum da fox virus isolate a RBD da kuma 4 daga cikinsu suna located a cikin mahaɗin mahaɗin haɗi don hulɗa tare da ACE2 mai karɓa.
SARS-CoV fox yana da sauye-sauyen K479N da S487T a cikin RBD, wanda zai iya haɓaka alaƙar hulɗar furotin tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomi, waɗannan amino acid biyu na maye gurbin na iya zama da muhimmanci ga yadda kwayar cutar take daidaitawa ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da masu karɓar kwayar halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S sunadarai yana nuna cewa ƙirar haɗin S sunadarai tare da ACE2 na ɗan adam na iya canzawa.
A gaskiya ma, wani binciken cryo-EM ya nuna cewa alaƙar ACE2 na ɗan adam da SARS-CoV-2 S sun ninka sau 10 zuwa 20 fiye da alaƙar ACE2 na ɗan adam da SARS-CoV S.
Abu mai mahimmanci kuma da za a sani shine ko akwai wasu masu karɓar karɓa waɗanda za a iya buƙata don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 kuma yana da alaƙa da ACE2, amma tare da wani ɓangare daban a cikin S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da kuma 9-O-therasethylated sialic acid don HCoV-OC43.
Waɗannan masu karɓa na iya taka rawa a nasarar daidaita wannan CoV a cikin ɗan adam bayan watsawa tsakanin jinsuna daga mai masaukin dabbobi.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon watsa HCoV tsakanin jinsuna kuma ana sarrafa shi ta wasu abubuwan dogaro da ƙuntatawa na mai masaukin baki.
Wannan bambancin da ke tsakanin mutanen da suke da furotin da ke cikin gidajen abinci na halitta, kamar su bat da Arabian camels da kuma rodents, zai iya zama wani shinge ga watsawa tsakanin jinsuna.
HCoVs dole ne su ɗauki nauyin dogara ga mai masaukin baki kuma su keta abubuwan hanawa na mai masaukin baki don samun nasara a watsawa tsakanin jinsuna.
A wannan yanayin, dole ne a gano kuma a bayyana abubuwan da ke sa abubuwa su kasance a cikin kwayoyin da ke cikin wannan muhimmin wuri na hulɗa tsakanin ƙwayoyin cuta da kuma masu gida.
Yin amfani da fasahar CRISPR mai saurin gaske na iya zama da amfani wajen tace dukkanin kwayoyin halittar don duba abubuwan dogaro da kuma hana SARS-CoV-2 mai gida.
Sabon HCoV ya bayyana: komawar farkon barkewar cutar
Bambancin CoV na bat yana ba da babbar dama ga fitowar sabbin HCoVs.
A wannan yanayin, CoV na bat yana aiki a matsayin ɓoye na HCoV.
Bugu da ƙari, saurin canzawa da kuma sake haɗuwa da kwayoyin halitta sun kuma motsa juyin HCoVs kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, samun ko rasa sabon kwayar halittar mai maye gurbin kwayar cutar na iya canja fasalin kwayar cutar sosai.
A cikin sunadarai masu amfani da SARS-CoV, ana tsammanin ORF8 yana da muhimmiyar rawa wajen daidaitawa ga ɗan adam saboda an gano kwayar cutar bat-SARS-CoV da aka ware tana ƙin wasu sunadarai na ORF8.
SARS-CoV mai fasalin kawar da kwayar cuta 29 an gano shi a cikin wani nau'in da aka ware a farkon barkewar cutar a cikin mutane.
Wannan cirewar ya raba ORF8 zuwa ORF8a da ORF8b kuma ana zaton yana da maye gurbin maye gurbin da ke tallafawa sauyawar mai masaukin baki.
Bugu da ƙari, SARS-CoV na iya samun tarihin haɗuwa tare da layin alfa-CoV da gamma-CoV, tare da gano ƙananan ƙananan ƙananan yankuna a cikin RNA polymerase wanda ya dogara da RNA.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10, da kuma wasu nsp14.
Hakazalika, an nuna cewa an samu sake haɗuwa tsakanin zuriya daban-daban a cikin annobar MERS-CoV, wadda ta faru a cikin raƙuman Arabiya a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan da ke faruwa a cikin wasu HCoVs inda HCoVs ke sake haɗuwa da wasu CoVs na dabbobi a cikin ƙwayoyin halittar su.
Ya kamata a lura cewa zaɓin wucin gadi na iya taka rawa a cikin canje-canje na ba da gangan a cikin kwayar cutar, mai yiwuwa ta hanyar sakin kwayar cutar daga matsin zaɓin da ta fuskanta, kamar ta tsarin garkuwar jiki na mai masaukin baki.
Misali na wannan tasirin shine asarar ORF4 gaba ɗaya a cikin kwayar cutar HCoV-229E ta hanyar cire nucleotides biyu.
Yayin da ORF4 mai cikakke za a iya lura da shi a cikin bat da camel viruses da ke da alaƙa da HCoV-229E, alpha-CoV alpaca yana nuna shigar da nucleotide guda ɗaya wanda ke haifar da sauya fasalin.
A ƙarshe, an kuma motsa juyin halittar sabon HCoV ta matsin zaɓin a cikin rukunin mai masaukin.
An gano rashin bayyanar cututtuka ko kuma rashin bayyanar cututtuka lokacin da batutuwan suka kamu da CoV, wanda ke nuna daidaituwa tsakanin CoV da batutuwan.
Ya bayyana cewa batutuwan sun dace da CoV sosai ta fuskar jiki da kuma jiki.
Alal misali, rashin aiki a kunna amsa mai hana kumburi a cikin bat zai rage cutar da ke haifar da CoV sosai.
Bugu da ƙari, aikin kwayar halitta a cikin bat an matse shi saboda ƙaruwar tsarin ƙwayoyin halitta na kwayar halitta mai hanawa NKG2/CD94 da ƙananan ƙididdigar ƙididdigar ƙwayoyin cuta na Histocompatibility na farko.
Bugu da ƙari, yawan nau'in oxygen mai saurin motsa jiki (ROS) na ayyukan metabolism na bat zai iya hana kwafin CoVs kuma ya shafi gyaran da exoribonuclease ke yi don haka ya ba da matsin lamba don ƙirƙirar kwayar cutar mai saurin kamuwa da cuta lokacin da ta shiga cikin sabon mai masaukin.
Ƙarin kwayar cuta ta CoV na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da samun sabon furotin ko fasalin furotin don daidaitawar mai masaukin baki.
Saboda haka, ba daidaituwa ba ce cewa sababbin ƙwayoyin cuta guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da ƙananan alamu a cikin mahalarta, kamar su bat da raƙumi.
CoVs suna yin kwafi sosai ba tare da haifar da amsawar garkuwar jiki mai ƙarfi ba.
Wannan shi ne asirin da ke tattare da kamuwa da cuta a cikin mutane.
Alamun suna da tsanani musamman saboda yawan kunnawar amsawar rigakafi da kuma guguwar cytokine, tare da lalacewar huhu da ke da tsanani idan amsawar rigakafin ta yi ƙarfi.
Akasin haka, a cikin masu dauke da cutar da ba su da alamun cutar, amsawar garkuwar jikin ta rabu da kwayar cutar.
Irin wannan dabarar don yanke shawarar alaƙar amsawar rigakafi na iya zama da amfani a cikin maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin bat.
Saboda haka, bayar da interferon nau'in I, aƙalla a farkon kamuwa da cutar SARS-CoV-2 a cikin mutane, ya kamata ya zama da amfani.
Bugu da ƙari, kunnawar NLRP3 na kumburi a cikin bat yana da lahani.
Saboda wannan dalili, hana NLRP3 na kumburi tare da MCC950 na iya zama da amfani wajen kula da COVID-19.
Bayyanar SARS-CoV-2 ta bi hanyar bayyanar SARS-CoV da MERS-CoV.
Yayin da aka gano beta-CoVs na bat da ke raba kashi 95% na kwayar cutar tare da SARS-CoV, an kuma gano CoVs na bat da ke raba kashi 96% na kwayar cutar tare da SARS-CoV-2.
Ko da yake an gano cewa foxes da sauran dabbobi a kasuwa suna dauke da kwayar cutar da ta yi daidai da SARS-CoV, ba a gano wani mai watsa shiri na kai tsaye ga SARS-CoV-2 ba.
An gano beta-CoV na albasa mai matukar kama da SARS-CoV-2, wanda ke nuna cewa albasa na iya taka rawa a matsayin daya daga cikin mahalarta matsakaici ko kuma beta-CoV na albasa na iya ba da gudummawar wani yanki na kwayoyin halitta a cikin sigar ƙarshe ta SARS-CoV-2.
Duk da cewa har yanzu ana ta tambaya, babu wata hujja da ta nuna cewa SARS-CoV-2 na mutum ne ko dai da gangan ko kuma ba da gangan ba.
CoVs sun sake zama abin lura saboda annobar SARS-CoV-2 da ta faru kwanan nan.
Nazarin CoVs a cikin bat da sauran dabbobi ya canza ra'ayinmu game da mahimmancin asalin dabbobi da kuma ma'adinan dabbobi don HCoVs a cikin watsawa ga mutane.
Akwai tabbaci mai yawa da ke nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun samo asali ne daga bat da kuma yaduwa ga mutane ta hanyar mai watsa shiri.
Ganin cewa kamuwa da cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da foxes a cikin kasuwar ruwa, yana iya zama rufe kasuwar ruwa da kashe duk foxes a ciki wanda ya kawo ƙarshen barkewar cutar SARS.
A irin wannan dalili, ya kamata a cire tururuwa daga kasuwannin da ke da ruwa don hana yaduwar kwayar cutar, saboda gano wasu layukan beta-CoV na tururuwa da ke da kusanci da SARS-CoV-2.
Duk da haka, gaskiyar da kuma hanyar da SARS-CoV-2 ke yaduwa ga mutane ta hanyar tsuntsaye da sauran dabbobi masu shayarwa har yanzu suna buƙatar bayyanawa a cikin binciken gaba.
A gefe guda, MERS-CoV ya daɗe yana cikin raƙuman Arabiya.
Ta zama hanya mai muhimmanci na sufuri da kuma tushen nama, madara, fata, da kuma kayan ɗamara ga mutanen yankin.
An rarraba raƙuman Arabiya a dukan Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu mu kashe dukkan raƙuma ba don mu iya shawo kan cutar MERS, kamar yadda ake yi a kasuwar namun daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar MERS, dole ne a yi cikakkiyar hanya don samar da allurar rigakafin raƙuma da ke da tasiri akan MERS-CoV kuma a haɗa ta da sauran matakan sarrafa kamuwa da cuta.
Kafin mu kawar da wannan kwayar cutar, za a iya samun sabon nau'in kwayoyin halitta da zai iya haifar da annoba.
Akwai nau'o'in kwayar cutar da ke yaduwa a cikin daji.
Musamman ma, ƙwayoyin cuta na bat da ke da yiwuwar zama dabbobi sun bambanta sosai.
Akwai yiwuwar cewa wannan kwayar cutar ta zoonotic za ta iya juyawa kuma ta sake haɗuwa, wanda hakan zai haifar da fitowar sabbin kwayar cutar da za ta iya yaduwa da kuma/ko kuma ta yi kisa ga mutane a nan gaba.
Dole ne a daina cin naman daji a wasu wurare a kasar Sin domin rage hulda da dabbobi.
Tare da mummunan kwarewar SARS, MERS, da COVID-19, ya kamata a yi shiri da kuma inganta tsarin magance su.
A gaskiya, ƙwayoyin cuta da yawa sun kasance a duniyar nan tun zamanin dā.
Waɗannan ƙwayoyin cuta suna cikin ɗakunan ajiya na halitta har sai an sami damar yaduwa.
Ko da yake batutuwan suna da halaye da yawa da ke taimakawa wajen yaduwar kwayar cutar, za a iya rage damar da mutane ke da shi na hulɗa da batutuwan da sauran namun daji idan aka umurci mutane su guje wa namun daji.
Ana bukatar ci gaba da sa ido kan dabbobi masu shayarwa don fahimtar yanayin CoV da mahaifarsa, wanda zai zama da amfani wajen hana yaduwar dabbobi zuwa ga mutane da kuma barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar ta kwayar cuta ita ce mutane su nisanta kansu daga mahalli na halitta na kwayar cutar ta kwayar cuta.
Ba a gano wasu ɓangarorin jigon asalin SARS-CoV-2 ba.
Na farko, idan batutuwan sun watsa kwayar cutar SARS-CoV-2 ga tsuntsaye, yanayin da batutuwan da tsuntsaye ke raba yanayin muhalli yana da mahimmanci a sani.
Na biyu, idan batutuwan suna da rawar kai tsaye a watsawa ga mutane, dole ne a ƙayyade yadda mutane ke hulɗa da batutuwan.
Na uku, idan akwai wani dabba mai shayarwa na uku da yake aiki a matsayin mai watsa shiri na ainihi, ya kamata a bayyana yadda dabba mai shayarwa take hulɗa da sauran nau'in, waɗanda suka haɗa da mutane, bat da tsuntsaye.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, ciki har da dabbobin gida, na iya zama masu saukin kamuwa da SARS-CoV-2, dole ne a yi gwaji da kuma sa ido kan kamuwa da cutar.
Ko dai a cikin bat, tsuntsaye, ko wasu dabbobi masu shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kusan kwayar cutar da ta kama za a iya gano ta a cikin mahaifarta na halitta a nan gaba.
Ci gaba da bincike a cikin wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman abubuwan da ke tattare da rigakafi da sarrafa COVID-19 a cikin mutane.
Ana bukatar sabunta ka'idojin ganewar asali na COVID-19 da kuma wanda aka tabbatar da cutar.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar gaggawa don ganewar asali da kuma kula da sabon kamuwa da kwayar cutar coronavirus 2019 (2019-nCoV). Wannan jagorar ya dogara ne akan kwarewarmu kuma ya zama kyakkyawan tunani don yaƙar cutar a duk duniya.
Duk da haka, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma iliminmu da wayewarmu suna ƙaruwa bisa binciken bincike da ake yi da kuma kwarewar asibiti; saboda haka, ana ci gaba da sabunta hanyoyin ganewar asali da kulawar.
A cikin wannan wasika, mun amsa ɗaya daga cikin maganganun da ke cikin jagorarmu kuma mun samar da sabbin ka'idojin ganewar asali don al'amarin da aka zata da al'amarin da aka tabbatar bisa ga Jagoran Ganowa da Kulawa don COVID-19 (na bakwai) wanda Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin ta bayar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda a halin yanzu ana kiransa da sunan cutar coronavirus na 2019 (COVID-19) kuma an sanya wa kwayar cutar sunan coronavirus na 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don yaƙi da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagorar gaggawa kuma an buga ta ta yanar gizo a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
An yi amfani da wannan littafin tun da aka wallafa shi.
Duk da haka, ya kamata a lura cewa COVID-19 sabuwar cuta ce, kuma iliminmu da wayewarmu suna ƙaruwa bisa binciken bincike da ake yi da kuma kwarewar asibiti; saboda haka, ana ci gaba da sabunta hanyoyin ganewar asali da kulawar.
Misali, Jagorar Ganowa da Kulawa don COVID-19 wanda Hukumar Lafiya ta Jamhuriyar Jama'ar Sin ta fitar (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, hukumar ta fitar da editoci bakwai tare da wasu mahallin da aka canza sosai.
Jagoranmu ya karɓi bayani daga Zhou et al., sun gabatar da shawarwari masu sauƙi na ƙididdigar bisa ga kwarewarsu ta asibiti.
Sakamakon binciken ya ba da sabon bayani game da cutar kuma ya zama muhimmiyar ma'ana ga duniya.
Muna goyon bayan aikin da suka yi kuma muna godiya.
Duk da haka, sakamakon aikin su ya bukaci sabuntawa bisa ga sabon Jagorar Ganowa da Kulawa don COVID-19 (na bakwai na gwaji) da kuma sabon binciken.
Dangane da fitowar ta bakwai (3 Maris 2020), don tabbatar da yanayin da ake tsammani ana buƙatar haɗuwa da ɗayan tarihin tarihin cutar tare da bayyanannun bayyanannun asibiti guda biyu don yin cikakken bincike, ko kuma ana buƙatar cika bayyanannun bayyanannun asibiti guda uku idan babu bayyananniyar tarihin cutar:
Tarihin cutar: (1) tarihin tafiya ko zama a birnin Wuhan da ke kewaye, ko kuma wasu al'ummomin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin hulɗa da wani mutum da ya kamu da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin hulɗa da wani mai zazzabi ko kuma wanda ke fama da cututtukan numfashi daga birnin Wuhan da ke kewaye, ko kuma wasu al'ummomin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtukan; (4) tarihin hulɗa da wani rukunin mutane da aka tabbatar da cutar (≥ 2 da suka kamu da zazzabi da/ko kuma cututtukan numfashi da suka faru cikin makonni 2 a wani karamin yanki, kamar gida, ofis, aji, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) fasalin hoto na kamuwa da cutar COVID-19; (3) jimlar adadin ƙwayoyin jini na nuna ƙimar ƙwayoyin lymphocyte na al'ada, raguwa, ko raguwa a farkon matakin kamuwa da cuta.
Ganowar tabbatar da cutar ya kamata ya dogara da yanayin da ake tsammani tare da ɗayan waɗannan pathogenic ko hujjojin serological kamar haka: (1) gwajin PCR na ainihi mai kyau don SARS-CoV-2; (2) jerin dukkanin kwayoyin cutar sun nuna babban daidaituwa ga sabon coronavirus da aka sani; (3) tabbatacce ga takamaiman IgM antibody da IgG antibody ga SARS-CoV-2 a cikin gwajin jini; ko kuma canzawar takamaiman IgG na SARS-CoV-2 daga tabbatacce zuwa mara kyau, ko titer ya ƙaru da ≥4 sau biyu a lokacin farfadowa sama da matakin a lokacin gaggawa.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihin lokacin nucleic acid a cikin samfurin numfashi ko jini a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara gano kwayar cuta a cikin samfurin jini a cikin fitowar ta huɗu (Janairu 27, 2020) da ta biyar (Fabrairu 8, 2020); sannan, an ƙara hujja ta serological a fitowar ta bakwai.
Wannan gyare-gyare ya dogara ne akan ci gaba da bincike na masu bincike don neman mafi kyawun kayan aikin gano nucleic acid don saurin ganewar asali, da kuma samfurori daga hanyoyin numfashi ciki har da ɗaukar jini, wanda ke haɓaka wadatar samfuran daban-daban, kuma yana tallafawa shigar da tabbataccen sakamakon antibody a cikin ka'idojin da aka tabbatar.
Bugu da ƙari, akwai ƙarin tabbaci da ke tunasar da mu mu mai da hankali ga marasa lafiya da ba su da alamun bayyanar cututtuka.
Saboda haka, ya kamata a sabunta jadawalin Zhou et al. domin sun rarraba mutanen da ba su da alamun asibiti a matsayin masu "ƙarancin haɗari".
Tsarin ƙididdigar kuma yana buƙatar tabbatarwa a cikin aiki da nazarin asibiti na gaba.
A ƙarshe, muna fatan ƙarin tabbaci zai bayyana kuma mu nemi masu karatu su yi sharhi.
Don ganewar cutar da kuma tabbatar da cutar, muna ba da shawarar bin kuma bin sabon jagora a cikin ƙasarsu.
Ƙungiyarmu za ta kuma riƙa sabunta jagororinmu a kai a kai don taimaka mana.
Bangladesh ta bayar da rahoton sabbin mutuwar COVID-19 guda biyar, wanda ya kai na kowacce rana
Jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar sakamakon COVID-19 a wannan rana.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Cututtuka da Bincike (IEDCR) ta Bangladesh ta ba da rahoton adadin mutanen da suka kamu da cutar da suka hada da masu aiki 114 da masu warkewa 33 da ke zaune a gida.
An samu mutuwar mutane 17.
A wani rahoto da aka fitar a shafin yanar gizo, daraktan IEDCR, Dr Meerjady Sabrina Flora, ta ce mutuwar ta hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutum biyu sun haura shekara 60, biyu sun haura shekara 51 zuwa 60, kuma mutum ɗaya ya haura shekara 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu daga birnin Dhaka ne.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke kwance a asibitin Kuwait Maitree.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufuri da Tituna Obaidul Quader ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a tun daga ranar 26 ga watan Maris kuma an shirya za ta kare a ranar Asabar, 4 ga watan Afrilu.
Ana ci gaba da ba da izinin jigilar kayayyakin rayuwa - magani, man fetur, da abinci.
An fara samun cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar daya daga cikinsu.
A ranar 19 ga Maris, an warkar da dukan mutanen uku.
Cutar SARS-CoV-2 ta zarce miliyan daya a duniya
A ranar Alhamis, jimillar adadin masu kamuwa da cutar korona SARS-CoV-2 ya zarce miliyan daya a duniya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla 52 000 na mutuwar da aka danganta da COVID-19, cutar da coronavirus ke haifarwa.
Wannan ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko da Zambia ta samu mutuwar ta farko da ta shafi cutar korona.
Koriya ta Arewa ta yi ikirarin, a ranar Alhamis, cewa ita ce daya daga cikin 'yan kasashen da suka kasance ba su da kamuwa da cutar korona.
Har zuwa jiya, Hukumar Lafiya ta Duniya (WHO) ta ba da rahoton 1,051,635 da aka tabbatar da su, ciki har da 79,332 a cikin awanni ashirin da huɗu tun daga karfe 10 na safe (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu fiye da mutane 244,000 da suka kamu da cutar korona, wanda ya yi sanadiyar mutuwar mutane 5,900.
Kamfanin CBS News ya ruwaito, yana ambaton bayanan Jami'ar Johns Hopkins, cewa akwai sama da mutane 1,000 da suka mutu a Amurka sakamakon kamuwa da cutar korona.
A dukan duniya, ƙasashe suna sanar da ƙarin matakai don hana yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin, magajin garin Moscow, ya tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
A kasa baki daya, Shugaba Vladimir Putin ya bayyana cewa, 'yan kasar Rasha za su ci gaba da samun albashi ba tare da sun je aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar Portugal ta yi zabe don tsawaita dokar ta baci na tsawon kwanaki 15; zaben ya wuce da kuri'u 215 a kan wannan, goma suka yi kaura, kuma daya ya ki.
Saudiyya ta tsawaita dokar hana fita daga birnin Makka da Madina har tsawon yini; a baya, dokar ta kasance tsakanin karfe uku na yamma zuwa shida na safe.
Thailand na shirin saka dokar hana fita tsakanin karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
Shaguna a Ostareliya sun rage yawan kayan wanka da za su saya
A ranar Lahadi da kuma Asabar da yamma, manyan kantunan Woolworth da Coles na Australia sun rage iyakar sayen kayan wanka zuwa biyu da kuma kunshin daya a kowane ma'amala a duk shagunan da ke kasar.
ALDI ta kuma kafa iyaka ta fakiti guda, a ranar Litinin.
An sanar da wannan takunkumi a matsayin sako a akwatin kudi da kuma shafin Facebook na kamfanin.
An bayar da rahoton cewa masu siye suna tara kayayyaki saboda tsoron COVID-19 idan jama'a suka yi keɓewa.
A ranar Laraba, Woolworths ta kuma rage sayen kayan wanka don isar da kaya zuwa gida zuwa fakiti ɗaya a kowane oda.
Wannan canjin ya biyo bayan iyakancewar fakiti huɗu a kowace ma'amala da Woolworths da Coles suka yi a ranar 4 da 5 ga Maris.
A cikin sanarwar da ya fitar a ranar 8 ga watan Maris, Coles ya ruwaito cewa tare da sanya takunkumin a kan fakitin guda hudu, "yawancin shagunan har yanzu suna da isasshen kaya a cikin awa daya da isar da su", yana mai kiran bukatar "marasa misali", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira ta "ba zato ba tsammani".
Sayarwa ta "hujja" a makon da ya gabata, a cewar wani mai magana da yawun Woolworths.
Costco a Canberra ma ya takaita adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don kauce wa ƙarancin, Coles ya ba da umarnin ƙarin marufi daga masu samarwa da haɓaka yawan jigilar kayayyaki, Woolworths ya ba da umarnin ƙarin kayan aiki, yayin da ALDI ke ba da kayan aiki don ayyukan musamman na ranar Laraba.
Russell Zimmerman, shugaban hukumar Retailers Association of Australia, ya ce 'yan kasuwa suna kokarin kara yawan kayayyaki, amma takunkumin da hukumomin karamar hukuma suka kafa game da lokacin da za a kai motocin ya sa hakan ya yi wuya.
Ya yi tsammanin farashin samarwa zai karu, yayin da masu samarwa ke kokarin biyan bukatar, da kuma karancin tallace-tallace na musamman.
A ranar Talata, ALDI ta sanar da cewa saboda ta saki kayayyaki da wuri, wasu shagunan ba za su iya gudanar da ranar Laraba ta musamman ba.
A wani rahoto da aka wallafa a shafin News.com.au, Dr. Gary Mortimer, ƙwararren mai sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shaguna suna cika da kayayyaki kowace dare.
Ya nanata cewa, kayan wanki suna da yawa, saboda haka, ba su da yawa kuma idan aka sayar, suna sa sarari a kan ɗakunan ajiya, saboda haka, ana samun ƙarancin kayayyaki.
Coles da Woolworths sun yi imanin cewa idan akwai abubuwa da yawa a kan shelf, idan za a iya sayen kayayyaki kamar su wankin wanka da kuma kayan shayarwa, kuma idan akwai su da yawa, za a iya rage fargaba, in ji Russel Zimmerman a ABC News.
Kamfanin da ke yin kayan wanka mai sake amfani da shi wanda ke ba da abin kunya ya ce a ranar Laraba da ta gabata cewa sun kasa.
Kimberly-Clark, wanda ke yin Kleenex Toilet Tissues, da kuma Solaris Paper, wanda ke yin Sorbent, sun nace suna aiki 24/7 don kiyaye wadata, kamar yadda News.com.au ta ruwaito.
Domain.com, wani shafin sayar da kayayyaki, ya ruwaito cewa wasu masu sayar da kayayyaki sun ba da kayan wanka kyauta ga masu fara yin gwanjo a Melbourne, yayin da aka yi karancin gwanjo saboda masu sayen suna hutu don doguwar hutun ranar Labor Day.
Mujallar ranar Alhamis na NT News, wata jarida da ake bugawa a Darwin, ta ƙunshi shafuffuka takwas na abin sakawa da aka yi niyyar yankewa kuma a yi amfani da su a matsayin kayan wanka.
Shaguna sun yi jinkirin aiwatar da takunkumi, kamar yadda ABC Australia ta ruwaito a ranar 3 ga Maris, suna cewa ba su da shirin aiwatar da takunkumin sayayya.
Russell Zimmerman ya ƙara da cewa wasu kayayyaki ma suna cikin babban bukata, sun haɗa da abin rufe fuska, kayan shafawa, abinci mai bushewa, sabulu, da kuma gari.
Hakazalika a waje da Australia, a ranar Lahadi da yamma, an lura cewa kantin sayar da kayayyaki na Ocado na Birtaniya ya ƙuntata sayen tawul din Andres zuwa fakiti biyu na 12 na takarda.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19 mai gudana - cutar da coronavirus SARS-CoV-2 ke haifarwa - a matsayin annoba.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yadu, ba yadda cutar take da hatsari ba, WHO ta lura da bukatar karfafawa gwamnatoci gwiwa su dauki mataki:
Dukkanin kasashe na iya canza yanayin cutar.
Idan gwamnati ta gano, gwada, magance, ware, da kuma tura mutanenta a mayar da martani, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna cikin damuwa sosai saboda yawan yaduwar cutar da kuma tsananin ta da kuma jinkirin da ake yi.
Wani tsohon darektan Hukumar Kula da Cututtuka da Cututtuka a Amirka, Dr. Tom Frieden ya ce wannan annoba "ba ta taɓa faruwa ba".
Ya ce a cikin wani rahoto da CNN ta wallafa a watan Fabrairu, "ban da mura, babu wata kwayar cuta ta numfashi da aka taɓa lura da ita tun daga lokacin da ta soma ya zuwa lokacin da ta ci gaba da yaɗuwa a dukan duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa "ba mu taɓa ganin annobar da coronavirus ta haifar ba".
Ya ci gaba, "kuma ba mu taɓa ganin wata annoba da za a iya sarrafawa a lokaci ɗaya ba".
Sabon matsayin annobar ya biyo bayan shawarar da WHO ta yanke a watan Janairu wanda ya ayyana annobar a matsayin gaggawa ta kiwon lafiyar jama'a da ke damun duniya.
Daraktan Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
Har zuwa ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ruwaito akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya yi sanadiyar mutuwar mutane sama da 4,600.
Cutar cutar coronavirus ta 2019-2020 ita ce cutar cutar coronavirus ta 2019 (COVID-19) da ke gudana kuma ana haifar da cutar coronavirus mai saurin numfashi mai saurin 2 (SARS-CoV-2).
An gano cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin Matsalar Lafiya ta Duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Har zuwa 10 ga Afrilu 2020, an samu rahoton kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya haifar da mutuwar mutane 97,000.
An warkar da mutane 364,000.
An kiyasta adadin mutuwar cutar ya kai kashi 4 cikin 100 a kasar Sin, yayin da a duniya ya kai 13.04% zuwa 0.08% a New Zealand.
Alamun da ake samu sun haɗa da zazzaɓi, tari, da kuma numfashi.
Ƙari ga haka, ana iya samun ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci daga bayyanar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu riga-kafi ko magani na musamman da aka sani.
Babban maganin shine maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuk
Hukumomi a dukan duniya sun amsa da kafa takunkumin hana mutane zuwa wurare dabam-dabam, da keɓe mutane, da dokar dare, da kuma hana mutane yin aiki a wuraren da ake haɗari.
Cutar ta haifar da mummunan rikice-rikicen zamantakewar tattalin arziki na duniya, jinkiri ko soke ayyukan al'adu, siyasa, addini, wasanni, da kuma yawan karancin kayayyaki da aka kara da sayayya.
An rufe makarantu da jami'o'i a ƙasashe 193 da kuma a yankuna, wanda ya shafi kashi 99.4 cikin ɗari na ɗaliban duniya.
Rashin gaskiya game da cutar ya bazu a yanar gizo kuma akwai wasu abubuwan da ke nuna kyamar kasashen waje da nuna wariya ga mutanen China, mutanen da ke da asalin Asiya ta Gabas ta Tsakiya da kuma bayyanarsu, da kuma mutanen da suka fito daga yankunan da ke da manyan shari'o'in cutar.
Saboda rage tafiye-tafiye da kuma rufe manyan masana'antu, gurɓataccen iska da fitowar iskar carbon sun ragu.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei), sun ba da rahoton cluster na cutar huhu da ba a san dalilin ba a ranar 31 ga Disamba, 2019 kuma an gudanar da bincike a farkon Janairu, 2020.
Yawancin waɗannan lamuran sun danganci Kasuwar Kasuwancin Kayan Kifin Kayan Kifin na Huanan kuma saboda haka ana zargin cewa kwayar cutar ta zoonotic ne.
Kwayar cutar da ke haifar da annobar an kira ta SARS-CoV-2, sabuwar kwayar cutar da aka gano kuma tana da alaƙa da coronavirus bat, coronavirus na tengger, da SARS-CoV. Mutumin farko da ke da alamun da aka sani ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da alamun da aka ambata a baya.
Daga cikin rukunin farko na masu cutar da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance suna da alaƙa da wannan kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya yi hasashen cewa wani shari'ar da za a iya ganowa zuwa 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, mai yiwuwa shine na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, tare da sabbin shari'o'in da aka ruwaito sun ragu a China, amma ba zato ba tsammani sun karu a Italiya, Iran, da Koriya ta Kudu, sabon adadin shari'o'in da ke wajen China ya zarce sabon adadin shari'o'in da ke cikin China a karon farko.
Wataƙila akwai ƙaruwar adadin waɗanda ba a ba da rahoton su ba, musamman ma a tsakanin mutanen da ke da ƙananan alamu.
Har zuwa 26 ga Fabrairu, ƙananan adadin masu kamuwa da cutar sun kasance a cikin matasa, tare da mutanen da shekarunsu ba su kai 19 ba suna da kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan ilimin kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya suna buƙatar kamuwa da cutar kafin a sami rigakafin rukuni.
Lamarin ya shafi adadin mutanen da suka yi gwajin COVID-19 kuma sakamakon gwajin ya tabbatar da tabbatacce bisa ga ka'idojin hukuma.
Har zuwa 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa sun kafa ƙa'idodin hukuma na ƙin gwada mutane da ke da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, an kiyasta cewa kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma cewa wannan kamuwa da cutar da ba a rubuta ba ce ta haifar da kashi 79% na kamuwa da cutar.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi adadin da aka ruwaito.
Kwanan nan, an kiyasta cewa adadin haihuwa na COVID-19 ya kai 1.4 zuwa 2.4.
Wani bincike da aka wallafa da Cibiyar Kula da Cututtuka da Cututtuka ta Amirka ya ce wannan adadi zai iya kaiwa 5.7.
Yawancin mutanen da ke fama da COVID-19 sun warke.
Ga waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da kwanaki 14 a mafi yawan lokuta.
Tun daga 10 ga Afrilu 2020, kusan mutuwar 97,000 an danganta su da COVID-19.
A China, har zuwa 5 ga Fabrairu, kusan kashi 80% na mutuwar sun faru ne a cikin mutanen da suka haura shekaru 60 kuma kashi 75% suna da cututtukan da suka riga sun faru, waɗanda suka haɗa da cututtukan zuciya da ciwon sukari.
Adadin mutuwar COVID-19 na gaske na iya zama mafi girma, saboda ƙididdigar hukuma ba za ta haɗa da mutanen da suka mutu ba tare da an gwada su ba, misali, a gida, a gidan kulawa, da sauransu.
Bayanai na Italiya sun gano cewa adadin mutuwar da aka samu a lokacin annobar ya wuce adadin mutuwar COVID na hukuma da sau 4-5.
Wata mai magana da yawun cibiyar kula da cututtuka ta Amurka ta ce, "Mun san cewa adadin mutuwar da aka sanar ya fi na ainihi", wani bayani da aka tabbatar da shi ta hanyar rahotanni na rashin tabbaci game da karancin lissafi a Amurka.
Mutuwa ta farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ita ce a Faransa a ranar 14 ga watan Fabrairu.
Har zuwa 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da goma sha biyu a Iran, Koriya ta Kudu, da Italiya.
Har zuwa 13 ga watan Maris, sama da kasashe 40 da yankuna sun bayar da rahoton mutuwar, a duk nahiyoyi, sai dai Antarctica.
Wannan adadi ya bambanta ta yanki da kuma tsawon lokaci, kuma yana da tasiri ta yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan kulawa, lokaci tun farkon barkewar cutar, da halayen yawan jama'a kamar shekaru, jinsi, da lafiyar gabaɗaya.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan adadi ya bambanta da yankin.
A China, kimantawar mutuwar mutum zuwa mutum ya ragu daga 17.3% (ga mutanen da ke da alamun cutar 1-10 ga Janairu 2020) zuwa 0.7% (ga mutanen da ke da alamun cutar bayan 1 ga Fabrairu 2020). Sauran matakan sun hada da adadin mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga wata cuta, da kuma adadin mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu (da wadanda ba a gano ba) da suka mutu daga wata cuta.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin wani takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'a.
Wasu masana kimiyya sun yi ƙoƙari su ƙididdige waɗannan adadi a cikin wasu mutane.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta yawan mutuwar kamuwa da cutar a cikin annobar tsakanin kashi 0.1% da 0.39%.
Ƙarshen wannan ƙididdigar ya yi daidai da sakamakon gwajin farko na bazuwar COVID-19 a Jamus da kuma binciken ƙididdiga wanda ya bincika tasirin gwajin akan ƙididdigar CFR.
Hukumar Lafiya ta Duniya ta tabbatar da cewa za a iya shawo kan annobar.
Ba a san lokacin da za a kai wannan annoba ba kuma za ta iya bambanta da wuri.
Maciej Boni na Penn State University ya lura: "Idan ba a sarrafa shi ba, annoba tana yawan tashi kuma ta soma raguwa sa'ad da ta rasa mai masaukin da take da shi.
Amma, a yanzu ba shi da sauƙi a yi hasashen lokacin da hakan zai faru".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya yi imanin cewa "za a iya kawo karshen annobar a watan Yuni" idan za a iya yin amfani da kasar baki daya wajen bin shawarar WHO kan matakan da za a dauka don dakatar da yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski na London School of Hygiene & Tropical Medicine ya bayyana cewa SRS-CoV-2 "zai ci gaba da yaduwa, mai yiwuwa har zuwa shekara ɗaya ko biyu".
Wani bincike da aka yi a Imperial College da Neil Ferguson ya yi, ya ce za a bukaci a yi takunkumi da wasu matakan "har sai an samu rigakafin (watakila na tsawon watanni 18 ko fiye da haka)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin cewa ba shi da wata dama cewa wannan kwayar cutar, saboda tana da saurin yaduwa, za ta iya ɓacewa gaba ɗaya" kuma cutar "na iya zama wata cuta ta yanayi, tana dawowa kowace shekara".
Rashin cutarwa na maimaitawa zai dogara ne akan garkuwar garkuwar da kuma yawan canjin.
Alamun COVID-19 na iya zama marasa takamaiman kuma wanda ya kamu da cutar na iya zama ba shi da alamun.
Alamun biyu da suka fi kowa su ne zazzabi (88%) da kuma tari mai bushe (68%).
Alamun da ba sa yawan faruwa sun hada da gajiya, samar da kumburin numfashi (phlegma), rashin iya jin ƙanshi, ƙarancin numfashi, ciwon haɗin gwiwa da tsoka, ciwon makogwaro, ciwon kai, jin ƙai, amai, haemoptisis, diarrhea, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ta lissafa alamun gaggawa da suka hada da wahalar numfashi, danko ko ciwon kirji, rikicewar kwatsam, wahalar tafiya, da kuma bluishness a fuska da lebe; ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun sun bayyana.
Wasu mutane da suka kamu da cutar na iya zama marasa asibiti, wato ba su da alamun asibiti, amma suna da sakamakon gwajin da ya tabbatar da kamuwa da cutar, saboda haka, masu bincike sun ba da shawarar cewa waɗanda ke da kusanci da wanda aka tabbatar da kamuwa da cutar su kula sosai kuma a gwada su don tabbatar da cewa ba su kamu ba.
Sinanci sun kiyasta cewa asymptomatic ratio ya kai kashi 44 cikin dari.
Lokacin da cutar ta kamu da cutar (lokacin tsakanin kamuwa da cutar da kuma bayyanar cututtuka) yawanci yana tsakanin kwanaki 1 zuwa 14, mafi yawan lokuta kwanaki 5.
Ana ci gaba da bincika yadda cutar take yaɗuwa.
An yi imanin cewa COVID-19 ya yadu ne musamman ta hanyar kusanci da kuma ta ƙananan ɗigon ruwa da aka samar yayin tari, hancin, ko magana; kusanci shine lamba tsakanin mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya gano cewa tari da ba a rufe ba zai iya haifar da saukad da ruwa mai tsawon mita 4.5 (mita 15) zuwa mita 8.2 (mita 27).
Wasu masu bincike sun yi hasashen cewa za a iya yada kwayar cutar ta hanyar kananan ruwa-ruwa da ke rayuwa a cikin iska kuma ana samar da su yayin magana. Hakanan ana iya samar da ruwa-ruwa na numfashi yayin numfashi, gami da lokacin magana, kodayake ba a yada kwayar cutar ta iska ba.
Za a iya saukowa cikin hanci ko bakin wani da ke kusa ko kuma a sha shi a cikin huhu.
Wasu hanyoyin kiwon lafiya, kamar su yin amfani da intubation da kuma yin amfani da na'urar motsa zuciya (RJP), suna iya sa abubuwa da ke cikin numfashi su zama aerosol kuma su yaɗu ta iska.
Ana iya samun cutar ta wurin taɓa abubuwa masu gurɓataccen abu, har da fata, da idanu, hanci, da baki.
Duk da cewa akwai damuwa cewa kwayar cutar za ta iya yaduwa ta hanyar kwance, an yi imanin cewa wannan hadarin yana da ƙarancin gaske.
Gwamnatin kasar Sin ta yi watsi da yiwuwar watsa SARS-CoV-2 ta hanyar magungunan jini. Kwayar cutar tana yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun gwada tabbatacce har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya samun yaduwar cutar kafin bayyanar cututtuka.
Rahotanni kaɗan ne kawai na asymptomatic waɗanda aka tabbatar da su a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano asymptomatic watsawa yayin binciken tuntuɓar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu ko uku, kuma zai iya rayuwa a kan ruwa na tsawon sa'o'i da kwanaki.
Musamman, an gano cewa za a iya gano kwayar cutar har tsawon kwanaki uku a kan filastik (polypropylene) da bakin karfe 304, rana ɗaya a kan kwali, kuma sama da awanni huɗu a kan tagulla.
Duk da haka, wannan ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu tabbacin cewa dabbobi na iya yada cutar zuwa ga mutane, duk da cewa hukumomin Burtaniya sun ba da shawarar wanke hannu bayan hulɗa da dabbobi, kamar bayan hulɗa da wuraren da mai yiwuwa mutum ya taɓa.
Kwayar cutar coronavirus mai saurin numfashi 2 (SARS-CoV-2) sabuwar kwayar cuta ce, da aka fara warewa daga mutane uku da ke fama da cutar huhu da ke da nasaba da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 suna da alaƙa da coronavirus a cikin yanayi. A waje da jikin mutum, za a iya lalata kwayar cutar idan ta fuskanci sabulu na gida, wanda ke narkar da murfin kariya. SARS-CoV-2 yana da dangantaka ta kusa da SARS-CoV na farko.
An yi imanin cewa kwayar cutar ta zoonotic ne.
Binciken kwayoyin halitta ya nuna cewa coronavirus din ya kasance cikin kwayar cutar Betacoronavirus, a cikin wani nau'in Sarbecovirus (B lineage) tare da wasu nau'ikan bat.
Wannan kwayar cutar tana da kamannin kashi 96% a matakin dukkanin kwayoyin halitta da wasu kwayoyin cutar bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a wasu sassan tsarin kwayoyin halittar da ke tsakanin kwayar cutar tenggiling da kwayar cutar mutum.
Ya zuwa yanzu, kwatancen dukkanin kwayoyin halitta sun gano kusan kashi 92% na kamanceceniya tsakanin kwayar cutar tengle-ring da SARS-CoV-2, bai isa ya tabbatar da cewa tengle-ring shine mai watsa shiri na SARS-CoV-2 ba.
Ana iya gane kamuwa da kwayar cutar ta hanyar bayyanar cututtuka, amma a ƙarshe an tabbatar da shi ta hanyar maganin polymerase chain reaction (rRT-PCR) a cikin ɓoye mai kamuwa da cuta ko kuma ta hanyar CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR saukin ji, amma ba shi da takamaiman bayani, tare da yawan fasalin da ake gani da ke shafar ciwon huhu da sauran cututtukan da ke faruwa.
A watan Maris na shekarar 2020, Kwalejin Kula da Maganin Radiology ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT don tantancewa ko kuma a matsayin gwajin farko na gano COVID-19".
WHO ta wallafa wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda aka fara rarrabawa a ranar 17 ga Janairu.
Gwajin yana amfani da halayen sarkar polymerase mai jujjuyawar lokaci na ainihi (rRT-PCR).
Ana iya yin gwajin a kan numfashi ko jini.
Sakamakon yana zuwa cikin sa'o'i da yawa zuwa kwanaki da yawa.
A cikin al'ada, ana yin wannan gwajin ne a kan hanci da hanci, amma ana iya amfani da hanci da hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin serological wanda ke gano antibodies.
Ya zuwa 6 ga Afrilu 2020, babu wani daga cikin waɗannan gwajin da ya tabbatar da cewa ya isa ya amince da amfani da shi a ko'ina.
A Amurka, an amince da gwajin da Cellex ya samar don amfani na gaggawa, kawai ta hanyar kwararrun dakunan gwaje-gwaje.
Abubuwan da ke nuna hoton radiography da kuma CT a cikin mutanen da ke da alamun sun hada da rashin daidaituwa na gilashin ƙasa da kuma rashin fitowar pleural.
Ƙungiyar Radiology ta Italiya tana tattara bayanai a kan layi na duniya don gano hotuna na waɗanda suka kamu da cutar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, yin hoto ba tare da tabbatar da PCR ba yana da iyakantaccen takamaiman bayani game da gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa duk da cewa ba su da takamaiman kamuwa da cuta, hotuna sun fi sauri kuma sun fi saukin ganewa wanda ya sa aka ba da shawarar yin la'akari da su a matsayin kayan aikin tacewa a yankunan da ake annobar.
An kirkiro cibiyar sadarwa ta kwakwalwa mai amfani da hankali don gano fasalin hoto na kwayar cuta ta hanyar radiography da CT.
Dabaru don hana yaduwar cutar sun haɗa da kiyaye tsabtace jiki sosai, wanke hannu, guje wa taɓa idanu, hanci, ko baki kafin wanke hannu, da kuma sanya tawul lokacin da kake tari ko sneeze da kuma jefa tawul kai tsaye a cikin shara.
An shawarci mutanen da suka riga sun kamu da cutar su sanya abin rufe fuska a wuraren da jama'a suke.
An kuma bada shawarar matakan kariya ta jiki don hana yaduwar cutar. Gwamnatoci a yankuna daban-daban sun takaita ko kuma sun bukaci a dakatar da duk tafiye-tafiye marasa mahimmanci zuwa da kuma daga ƙasashe da yankunan da cutar ta shafa.
Amma, cutar ta kai ga yaduwar al'umma a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar ta bazu a cikin al'umma, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da mutanen da za su iya kamuwa da cutar su yi amfani da matakan kariya na yau da kullun, matakan hana tuntuɓar, da kariya ta ido. Binciken tuntuɓar muhimmin mataki ne ga hukumomin kiwon lafiya don tantance tushen kamuwa da cuta da hana ƙarin yaduwa.
Amfani da bayanan wurin wayar salula ta gwamnati don wannan dalili ya haifar da matsalar sirri, tare da fitowar sanarwa daga Amnesty International da kuma kungiyoyi sama da 100 da ke kira ga hana irin wannan sa ido.
An aiwatar da aikace-aikacen hannu daban-daban ko kuma an ba da shawarar yin amfani da su da son rai, kuma a ranar 7 ga Afrilu 2020, sama da gungun masana goma sha biyu suna aiki kan mafita mai aminci, kamar amfani da Bluetooth don yin rikodin kusanci mai amfani da wasu wayoyi.
Bugu da ƙari, masu amfani za su karɓi saƙo idan sun kasance kusa da wani wanda ya gwada tabbatacce ga COVID-19. Rashin fahimta game da yadda za a hana kamuwa da cuta; misali, wanke hanci da yin hanci da maganin hanci ba su da tasiri.
Babu riga-kafin COVID-19, duk da cewa kungiyoyi da dama na aiki wajen samar da shi.
Ana ba da shawarar a wanke hannu don hana yaduwar cuta.
CDC ta ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa na aƙalla sakan ashirin, musamman bayan sun fita bayan gida ko kuma idan hannayensu suna da datti; kafin su ci abinci; da kuma bayan sun yi hanci, sun yi tari, ko kuma sun yi tari.
Wannan ya faru ne domin, a wajen jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida wanda ke lalata garkuwar ta.
Bugu da ƙari, CDC ta ba da shawarar yin amfani da maganin tsabtace hannu na barasa wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa ta hanyar girma lokacin da sabulu da ruwa ba su samuwa.
Hukumar ta WHO ta ba da shawarar kada a taɓa idanu, hanci, ko baki kafin a wanke hannu.
Za'a iya lalata farfajiyar ta amfani da wasu magunguna (a cikin minti daya na maganin kashe kwayoyin cuta ga farfajiyar bakin karfe), gami da ethanol 6271%, isopropanol 50100%, sodium hypochlorite 0.1%, hydrogen peroxide 0.5%, da povidone-iodine 0.27.5%.
Wasu magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan akwai wasu lokuta da aka yi tsammanin ko kuma an tabbatar da cutar COVID a wuraren da jama'a ke amfani da su, kamar ofisoshin ko wuraren kula da yara, ya kamata a tsabtace dukkan wuraren kamar ofisoshin, dakunan wanka, wuraren da jama'a ke amfani da su, da kayan aikin lantarki da ake amfani da su kamar su kwamfutar hannu, allon taɓawa, keyboard, na'urar sarrafawa ta nesa, da na'urar ATM da mai cutar ke amfani da ita.
Ƙungiyar Kiwon Lafiya ta ba da shawarar cewa mutane su rufe bakinsu da hancinsu da wuyan hannu ko kuma su yi amfani da tawul sa'ad da suke yin tari ko kuma hancin, kuma su zubar da tawul ɗin nan da nan.
Ana ba da shawarar sanya abin rufe fuska ga mutanen da za su iya kamuwa da cutar saboda sanya abin rufe fuska na iya rage girman da nisan ruwan da ke fitowa daga numfashi yayin magana, hancin da kuma tari.
Hukumar lafiya ta duniya ta fitar da umarni kan lokacin da kuma yadda ake sanya abin rufe fuska.
Stephen Griffin, wani masanin ilimin cututtuka a Jami'ar Leeds ya ce: "Samun abin rufe fuska zai iya rage sha'awar mutane su taɓa fuska da hannaye marasa tsabta, wanda shi ne tushen watsa cutar".
WHO ta ba da shawarar yin amfani da abin rufe fuska ta hanyar mutanen da ke da lafiya kawai idan suna da babban haɗari, kamar waɗanda ke kula da waɗanda ke fama da COVID-19, kodayake WHO ta kuma yarda cewa sanya abin rufe fuska na iya taimakawa hana mutane taɓawa fuskokinsu.
Wasu kasashe sun fara karfafawa jama'a yin amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'anta wanda ba na likita ba. China ta ba da shawarar musamman yin amfani da abin rufe fuska na likita mai amfani da shi ga mutanen da ke da lafiya, musamman ma lokacin da suke kusa da (1 mita (3 feet) ko ƙasa da haka) tare da wasu.
Hong Kong ta ba da shawarar sanya abin rufe fuska na tiyata yayin amfani da sufuri na jama'a ko kuma zama a wuraren da mutane suke da yawa.
Hukumomin kiwon lafiya na Thailand sun aririci mutane su yi takunkumin sutura a gida kuma su wanke shi kowace rana.
Jamhuriyar Czech da Slovakia sun hana jama'a fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga watan Maris, Vietnam ta bukaci dukkan 'yan kasarta da su sanya abin rufe fuska a lokacin da suke fita a fili don kare kansu da sauran mutane.
Gwamnatin Austria ta bukaci duk wanda ya shiga cikin gidan wuta ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasarta da su sanya abin rufe fuska a wuraren jama'a.
Taiwan, wadda ke samar da abin rufe fuska miliyan goma a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da na bas da ke tsakanin birane su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta bukaci a sanya abin rufe fuska a duk lokacin da mutum ya fita waje, kuma ta bada shawarar yin abin rufe fuska na gida ga wadanda ba su iya sayan abin rufe fuska ba.
Ana amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Iyakancewar zamantakewa (wanda ake kira kuma iyakancewar jiki) wani nau'in hana kamuwa da cuta ne wanda ake nufi da rage yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin hana mutane shiga cikin jama'a sun haɗa da keɓewa; hana mutane yin tafiye-tafiye; da kuma rufe makarantu, wuraren aiki, filayen wasa, gidajen kallo, ko kuma wuraren kasuwanci.
Mutane za su iya yin amfani da hanyoyin hana mutane yin abubuwa ta hanyar zama a gida, rage tafiye-tafiye, guje wa wuraren da mutane suke da yawa, yin magana ba tare da tuntuɓar mutane ba, da kuma nisantar mutane.
A yau, gwamnatoci da yawa suna tilasta ko kuma kira ga takunkumin zamantakewa a yankunan da cutar ta shafa.
An rage yawan mutane da aka ba da shawarar ta hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya, daga mutane 250 (idan ba a san akwai yaduwar COVID-19 a yankin ba) zuwa 50, sannan zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana tarurruka a wuraren jama'a da suka shafi sama da mutane biyu. Dattijai da mutanen da ke da yanayin rashin lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin rigakafin da ke da haɗarin kamuwa da cuta mai tsanani da rikitarwa sun ba da shawarar CDC su kasance a gida kamar yadda zai yiwu a yankunan da ke fama da cutar a matakin jama'a. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara canza kalmar "tsabtace zamantakewar" zuwa "tsabtace jiki", don bayyana cewa manufar ita ce rage haɗuwa ta jiki ta hanyar kiyaye alaƙar zamantakewa, ko dai a zahiri ko ta nesa.
Amfani da kalmar "iyakancewar zamantakewa" yana ba da ra'ayin cewa mutane su ware kansu gaba ɗaya daga zamantakewa kuma kada su ƙarfafa mutane su ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar.
Wannan shawarar ta haɗa da ƙarfafawa a yi jima'i da wanda kuke zama tare da shi kuma ba shi da kwayar cutar ko kuma alamun cutar.
An bada shawarar ware kai a gida ga mutanen da aka gano suna da cutar COVID-19 da kuma waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun fitar da cikakkun bayanai game da keɓe kai daidai. Gwamnatoci da yawa sun ba da umurni ko kuma sun ba da shawarar keɓe kai ga dukan mutanen da ke zaune a yankunan da cutar ta shafa.
An ba da umarnin da ya fi tsauri na keɓe kai ga mutanen da ke cikin rukunin da ke da haɗari.
Mutanen da ke da yiwuwar kamuwa da COVID-19 da kuma waɗanda suka yi tafiya kwanan nan zuwa ƙasashe ko yankuna da ke da yaduwar COVID-19 an shawarce su da su keɓe kansu na tsawon kwanaki 14 tun lokacin da aka yi musu yiwuwar kamuwa da cutar.
Dabaru a cikin sarrafa annoba sune hanawa ko kawarwa, da kuma ragewa.
Ana gudanar da rigakafin a farkon barkewar cutar kuma ana nufin ganowa da kebe mutanen da suka kamu da cutar da kuma aiwatar da wasu matakai don sarrafa kamuwa da cuta da kuma allurar rigakafi da nufin dakatar da yaduwar cutar a cikin yawan jama'a.
Lokacin da ba zai yiwu a daina hana yaduwar cutar ba, ƙoƙari na gaba ya koma matakin ragewa: ana ɗaukar waɗannan matakan don rage yaduwar cutar da rage tasirinsa ga tsarin kiwon lafiya da al'umma.
Za a iya yin hada-hadar hanawa da ragewa a lokaci guda.
Rushewa na buƙatar ƙarin matakan matsananci don juya annobar ta hanyar rage ƙimar haihuwa zuwa ƙasa da 1. Wani ɓangare na gudanar da annobar cutar cuta shine ƙoƙarin rage ƙaruwar annobar, wanda aka sani da rage ƙirar annobar.
Wannan yana rage haɗarin samun matsala a kulawar lafiya kuma yana ba da ƙarin lokaci don haɓaka allurar rigakafi da magani.
Sauran matakan da aka dauka don dakile annobar sun hada da matakan kariya na mutum, kamar tsaftace hannu, sanya abin rufe fuska, da kuma keɓe kai; matakan matakin al'umma da aka tsara don takunkumin jiki, kamar rufe makarantu da soke taron taro; shigar da jama'a don karfafa karbuwa da shiga cikin irin wannan tsoma baki; da kuma matakan matakin muhalli, kamar tsabtace farfajiyar. Sauran matakai masu mahimmanci da aka yi niyyar hana annobar sun faru a China yayin da cutar ta zama mai tsanani, kamar su keɓewar gari gaba ɗaya da sanya takunkumin tafiye-tafiye.
Sauran ƙasashe ma sun ɗauki matakai da suka shafi hana yaduwar cutar.
Koriya ta Kudu ta gabatar da tsaftace-tsaftace da kuma keɓewar gida, tare da bayar da gargadi game da motsin mutane masu kamuwa da cutar.
Singapore tana ba da tallafi na kuɗi ga waɗanda ke kamuwa da cutar da ke keɓe kansu kuma tana ba da babbar tarar ga waɗanda suka kasa yin hakan.
Taiwan ta kara samar da takunkumin rufe fuska kuma ta hukunta tarin kayan kiwon lafiya. Simulations ga Burtaniya da Amurka sun nuna cewa ragewa (ragewa, amma ba dakatar da yaduwar annobar) da kuma kawarwa (juya ci gaban annobar) suna da manyan kalubale.
Manufofin rage yawan cutar za su iya rage yawan bukatar kiwon lafiya da kashi biyu cikin uku da mutuwar mutane da rabi, amma har ila yau, zai iya kai ga dubban dubban mutuwar mutane da kuma matsalar kula da lafiyar jama'a.
Ana iya zaɓin kawar da cutar, amma ana buƙatar kiyaye ta muddin cutar tana yawo a cikin yawan mutane (ko kuma har sai an sami allurar rigakafi, idan an fara cimma wannan), saboda in ba haka ba, yaduwar cutar za ta sake tashi da sauri yayin da aka sassauta matakan kawar da cutar.
Maganganun na dogon lokaci don shawo kan annobar na da tasiri a zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafi da aka amince da shi don COVID-19, amma ana ci gaba da kokarin ci gaba, wanda ya hada da gwajin magungunan da ake da su.
Shan magani na hana kamuwa da mura, shan ruwa mai yawa, da kuma hutu na iya taimaka wajen rage alamun.
Dangane da tsananin cutar, za a iya bukatar maganin oxygen, ruwan da ake sakawa cikin jijiya, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya sa yanayin marasa lafiya ya yi muni.
Wasu abubuwa da aka amince da su a baya don maganin wasu cututtukan kwayar cuta ana binciken su don amfani da su wajen maganin COVID-19.
WHO ta kuma bayyana cewa wasu "magungunan gargajiya da na gida" na iya rage alamun cutar SARS-CoV-19.
WHO ta ce inganta iya aiki da daidaita ayyukan kiwon lafiya ga bukatun marasa lafiyar COVID-19 mataki ne na farko a mayar da martani ga annobar.
ECDC da ofishin WHO na Yammacin Turai sun ba da jagororin ga asibitoci da ayyukan kiwon lafiya na farko don sauya albarkatu a matakai daban-daban, gami da mayar da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, idan ya yiwu soke hanyoyin zaɓin, warewa da keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa mai ƙarfi ta hanyar horar da ma'aikata da haɓaka adadin masu motsa jiki da gadaje.
Akwai ra'ayoyi da yawa game da asalin farkon yanayin (wanda ake kira marasa lafiya).
An gano farkon sanannen sabon cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
An lura da tarin cutar huhu da ba a san dalilin da ya sa ba a ranar 26 ga watan Disamba kuma likita Zhang Jixian a asibitin lardin Hubei ne ya kula da shi, wanda ya sanar da CDC na Wuhan Jianghan a ranar 27 ga watan Disamba.
A ranar 30 ga watan Disamba, wasu likitoci a asibitin Wuhan Central Hospital sun sanar da takwarorinsu game da "kwayar cutar korona mai kama da SARS".
Likitoci takwas, ciki har da Li Wenliang, 'yan sanda sun yi musu kashedi don yaɗa jita-jita, kuma wani, Ai Fen, shugabanninsa sun tsawata masa saboda gargaɗin da ya yi.
Hukumar Lafiya ta Wuhan ta ba da sanarwar ga jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An kai rahoto kan wasu cututtuka na cutar huhu da ba a san su ba ga hukumomin lafiya a Wuhan, wanda ya sa aka fara bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa sauran lardunan kasar Sin, wanda aka karfafa shi ta hanyar ƙaura a lokacin Sabuwar Shekarar Lunar kuma saboda Wuhan babbar cibiyar sufuri ce da kuma hanyar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana, ciki har da mutane biyu a Beijing da mutum daya a Shenzhen.
Bayanai na hukuma sun nuna cewa mutane 6,174 ne suka kamu da cutar a ranar 20 ga Janairu, 2020.A ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin kasashe da suka fi kowacce a duniya da ke da adadin wadanda suka kamu da cutar.
Kimanin kasashe 200 da yankuna suna da akalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun takaita motsi da kuma sanya iko a kan iyakoki.
Amsar kasa ta hada da matakan kariya, kamar su keɓewa (wanda aka fi sani da dokar zama a gida, dokar shiga gida, ko keɓewar yanki) da kuma dokar dare. A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kuma kusan kashi 90% na yawan jama'a, suna cikin wani nau'in keɓewar yanki a Amurka, sama da mutane miliyan 50 ke keɓewa a Philippines, kimanin mutane miliyan 59 ke keɓewa a Afirka ta Kudu, da mutane biliyan 1.3 ke keɓewa a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin wani irin keɓewar yanki, wanda ya ƙaru zuwa biliyan 2.6 bayan kwana biyu, wanda kusan kashi ɗaya bisa uku na yawan mutanen duniya ne.
Ana iya gano farkon tabbatar da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; rahoto guda da ba a tabbatar da shi ba ya nuna farkon shari'ar a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da tarin cututtukan huhu da ba a san dalilin su ba a ranar 26 ga watan Disamba; asibitin ya sanar da CDC na Jianghan wannan binciken a ranar 27 ga watan Disamba.
Gwajin farko na kwayoyin halittar da aka yi wa samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai kwayar cutar SARS.
An sanar da sanarwar ga jama'a ne daga Hukumar Lafiya ta Wuhan a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
Lokacin da aka yi wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan saboda "yaɗa jita-jita" game da annobar.
Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin da farko ta yi ikirarin cewa babu "bayyanannen shaida" na kamuwa da cutar daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na kawo karshen cutar da babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yaƙin jama'a" domin dakile yaduwar cutar.
A cikin abin da aka kira "mafi girma a tarihin bil'adama", an sanar da dokar hana fita a ranar 23 ga watan Janairu don dakatar da zirga-zirgar shiga da fita daga Wuhan, kuma an fadada zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekara ta Lunar (Janairu 25) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti bayan haka, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
A ranar 26 ga watan Janairu, gwamnatin ta tsara wasu matakai don shawo kan barkewar COVID-19, gami da bayar da sanarwar kiwon lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a cikin ƙasar.
Yankin Hong Kong da Macau sun ɗauki wasu matakai, musamman a batun makarantu da jami'o'i.
An fara aiwatar da matakan yin aiki daga nesa a wasu yankuna na kasar Sin.
An kafa takunkumin hana zirga-zirga a ciki da wajen Hubei.
An gyara hanyoyin sufuri na jama'a kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin na ɗan lokaci.
An yi amfani da takunkumi kan motsin jama'a a birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu nau'ikan takunkumi a waje. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana "shigo da" cutar daga wasu ƙasashe.
Misali, Beijing ta sanya wa dukkan masu yawon bude ido na kasa da kasa da ke shiga birnin dokar killacewa na kwanaki 14. A ranar 23 ga watan Maris, an samu kwayar cutar kasar Sin guda daya a cikin gida kwanaki biyar da suka gabata, a wannan yanayin ta hanyar wani dan yawon bude ido da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan China Li Keqiang ya ba da rahoton cewa an toshe yaduwar cututtukan da aka watsa a cikin gida kuma an sarrafa annobar a China.
A wannan rana an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan da aka fara keɓewar yankin. Ma'aikatar Harkokin Wajen Jamhuriyar Jama'ar Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar masu riƙe da biza ko izinin zama daga ranar 28 ga Maris zuwa gaba, ba tare da wani takamaiman bayani game da lokacin da wannan manufar za ta ƙare ba.
Dole ne mutanen da suke son shiga kasar Sin su nemi biza a ofishin jakadancin kasar Sin ko kuma ofishin jakadancin kasar.
A ranar 30 ga Maris, gwamnatin kasar Sin ta karfafa wa 'yan kasuwa da masana'antu gwiwa su sake budewa tare da samar da kudaden karfafa gwiwa ga kamfanoni.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa COVID-19 ya bazu zuwa Koriya ta Kudu daga China.
A ranar 20 ga Fabrairu, hukumar kiwon lafiya ta kasar ta bayar da rahoton karuwar adadin wadanda suka kamu da cutar, wanda yawanci ya samo asali ne daga taron wani sabon addini a Daegu, wanda aka sani da Shincheonji Church of Jesus.
Masu bin Shincheonji da suka ziyarci Daegu daga Wuhan ne ake zargin sun haddasa annobar.
A ranar 22 ga watan Fabrairu, daga cikin masu bin coci 9,336, 1,261 ko kuma kusan kashi 13 cikin 100 sun nuna alamun cutar.
A ranar 28 ga Fabrairu, an samu fiye da mutane 2,000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka yi ya tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma yi wa jadawalin jiragen sama wasu canje-canje. Koriya ta Kudu ta gabatar da abin da ake ganin shi ne mafi girma kuma mafi kyawun shirin da aka tsara a duniya don tace kwayar cutar a cikin jama'a, keɓe duk wanda ke da cutar, da kuma bin diddigin waɗanda suka yi hulɗa da su da kuma keɓe su.
Hanyoyin tacewa sun hada da wajibi na bayar da rahoton alamun kai tsaye ta hanyar sabbin masu zuwa daga kasashen waje ta hanyar manhajar wayar salula, gwajin kwayar cutar ta gari ko ta hanyar tuki tare da sakamakon da ake samu a rana mai zuwa, da kuma kara karfin gwajin zuwa sama da mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu na samun nasara wajen shawo kan annobar duk da cewa ba a killace dukan biranen ba. Da farko dai, ra'ayoyin jama'ar Koriya ta Kudu sun rabu game da yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takarda neman a tsige Shugaba Moon saboda ikirarin da suka yi cewa gwamnati ta yi kuskure wajen magance annobar, ko kuma a madadin haka, sun yaba da yadda shugaban ya amsa.
A ranar 23 ga Maris, Koriya ta Kudu ta bayar da rahoton cewa tana da mafi ƙarancin adadin masu kamuwa da cutar a cikin kwana ɗaya cikin makonni huɗu.
A ranar 29 ga Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu, za a keɓe duk waɗanda suka shigo daga ƙasashen waje na tsawon makonni biyu.
A cewar rahotanni na kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi buƙatun taimako na gwajin kwayar cutar daga ƙasashe 121.
Iran ta bayar da rahoton farkon tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom kuma, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu sun mutu a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da sauran al'adu, wasanni, da sallar Juma'a, da kuma rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware tiriliyan biyar na real don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, kawai za a killace mutane.
An sanar da shirin rage zirga-zirgar birane a watan Maris, duk da cewa ana ci gaba da samun cunkoson zirga-zirga a cikin birane a lokacin Sabuwar Shekarar Farisa.
Wurin ibada na Shi'a a Qom ya kasance a bude ga masu aikin hajji har zuwa 16 ga Maris, 2020. Bayan China, Iran ta zama cibiyar yaduwar cutar a watan Fabrairu.
A yayin da ake ikirarin cewa an rufe adadin cutar a Iran, sama da kasashe goma sun koma Iran a ranar 28 ga watan Fabrairu, wanda ke nuna cewa adadin cutar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, inda aka ce 23 daga cikin mambobinta 290 sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin gidan yarin na Iran da su saki masu kare hakkin dan adam da aka tsare saboda zanga-zangar lumana ba tare da wani sharadi ba, kuma, na ɗan lokaci, su saki duk fursunonin da suka cancanta.
An ce akwai babban hadarin yaduwa a cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, waɗanda kuma ba su da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana daya, wanda shi ne mafi girma a kasar tun farkon annobar.
Har zuwa ranar 17 ga watan Maris, a kalla 'yan siyasa 12 ko jami'an gwamnati na Iran da suka gabata ko na yanzu sun mutu sakamakon cutar.
Har zuwa ranar 23 ga watan Maris, Iran na fuskantar sabbin mutane 50 a kowace awa daya da kuma mutuwar mutum daya a kowane minti goma saboda cutar coronavirus.
Wani jami'in WHO ya ce akwai yiwuwar cewa akwai masu kamuwa da cutar sau biyar a Iran fiye da yadda aka ruwaito.
An kuma ce takunkumin Amurka kan Iran na iya shafar ikon kasar wajen magance cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta shafa, ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da barkewar cutar a Italiya lokacin da matafiya biyu 'yan kasar Sin suka gwada tabbatacciyar cutar SARS-CoV-2 a Rome.
Lamarin ya karu sosai har ya sa gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa da kuma daga China tare da bayyana dokar ta baci.
Daga baya, an gano tarin cututtukan COVID-19 da ba su da alaƙa, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sanarwar sabuwar doka don hana barkewar cutar, wanda ya haɗa da keɓewa sama da mutane 50,000 daga birane daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce: "A yankunan da ake da annobar, ba a yarda mutane su fita su shiga.
An ba da umarnin dakatar da ayyukan aiki da wasanni a yankin. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai mutuwar mutum 100.
Duk manyan wasannin motsa jiki, ciki har da wasannin kwallon kafa na Serie A, za a gudanar da su a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin gaba daya na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Anesthesia, Analgesia, Resuscitation, da Intensive Care na Italiya (SIAARTI) ta buga shawarwarin ɗabi'a na likita game da hanyoyin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta mamaye matsayin China a matsayin kasa da ke da yawan mutuwar coronavirus a duniya bayan ta bayar da rahoton mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, Rasha ta ce ta tura jiragen yaki guda tara dauke da kayan aikin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da su, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, tare da mafi yawan wadanda suka kamu da cutar a yankin Lombardy.
Wani rahoto na CNN ya ce abin da ya kawo yawan mutuwar mutane shi ne yawan tsofaffin mutanen Italiya da kuma rashin iya gwada kowa da ke da cutar.
Da farko, amsar Burtaniya ga cutar ta kasance ɗaya daga cikin mafi rauni a cikin ƙasashe da abin ya shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane irin takunkumin zamantakewa ko keɓewar jama'a ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin amsawa da rashin kulawa wajen magance damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwa da ke kira ga dakatar da duk tafiye-tafiye da hulɗar zamantakewar da ba ta da mahimmanci kuma ya ba da shawarar mutane suyi aiki daga gida, idan ya yiwu, da kuma guje wa wurare kamar mashaya, gidajen cin abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa, kamar su mashaya da cibiyoyin motsa jiki, dole ne a rufe su da wuri-wuri, kuma ta yi alƙawarin biyan kashi 80% na albashi ga ma'aikata har zuwa iyakar £2,500 a wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan hana zamantakewar jama'a, wanda ya hana tarurrukan mutane sama da biyu da kuma iyakance tafiye-tafiye da ayyukan waje kawai ga ayyukan da ake ganin suna da mahimmanci.
Ba kamar matakan da suka gabata ba, 'yan sanda ne ke tilasta wannan takunkumi ta hanyar biyan tarar da kuma rushe taron.
An umurci yawancin kasuwancin su rufe, sai dai waɗanda aka ɗauka "mahimmanci", waɗanda suka haɗa da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma wuraren aiki.
A ranar 20 ga watan Janairu, an gano mutum na farko da aka tabbatar da cutar COVID-19 a jihar Washington da ke arewa maso yammacin kasar, a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu, an kafa rukunin aikin yaki da cutar korona na fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya kuma ta sanya takunkumin shiga ga mutanen da suka zo daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar hukumar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa sun kirkiro nasu na'urar gwaji.
Duk da haka, Amurka ta jinkirta fara gwajin don haka ta ɓoye ainihin yanayin cutar a lokacin.
Gwajin ya kasance cikin rikici saboda kayan aikin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan aikin da ba na gwamnati ba (ta hanyar masana kimiyya, kamfanoni, da asibitoci) har zuwa karshen watan Fabrairu, da kuma takunkumin da aka sanya wa mutanen da suka cancanci yin gwaji har zuwa farkon watan Maris (ana buƙatar umarnin likita bayan haka).
Har zuwa ranar 27 ga Fabrairu, jaridar The Washington Post ta ba da rahoton cewa an yi gwaje-gwaje kasa da 4,000 a Amirka.
Har zuwa 13 ga Maris, The Atlantic ta ba da rahoton cewa an yi gwaji kasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ba da rahoto: "Mutane da yawa da suke da alamun cutar suna jira na sa'o'i ko kwanaki don a gwada su". Bayan an ba da rahoton mutuwar farko a ƙasar Amirka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya kafa dokar ta baci, kuma wasu jihohi suka bi wannan dokar.
Makarantu a yankin Seattle sun soke karatu a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, an sanar da Amurka game da hasashen tasirin sabon coronavirus a cikin ƙasar ta hanyar ƙungiyar masana cututtukan cututtuka a Imperial College London.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Coronavirus da Amsa ta Ƙarin Kuɗi, wanda ke ba da tallafin gaggawa na dala biliyan 8.3 ga hukumomin tarayya don amsa annobar.
Kamfanoni sun kafa takunkumin hana ma'aikata tafiya, sun soke taro, kuma sun karfafa ma'aikata su yi aiki daga gida.
An soke wasanni da kuma lokutan wasanni. A ranar 11 ga watan Maris, Trump ya sanar da hana tafiye-tafiye ga yawancin kasashen Turai, sai dai Birtaniya, na tsawon kwanaki 30, wanda ya fara aiki a ranar 13 ga watan Maris.
Washegari, ya faɗaɗa ƙuntatawa zuwa Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa domin samun kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko rage ayyukansu a fadin Amurka domin a rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da barkewar cutar a jihohi 50 da kuma a Gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa birnin New York yana da mutane 10,700 da suka kamu da cutar, fiye da adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan New York ya ce an yi nasarar aiwatar da takunkumin hana yaduwar jama'a saboda ƙididdigar ƙaruwar masu kamuwa da cutar ta ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an sami mutane 32,308 da suka kamu da cutar a birnin New York City, kuma mutane 672 ne suka mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta samu karin wadanda suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya.
A cewar rahotanni na kafofin watsa labarai a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita ka'idojin hana mutane shiga kasashen waje har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin asibiti mai suna USNS Comfort, mai gado 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 da coronavirus ta yi a cikin awanni 24.
A jihar New York, an zargi fadar White House da yin watsi da barazanar da kuma sarrafa sakonnin ta hanyar umarci jami'an kiwon lafiya da masana kimiyya da su daidaita maganganun jama'a da wallafe-wallafen da suka shafi kwayar cutar a ofishin Mataimakin Shugaban kasa Mike Pence.
Gabaɗaya, amincewa da yadda Trump ya gudanar da rikicin ya rabu tsakanin bangarorin.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayan masarufi daga China, wanda ya hada da kayan aikin likitanci masu mahimmanci.
An yi amfani da nazarin yanayin tafiyar jirgin sama don tsarawa da kuma hango hasashen yanayin yaduwar cutar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 daga Kungiyar Sufurin Jiragen Sama ta Duniya, mutane da suka fi tafiya daga Wuhan sun kasance a Bangkok, Hong Kong, Tokyo, da Taipei.
Dubai, Sydney, da Melbourne kuma an bayar da rahoton cewa su ne wuraren da mutane ke zuwa daga Wuhan.
An bayar da rahoton Bali a matsayin mafi ƙarancin iyawa a cikin shirye-shirye tsakanin manyan biranen tafiye-tafiye 20, yayin da biranen Ostiraliya ke da mafi ƙarancin iyawa. Australia ta fitar da Tsarin Amincewa da Gaggawa don Sabuwar Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
An ce har yanzu akwai abubuwa da yawa da ba a gano ba game da COVID-19, kuma cewa Ostiraliya za ta ba da hankali kan kula da kan iyakoki da sadarwa a cikin amsa cutar.
A ranar 21 ga watan Maris, Australia ta ayyana dokar ta-baci na kare lafiyar dan adam.
Saboda keɓewar sufuri na jama'a da aka sanya a Wuhan da Hubei, wasu ƙasashe suna shirin kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, musamman ta hanyar jirgi da aka yi haya daga ƙasashen da suka fito, tare da izinin hukumomin China.
Kanada, Amirka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand na cikin ƙasashe na farko da suka fara shirin kwashe 'yan ƙasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko dangin' yan Brazil, ban da 'yan Poland hudu, da wani dan China, da kuma wani dan kasar Indiya.
An saukar da mutanen Poland, China, da Indiya a Poland, inda jirgin ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
'Yan Brazil da suka je Wuhan sun killace a wani sansanin soja da ke kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa CFB Trenton don keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australia sun kwashe 'yan kasar su 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Kula da Yanayin Tsibirin Kirsimeti, wadda aka mayar da ita cibiyar killace mutane, inda suka zauna na tsawon kwanaki 14.
Jirgin saukar jiragen sama na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da wasu daga Australiya da Pacific) an killace su a sansanin sojin ruwa na Whangaparoa, a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin da ke dauke da fasinjoji 129 na Kanada da suka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin South African Airways da Gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan kasarta 112.
An yi gwajin lafiya kafin tashi kuma an bar wasu 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka yi gwajin rashin lafiya ne kawai aka mayar da su gida.
Bisa ga sakamakon gwajin, an ba da izini ga duk waɗannan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin, matukan jirgi, ma'aikatan otal,' yan sanda, da sojoji da ke cikin ayyukan jin kai; a matsayin abin da ya kamata, duk sun kasance a karkashin kulawa da keɓewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta bayyana cewa kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da agaji zuwa kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka da dama sun hada kai don tura agaji zuwa yankunan kasar Sin da cutar ta shafa, tare da wasu kungiyoyi da suka hada kai daga yankin Chicago; an bayar da rahoton cewa sun samu nasarar tura kayan rufe fuska 50,000 na N95 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, a hade tare da FedEx, ta tura kayan rufe fuska 200,000 da sauran kayan kariya, ciki har da safofin hannu da riguna, ta hanyar jigilar iska ta gaggawa zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da ƙoƙarin magance ta, da kuma kare "mutane masu haɗari a Afirka da Kudancin Asiya".
Interaktion ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan ɗaya zuwa Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safofin hannu na likita miliyan 18 zuwa China, Jamus ta ba da gudummawar kayan aikin likita da suka hada da rigunan Hazmat 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita zuwa China tare da alƙawarin ƙarin dala miliyan 100 a cikin tallafin kuɗi ga ƙasashen da abin ya shafa. Bayan da lamuran da ke cikin China suka daidaita, Amurka ta aika da taimako ga ƙasashen da cutar ta shafa.
A watan Maris, Sin, Cuba, da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya magance annobar coronavirus.
Kamfanin Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kuma riguna na kariya dubu 60 zuwa Addis Ababa, Habasha, domin kungiyar tarayyar Afirka ta rarraba su.
Daga baya, ya aika da kayan gwaji 5,000, da abin rufe fuska 100,000, da kuma na'urorin numfashi biyar zuwa Panama.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwa game da ingancin abin rufe fuska da kayan gwajin da aka yi a kasar Sin.
Misali, Spain ta janye kayan gwajin coronavirus 58,000 da aka yi da kasar Sin da suka yi daidai da kashi 30%; yayin da Netherlands ta janye 600,000 na kayan rufe fuska na kasar Sin da suka lalace.
Belgium ta kuma kwashe masks 100,000 da ba za a iya amfani da su ba, da ake zargin sun fito ne daga China, amma a zahiri daga Colombia.
A wani bangare kuma, tallafin da kasar Sin ta bayar ya samu karbuwa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani gaggawa na tallafi ga kasashe masu tasowa.
Hukumar ta WHO ta yaba wa gwamnatin kasar Sin kan kokarin da take yi na sarrafawa da kuma shawo kan annobar.
WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002-2004 lokacin da aka zargi hukumomin China da yin rufin asiri don haka suka hana rigakafin da kuma hanawa da kuma rikicin yanzu tare da gwamnatin tsakiya "ta ba da sabuntawa na yau da kullun don kauce wa tashin hankali a lokacin hutun Sabuwar Shekarar Lunar.
A ranar 23 ga watan Janairu, a mayar da martani ga matakin gwamnatin tsakiya na sanya takunkumin hana zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya ce duk da cewa matakin "a bayyane yake ba shawarar WHO ba ne", amma kuma "wani muhimmin alama ne na jajircewar da ake da ita na dakile barkewar cutar a inda cutar ta fi yawa" kuma ya kira shi "marasa misali a tarihin kiwon lafiyar jama'a". A ranar 30 ga watan Janairu, bayan tabbatar da yaduwar cutar daga mutum zuwa mutum a wajen China da kuma karuwar adadin masu kamuwa da cutar a wasu kasashe, WHO ta ayyana annobar a matsayin gaggawa ta gaggawa ta Duniya (PHEIC), wato PHEIC ta shida tun lokacin da aka fara aiwatar da annobar cutar cutar alade a shekarar 2009.
Darakta Janar na WHO Tedros Adhanom ya ce an bayyana PHEIC ne domin "hadarin yaduwar duniya, musamman ga ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi waɗanda ba su da tsarin kiwon lafiya mai kyau.
Da yake amsawa game da aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a aiwatar da matakan da ke kawo cikas ga tafiye-tafiye da cinikayya ta duniya ba tare da bukatarsu ba" kuma "WHO ba ta ba da shawarar hana cinikayya da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 da za a yi amfani da su wajen samar da kudade don shirya a kasashe masu karancin kudin shiga, tana mai ambaton gaggawa don tallafa wa kasashen da "ba su da tsarin gano mutanen da suka kamu da cutar idan annobar ta barke".
Tedros ya kara da cewa "iyakar ƙarfinmu yana kan mafi raunin sarkar" kuma ya bukaci al'ummar duniya da su "saka hannun jari a yanzu ko kuma su biya ƙarin a nan gaba". A taron manema labarai na ranar 11 ga Fabrairu, WHO ta sanya COVID-19 a matsayin sunan cutar ga wannan kwayar.
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya ba da "amsa ta hanyar rarraba dukkan iko na tsarin Majalisar Dinkin Duniya".
Bayan haka, Majalisar Dinkin Duniya ta kunna Kungiyar Gudanar da Rikicin don ba da damar daidaita duk amsar Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan maganin kiwon lafiya, yayin da sauran hukumomi za su iya amfani da ƙwarewarsu don magance tasirin annobar a fannonin zamantakewa, tattalin arziki, da ci gaba. "
A ranar 14 ga Fabrairu, an kunna wani Kungiyar Haɗin gwiwa ta China da WHO ke jagoranta; wannan tawagar tana da nufin samar da ƙwararrun ƙwararrun ƙasashen duniya da na WHO a China don taimakawa gudanarwar cikin gida da kimanta "taurin tsananin cutar da yaduwar cutar" ta hanyar gudanar da bita da tarurrukan tare da hukumomin matakin ƙasa da kuma yin ziyarar filin don kimanta "tasirin ayyukan magance su a matakin lardi da gunduma, wanda ya haɗa da birane da karkara".A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya dole ne ta yi ƙarin shiri don fuskantar yiwuwar cutar ta coronavirus" kuma ta ce, kodayake yana da wuri a kira ta a matsayin annoba, ƙasashe dole ne su kasance cikin "tsarin shiri".
A cikin martani ga barkewar cutar a Iran, WHO ta aika da Kungiyar Haɗin gwiwa zuwa can don kimanta halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga darajar barazanar coronavirus a duniya daga "babba" zuwa "mai matukar girma", wannan shine matakin tsaro da kimanta haɗarin mafi girma.
A wata sanarwa, Mike Ryan, babban darektan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin cewa, "Lokaci ya yi da kowace gwamnati a duniya za ta fuskanci gaskiya: Ku kasance a faɗake.
Wannan cuta na iya zuwa wurinku kuma dole ne ku kasance a shirye", kuma ya nace cewa matakan da suka dace na magance ta na iya taimakawa duniya ta guji "mafi munin".
Ryan ya ci gaba da cewa, bayanan na yanzu ba su ba da damar jami'an kiwon lafiya su ayyana annobar duniya ba, ya ce irin wannan sanarwar na nufin "ainihin mun yarda cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana annobar coronavirus a matsayin annoba.
Darakta Janar na WHO ya ce WHO "ta damu matuka game da yawan yaduwar cutar da kuma tsananin cutar, da kuma jinkirin da ake yi wajen magance ta". WHO ta sha suka saboda rashin kulawar da ta yi wajen magance cutar, wanda ya hada da jinkirin ayyana dokar ta baci ta kiwon lafiya da kuma rarraba cutar a matsayin annoba.
Daya daga cikin mummunan martani ya hada da takardar neman izini da mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu, wanda aka aika wa Darakta Janar na WHO Tedros Adhanom don neman ya yi murabus.
A ranar 26 ga Maris, 2020, dubun-dubatar masana harkokin kare hakkin dan adam na Majalisar Dinkin Duniya sun jaddada girmama hakkin kowane mutum yayin annobar COVID-19.
Ƙungiyar ta ce kowa yana da hakkin ya yi aikin ceton rai kuma gwamnati ce ke da alhakin yin hakan.
Ƙungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba za a yi amfani da su ba don yin wariya ga wasu rukuni.
Masana sun nanata cewa kowa yana da hakkin samun lafiya, har da nakasassu, 'yan tsiraru, tsofaffi, 'yan gudun hijira, marasa gida, matalauta, fursunoni, 'yan gudun hijira, da sauran kungiyoyin da ke bukatar tallafin gwamnati.
Kungiyoyin gwamnatoci na duniya suna kokarin magance tasirin zamantakewa da tattalin arziki na rikicin COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kaddamar da wani shiri na samar da cikakken bayani kan yadda ake gudanar da manufofin a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arziƙin duniya zuwa magance tasirin keɓaɓɓun keɓaɓɓu da ƙuntatawa na tafiye-tafiye, cibiyoyin dijital sun haɗa da Mai bin diddigin Manufofin Jiha, kuma suna da nufin taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe haɗin kai na duniya don magance ƙalubalen coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Ofishin Ministan Burtaniya Michael Gove, da kuma dan Shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda suka magance annobar da ta bulla a lardin Hubei na kasar Sin.
An sallami wasu jami'an gudanarwa na jam'iyyar kwaminis ta kasar Sin (CPC) dangane da yadda suka gudanar da aikin killacewa a yankin tsakiyar kasar, wanda ke nuna rashin gamsuwa da yadda hukumomin siyasa suka mayar da martani kan annobar a yankin.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da ikirarin da suka yi a baya game da barkewar cutar coronavirus da ta fara a Wuhan, kuma sun goyi bayan ka'idodin maƙarƙashiya game da COVID-19 da ke fitowa daga Amurka ko Italiya.
Gwamnatin Amurka Donald Trump ta kira coronavirus "virus na kasar Sin" ko "virus na Wuhan" kuma ta ce "aikin da China ke yi na rufe ido ya ba da karfi ga cutar da ta zama annoba ta duniya". Wannan furucin ya yi ta fama da wasu masu sukar nuna wariyar launin fata da kuma "jawo hankali daga gazawar gwamnatinsa wajen magance cutar korona".
Jaridar Daily Beast ta samu wani sakon gwamnatin Amurka wanda ke bayyana dabarun sadarwa kuma a bayyane yake ya fito ne daga kwamitin tsaron kasa, tare da dabarun da aka ambata a matsayin "Dukkanin China.
An gaya mana mu gwada kuma mu isar da wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma nuna kanmu a talabijin". Kafofin watsa labarai kamar Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin farfagandar da take yi don shafar duniya.
Shugaban harkokin wajen Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa, wanda ya ƙunshi yaƙi don samun tasiri ta hanyar jujjuya gaskiya da 'siyasa ta karimci.' "
Borrell ya kuma ce, "Tashin ya na tura saƙo da cewa, ba kamar Amurka ba, su abokan tarayya ne masu alhakin gaskiya".
China ta kuma bukaci Amurka ta dage takunkumin da ta kafa kan Syria da Venezuela da kuma Iran, kuma ta ce ta tura taimakon agaji ga kasashen biyu na karshe.
An dakatar da gudummawar Jack Ma ta kayan masks 100,000 ga Cuba ta takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da tura taimakon da aka yi niyya ga wasu ƙasashe zuwa ƙasarsu.
An kuma samu rigima game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria, da Switzerland; da Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta kwashe ɗarurruwan na'urorin numfashi da aka yi niyyar turawa zuwa ƙasar Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai ga Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce "Shayana ce kawai ke amsawa a bangaren kasashen biyu.
Hakika, wannan ba kyakkyawan alamar haɗin kai na Turai ba ne".
A ranar 22 ga watan Maris, bayan samun kiran waya daga Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya tura sojojin Rasha don aika da ma'aikatan lafiya na soja, motocin kashe cututtuka na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "babban jami'in siyasa" da ba a san sunansa ba da ya ce kashi 80 cikin ɗari na taimakon da Rasha take bayarwa "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Majiyar ta zargi Rasha da kai harin "na siyasa da kuma na diflomasiyya".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin ruwa mai dauke da kayan kiwon lafiya zuwa Amurka.
Kakakin gwamnatin Rasha Dmitry Peskov ya ce "a lokacin da yake ba da taimako ga abokansa a Amirka, [Putin] ya ɗauka cewa idan masu sayar da kayayyakin kiwon lafiya na Amirka suka samu zarafi, za su iya mayar da amsar idan bukata ta kama".
An shirya atisayen sojin NATO na "Defender 2020" a Jamus, Poland, da ƙasashen Baltic, wanda shine atisayen yaƙi mafi girma na NATO tun ƙarshen Cold War, za a gudanar da shi a ƙarami.
Sakatare Janar na Kamfen na Rashin Kare Nukiliya Kate Hudson ta soki atisayen Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, atisayen ba kawai suna sanya rayukan sojojin Amurka da na kasashen Turai da yawa da ke halarta cikin hadari ba, har ma da na mutanen kasashen da suke aiki". Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kimanin 'yan majalisa biyu da suka kamu da cutar tare da manyan' yan siyasa goma sha biyar na yanzu ko na baya.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wasika a bude ga shugabannin duniya don neman taimako kuma ya ce kasarsa na fama da cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran.
Masu sharhi na siyasa sun yi hasashen cewa hakan na iya yin illa ga damar da Donald Trump zai samu na sake zabarsa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki "taƙaddamar da keɓewar Japan da ke da wuyar fahimta" bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a sanya shi a cikin keɓewa na makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai, ra'ayoyin jama'ar Koriya ta Kudu sun rabu dangane da yadda Shugaba Moon Jae-in ya mayar da martani ga wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takarda, ko dai suna neman a tsige Moon, bisa zargin da suke yi game da kuskuren gwamnati wajen magance annobar, ko kuma suna yaba wa martanin da ta bayar.
Wasu masu sharhi sun nuna damuwa cewa hakan zai ba gwamnati damar ƙarfafa ikonta.
A Hungary, majalisar dokoki ta zabi ta ba Firayim Minista Viktor Orbán damar yin mulki ta hanyar dokar da ba ta da iyaka, ta dakatar da majalisa da zaɓen jama'a, da kuma hukunta mutanen da ake ganin sun yada bayanan karya game da cutar da kuma yadda gwamnati ke magance matsalar.
An zargi annobar coronavirus da karancin wadata, wanda ya samo asali ne daga karuwar amfani da kayan aiki a duniya don yaƙar annoba, sayayya saboda fargaba, da kuma katsewar ayyukan masana'antu da kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu sayayya da kuma katsewar masu samar da kayayyaki.
Wasu yankuna kuma suna shan wahala daga sayayya a cikin tsoro wanda ke haifar da rashin kayan masarufi, kamar abinci, wankin wanka, da ruwan kwalba, wanda ke haifar da karancin wadata.
A musamman, masana'antar fasaha sun yi gargadin jinkirin isar da kayayyakin lantarki.
A cewar darekta janar na WHO Tedros Adhanom, bukatar kayayyakin kariya ta kai ninki 100.
Wannan bukatar ta haifar da hauhawar farashi har sau ashirin na al'ada kuma ya haifar da jinkirin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan kuma ya haifar da karancin kayan kariya na jiki a duniya, kuma WHO ta yi gargadin cewa hakan zai yi illa ga lafiyar jama'a.
A Ostiraliya, annobar ta ba da sabon dama ga masu sayen daigou don sayar da kayayyakin Australiya a cikin China.
Wannan aikin ya haifar da karancin madara a wasu manyan kantuna kuma daga ƙarshe gwamnatin Australiya ta dakatar da shi. Duk da yawan adadin COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban bukatar kayayyakin abinci, waɗannan yankuna biyu sun guji karancin kayan abinci.
Matakan da Sin da Italiya suka dauka na yaki da tarin kayayyaki da kuma cinikin kayayyakin da ake bukata sun yi nasara sosai har aka iya kauce wa matsanancin karancin abinci da ake tsammanin zai faru a Turai da kuma Arewacin Amirka.
Arewacin Italiya, tare da yawan kayan aikin gona, ba su sami raguwa ba, amma farashin na iya ƙaruwa bisa ga wakilan masana'antu.
An gano shagon abinci marasa amfani na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin ke fitar da naman alade don tabbatar da wadatar abinci.
A Italiya ma, akwai irin wannan dokar, wadda ta bukaci masu sayar da abinci su ajiye kayan abinci a lokacin da ake bukatar gaggawa.
An ji koma bayan tattalin arzikin duniya a China: a cewar rahoton kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi rauni sosai a cikin watanni biyu na farko na shekarar 2020 sakamakon matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma tallace-tallace na sayar da kayayyaki sun ragu da kashi 20.5%.
Tun da babban yankin kasar Sin babban cibiyar tattalin arziki ne da masana'antu, ana ganin annobar ta haifar da babbar barazanar rashin zaman lafiya ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ta yi hasashen cewa kasuwannin za su ci gaba da zama masu saurin tashi har sai an sami cikakken bayani game da yiwuwar sakamakon karshe.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin koma bayan tattalin arziki na annobar a kan ci gaban duniya na iya wuce barkewar cutar SARS ta 2002-2004.
Wani ƙididdiga da masana suka yi a Jami'ar Washington da ke St. Louis ya ce annobar ta shafi fiye da dala biliyan 300 a sarkar samar da kayayyaki a duniya, wanda zai iya kaiwa shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ruwaito "kwarara" bayan farashin mai ya fadi matuka sakamakon karancin bukatarsa daga China.
A ranar 24 ga Fabrairu, kasuwannin hannayen jari na duniya sun fadi saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda karuwar fargabar annobar coronavirus, wasu alamun hannun jari na Amurka, wadanda suka hada da NASDAQ-100, S&P 500, da Dow Jones Industrial Average, sun yi raguwa sosai tun 2008, tare da Dow ta fadi maki 1,191, mafi girman raguwa na kwana daya tun bayan rikicin kudi na 20072008.
Ƙididdigar hannun jari uku sun rufe mako da raguwa fiye da kashi 10.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar bashi na gwamnatin China, amma ta riƙe Outlook Negative.
Hannun jari sun sake faduwa saboda fargabar cutar coronavirus, mafi girma ya faru ne a ranar 16 ga Maris.
Mutane da yawa suna tunanin cewa tattalin arziki zai koma baya.
Wani masanin tattalin arziki Mohamed El-Erian ya yaba wa matakin gaggawa na babban bankin kasar da kuma na jihar saboda lokacin da ya dace.
Babban bankin ya amsa da sauri fiye da yadda suka yi a lokacin matsalar kuɗi ta 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da aka fi shafa saboda takunkumin tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren shakatawa, da kuma matakan gwamnati na hana tafiye-tafiye a duk duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar jiragen sama saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya rushe.
Tasirin da masana'antar jiragen ruwa ke yi a wannan lokacin ya kai abin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa.
Cutar ta yi daidai da Chunyun, babban lokacin tafiye-tafiye da ke da alaƙa da hutun Sabuwar Shekarar Lunar.
An soke wasu manyan abubuwan da gwamnati da yankuna suka yi, ciki har da bikin Sabuwar Shekarar Lunar shekara-shekara, kuma kamfanoni masu zaman kansu sun rufe shaguna da wuraren shakatawa, kamar su Hong Kong Disneyland da Shanghai Disneyland.
An rufe bukukuwan Sabuwar Shekara da wuraren shakatawa da yawa don hana taron jama'a, gami da Tsibritar Birnin Beijing da kuma nunin haikalin gargajiya.
A larduna 24 daga cikin 31 na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa ranar 10 ga watan Fabrairu kuma sun umarci yawancin wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Wadannan yankuna suna samar da kashi 80% na GDP na kasar da 90% na fitar da kayayyaki.
Hong Kong ta kara yawan cututtukan da ke yaduwa zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris, kuma ta soke bikin Sabuwar Shekara.
Ziyarar 'yan kasuwa a Turai da Latin Amurka sun ragu da kashi 40 cikin dari.
Dillalan Arewacin Amurka da Gabas ta Tsakiya sun ragu da kashi 50-60 cikin dari.
Wannan kuma ya haifar da raguwar zirga-zirgar masu tafiya a ƙafa zuwa cibiyoyin cin kasuwa da kashi 33-43% a watan Maris idan aka kwatanta da watan Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duk duniya suna aiwatar da ƙarin matakan, kamar haɓaka tsabtace muhalli, shigar da na'urorin daukar hotuna don bincika yanayin zafin jiki na masu siye, da soke abubuwan da suka faru.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi tsauri a birnin Wuhan, mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Yawancin ma'aikatan karkara na kasar Sin miliyan 300 sun bar gidajensu a lardin Hubei ko kuma sun makale a lardin.
A cewar wani kimantawa na Bankin Tarayyar Tarayyar St. Louis, annobar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa 32%. Yankin keɓewa a Indiya ya sa dubun miliyoyin ma'aikatan bakin haure na Indiya (waɗanda ake biyan su ta hanyar albashi na yau da kullun) su zama marasa aiki. Binciken da Angus Reid Institute ya yi ya gano cewa kashi 44% na iyalai a Kanada sun sami wani nau'in asarar aiki. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka fara keɓewar yankin a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi taimakon rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan rabin a Jamus sun nemi tsarin aiki na gajeren lokaci da gwamnati ke tallafawa ma'aikatansu, wanda ake kira Kurzarbeit.
Faransa da Ingila sun karɓi tsarin biyan diyya na ɗan gajeren lokaci na Jamus.
A duk duniya, ayyukan fasaha da al'adun gargajiya sun sami mummunan tasiri daga cutar, wanda ya shafi ayyukan ƙungiyoyi da mutane, masu aiki da masu zaman kansu.
Kungiyoyin bangaren fasaha da al'adu suna kokarin daukaka manufofin su (wanda galibi ana samun kudaden su ne daga jama'a) na samar da damar al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikata da al'umma, da kuma tallafawa masu fasaha idan ya yiwu.
A watan Maris na shekarar 2020, a duk duniya da kuma a matakai daban-daban, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu sun rufe har abada, tare da soke ko jinkirta nune-nunen, abubuwan da suka faru, da kuma wasan kwaikwayon.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Sauran tasirin cutar da ke saurin girma shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide-kide, taron fasaha, da bikin ado.
An kuma yi wa masana'antar fim taɓo, domin Vatican ta sanar da soke bikin Makon Mai Tsarki a Roma, wanda ya faɗi a makon ƙarshe na lokacin tuba na Kirista na Azumi.
Yawancin diocese suna ƙarfafa Kiristoci tsofaffi su zauna a gida kuma kada su halarci Mass a ranar Lahadi; wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta kan layi ko talabijin, yayin da wasu ke ba da sabis na drive-in ko na zahiri.
Da aka rufe majami'u da kuma gidajen ibada da ke cikin cocin Katolika da kuma kwashe filin St. Peter daga masu bauta wa Allah, wasu addinai sun soke ayyuka kuma sun hana mutane yin taro a coci, masallaci, majami'a, haikali, da kuma gurdwara.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma an rufe wuraren ibada, yayin da Saudiyya ta hana masu yawon bude ido da mazauna yankin shiga wuraren ibada a Makka da Madina.
Wannan annoba ta haifar da babbar matsala ga kalandar wasanni ta duniya tun lokacin yakin duniya na biyu.
Yawancin manyan wasannin wasanni an soke su ko kuma an jinkirta su, gami da 2019-2020 UEFA Champions League, 2019-2020 Premier League, UEFA Euro 2020, NBA kakar 2019-2020, da kuma kakar NHL 2019-2020.
Cutar ta rikitar da shirin gasar wasannin 2020 na bazara, wanda aka shirya fara shi a ƙarshen Yuli; Kwamitin wasannin Olympic na kasa da kasa ya sanar a ranar 24 ga Maris cewa za a "sake tsara taron har zuwa bayan 2020, amma ba zai wuce bazara 2021 ba". A duk duniya, gidajen caca da sauran wuraren wasanni sun rufe kuma an jinkirta ko soke watsa shirye-shiryen wasannin poker.
Wannan ya haifar da yawancin 'yan caca suna juyawa zuwa caca ta kan layi, yawancin shafukan caca ta kan layi suna ba da rahoton ƙaruwa mai yawa na sabbin rajista. Har ila yau, masana'antar nishaɗi ta yi tasiri, tare da ƙungiyoyi da yawa suna jinkirta ko soke yawon shakatawa.
Yawancin manyan gidajen wasan kwaikwayo kamar Broadway sun jinkirta duk wasan kwaikwayon.
Masu zane-zane suna gano hanyoyi daban-daban don ci gaba da samarwa da raba ayyuka ta hanyar intanet a matsayin madadin ga wasan kwaikwayon gargajiya na yau da kullun, kamar wasan kwaikwayon watsa shirye-shiryen kan layi ko ƙirƙirar "bikin" na yanar gizo don masu zane-zane su yi, yadawa, da kuma buga ayyukansu.
An yi amfani da abubuwan da ake kira coronavirus a yanar gizo, inda mutane da yawa suka juya zuwa ga abin dariya da kuma shagala a cikin rashin tabbas.
Tun bayan barkewar cutar COVID-19, an lura da karuwar nuna wariya, kyamar kasashen waje, da wariyar launin fata ga mutanen asalin Sin da na Gabashin Asiya, da kuma mutanen da ke yankin da abin ya shafa a Turai, Amurka, da sauran ƙasashe.
An lura da irin wannan tsoro, rashin yarda, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya da Fasifik.
Rahoton na watan Fabrairu (lokacin da mafi yawan masu kamuwa da cutar ke cikin kasar Sin) ya nuna cewa akwai ra'ayin wariyar launin fata a kungiyoyi a duniya cewa 'yan kasar Sin sun cancanci kamuwa da cutar ko kuma su karbi abin da suke ikirarin cewa lada ne.
Wasu ƙasashe a Afirka ma suna fuskantar ƙaruwar rashin amincewa da China.
Mazauna Wuhan da Hubei da dama sun bayar da rahoton nuna wariya saboda asalin yankin su.
Akwai tallafi ga mutanen China, ta yanar gizo da kuma ta waje, da kuma ga mutanen da ke cikin yankunan da cutar ta shafa.
Bayan yaduwar annobar zuwa sabbin kasashe masu zafi, mutanen Italiya, kasar farko a Turai da ta fara fuskantar mummunan barkewar COVID-19, na iya zama abin zargi da kuma nuna kyamar kasashen waje. 'Yan ƙasa a ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takarda neman hana Sinawa shiga ƙasarsu a ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama ruwan dare a shafin Twitter.
Sinawa da sauran mutanen Asiya a Burtaniya da Amurka suna ba da rahoton karuwar yawan cin zarafin wariyar launin fata da kuma kai hari.
An soki shugaban Amurka Donald Trump saboda kiran coronavirus da "Cin virus", wani furcin da masu sukar ke ganin na nuna wariyar launin fata da kuma adawa da China.
Masu zanga-zanga a Ukraine sun kai hari kan motocin da ke dauke da 'yan Ukraine da baƙi da aka kwashe daga Wuhan zuwa Novi Sanzhary.
Dalibai daga Arewa maso Gabashin Indiya, wanda ke iyaka da China, da ke karatu a manyan biranen Indiya an bayar da rahoton cewa sun fuskanci cin zarafi dangane da annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na bangaren jihar a West Bengal Dilip Ghosh ya bayyana cewa Sin ta lalata yanayi kuma "saboda haka Allah yana rama musu".
Bayanin daga baya ya yi tir da shi daga ofishin jakadancin China a Kolkata, yana mai cewa "taurin kai". A China, kyamar 'yan kasashen waje da wariyar launin fata ga mutanen da ba 'yan kasar Sin ba sun yi ta taɓarɓarewa saboda annobar, tare da bayyana baƙi a matsayin "ƙazamar ƙasa" kuma ana niyya don "saye".
Yawancin jaridu da ke amfani da takunkumin biya sun cire shi don wasu ko duk labaran su na coronavirus.
Yawancin masu wallafa kimiyya suna samar da takardun kimiyya game da annoba a cikin hanyar budewa.
Wasu masana kimiyya sun fi son su raba sakamakon su da sauri a kan sabobin buga takardu, kamar bioRxiv.
Sabon cuta mai yaduwa  Cutar kamuwa da cuta mai saurin fitowa, sau da yawa sabo ne a cikin annobar ko hanyar watsa ta
Cin Duniya da Cututtuka - Binciken Cin Duniya da Cutar da Ke Yaduwa
Jerin annoba da annobar - Jerin mutuwar cututtukan da ke yaduwa
Cinikin namun daji da kuma cutar zoonosis - Rashin lafiyar da ke tattare da cinikin namun daji
Gwajin dakin gwaje-gwaje na cutar coronavirus na numfashi na 2019 (COVID-19) da kwayar SARS-CoV-2 ya hada da hanyoyin da ke gano kasancewar kwayar cutar da kuma wanda ke gano ƙwayoyin cuta da aka samar a cikin martani ga kamuwa da cuta.
An tabbatar da kwayar cutar a cikin samfurin ta hanyar RT-PCR, wanda ke gano RNA coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano kwayar SARS-CoV-2 RNA kawai.
Ana amfani da wannan gwajin don tabbatar da sabon kamuwa da cuta ko kuma wanda yake aiki.
Ana iya amfani da gano kwayoyin (serology) don ganewar asali da kuma sa ido kan al'umma.
Gwajin kwayar cutar yana nuna yawan mutanen da suka kamu da cutar, ya haɗa da mutanen da alamun cutar ba su da yawa da za a iya ba da rahoto ko kuma waɗanda ba su da alamun cutar.
Za a iya sanin ainihin mutuwar cutar da kuma matakin rigakafin a cikin al'umma daga sakamakon wannan gwajin.
Saboda iyakancewar gwaji, har zuwa Maris 2020, babu wata ƙasa da ke da ingantaccen bayanai game da yaduwar kwayar cutar a cikin al'ummarta.
Har zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambancin da ke tsakanin adadin gwajin da aka yi a ƙasashe.
Wannan canji kuma yana iya shafar yawan mutuwar da aka ruwaito, wanda wataƙila ya yi yawa a wasu ƙasashe.
Amfani da halayen sarkar polymerase da aka sake rubutawa na ainihi (rRT-PCR), ana iya yin wannan gwajin a kan samfuran numfashi da aka samo ta hanyoyi daban-daban, gami da tsotsa na hanci ko samfurin sputum.
A yawancin lokaci, ana samun sakamako cikin sa'o'i da yawa zuwa kwana biyu.
Gwajin RT-PCR da aka yi a kan hancin mutum yana da inganci ne kawai a makon farko na cutar.
Daga baya, kwayar cutar za ta iya ɓacewa a cikin makogwaro yayin da take ci gaba da yin kwafi a cikin huhu.
A madadin haka, ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, ana iya ɗaukar kayan samfurin daga cikin hanyoyin numfashi ta hanyar amfani da catheter na tsotsa ko kuma ana iya amfani da kayan da aka fitar ta hanyar tari (sputum).
An haɓaka ɗayan farkon gwajin PCR a Charité, Berlin, a cikin Janairu 2020 ta amfani da halayen sarkar polymerase da ke jujjuyawar lokaci (rRT-PCR), kuma ya samar da aƙalla kayan gwaji 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta kuma samar da gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan aikin gano cutar SARS-CoV-2 mai amfani da PCR (PowerChek Coronavirus) wanda ke da inganci a ranar 28 ga Janairu, 2020.
Na'urar tana neman "E" gene wanda duk beta coronavirus ke da shi, da kuma RdRp gene wanda yake takamaiman SARS-CoV-2.A cikin China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka karɓi amincewar amfani da gaggawa daga Hukumar Kula da Samfuran Kiwon Lafiya ta China don kayan aikin gano SARS-CoV-2 na PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) sun rarraba Sabon Coronavirus 2019 (2019-nCoV) Real-Time RT-PCR Diagnostic Panel ga dakunan gwaje-gwajen kiwon lafiya ta hanyar International Reagent Resource.
Daya daga cikin uku na gwajin kwayoyin halittar a cikin tsohuwar sigar kayan aikin gwajin ya ba da sakamako mara gamsarwa saboda kuskuren reagent, kuma adadin gwajin a CDC a Atlanta an iyakance; wannan ya haifar da matsakaita ƙasa da samfura 100 a kowace rana da aka sarrafa ta hanyar Fabrairu 2020.
An yi la'akari da cewa gwajin da ke amfani da bangarori biyu ba shi da tabbaci har zuwa 28 ga Fabrairu, 2020, kuma bayan haka ne aka ba da izinin yin gwajin ga dakunan gwaje-gwaje na jihar da na gida.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin ne bisa izinin Amfani da Gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da samuwar gwajin COVID-19 na RT-PCR a duk fadin kasar.
Hakanan, Quest Diagnostics ya sanya gwajin COVID-19 a cikin ƙasa a ranar 9 ga Maris, 2020.
Babu iyakancewar adadin da aka sanar; dole ne a tattara da sarrafa samfurin bisa ga bukatun CDC.
A Rasha, an samar da gwajin COVID-19 kuma an samar da shi ta Cibiyar Bincike ta Jiha ta Virology da Biotechnology VECTOR.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ne ta hanyar Hukumar Kula da Kiwon Lafiya ta Amurka. A ranar 12 ga Maris, 2020, Mayo Clinic ta ba da rahoton cewa ta haɓaka gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5, tare da babban girma wanda injin ɗaya zai iya yin kimanin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji a kan tsarin m2000 na Abbott; FDA ta riga ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ya kuma sami EUA daga FDA don gwaji wanda ya ɗauki kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar kara kuzari na isothermal nucleic acid wanda ba PCR ba.
Tun da ba a bukatar jerin juyin zafin jiki, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka kuma Abbott na sa ran kara samar da na'urori 50,000 a kowace rana. Ana ci gaba da gwajin da ke amfani da kwayoyin cutar ta monoclonal wanda ke da alaƙa da furotin nucleocapsid (N) na sabon kwayar cutar coronavirus a Taiwan, da fatan samar da sakamako cikin mintuna 15 zuwa 20 kamar gwajin hanzari na mura.
Wani bita na wallafe-wallafen da aka buga a watan Maris na shekarar 2020 ya kammala da cewa "hotunan kirji suna da ƙarancin ƙimar bincike a farkon matakin, kamar yadda binciken CT [computed tomography] zai iya kasancewa kafin bayyanar cututtuka".
Abubuwan da ke cikin CT sun haɗa da fasalin gilashin ƙasa na multilobal na biyu tare da rarraba kewayon, asymmetric, da na baya.
Ƙarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙashin ƙwarƙwararren ƙwarƙashin ƙwarƙwararren ƙwarƙwararren ƙwarƙwararren ƙwarƙwararren ƙwarƙwararren ƙwarƙwararru.
A Wuhan, wani bincike da ya kwatanta PCR da CT a wurin da annobar ta barke ya nuna cewa CT ya fi PCR saukin kamuwa da cutar, duk da cewa ba ta da takamaiman bayani, tare da fasalolin hoto da yawa da suka shafi ciwon huhu da sauran hanyoyin cutar.
A watan Maris na shekarar 2020, Kwalejin Kula da Magunguna ta Amurka ta ba da shawarar cewa "Kada a yi amfani da CT don yin bincike ko kuma a matsayin gwajin farko na gano COVID-19".
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shi ne samar da ƙwayoyin cuta da suka haɗa da IgM da IgG.
Ana iya amfani da shi don gano kamuwa da cuta a cikin mutane tun kimanin kwanaki 7 bayan bayyanar cututtuka, don ƙayyade rigakafin cutar, da kuma a cikin sa ido na al'umma. Ana iya yin bincike a cikin cibiyar bincike ta tsakiya (CLT) ko ta hanyar gwajin-wuri-na-kula (PoCT).
Tsarin sarrafa kansa mai girma a yawancin dakunan gwaje-gwaje na asibiti zai iya yin wannan binciken, amma wadatarsa zai dogara ne akan matakin samarwa ga kowane tsarin.
Don CLT, ana amfani da samfurin jini guda ɗaya, kodayake ana iya amfani da jerin samfuran don bin diddigin amsawar rigakafi.
Don PoCT, ana amfani da samfurin jini guda ɗaya wanda aka samo ta hanyar suturar fata.
Ba kamar hanyar PCR ba, ba a buƙatar matakan cirewa kafin bincike. A ranar 26 ga Maris, 2020, FDA ta ambaci cibiyoyi 29 da ke ba da sanarwar ga hukumomi kamar yadda ya cancanta kuma saboda haka yanzu suna iya rarraba gwajin rigakafin su.
A ranar 7 ga Afrilu, 2020, kawai gwajin guda ɗaya ne FDA ta amince da shi bisa izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su wanda zai iya gano IgG da IgA antibodies ga kwayar cutar a cikin samfurin jini.
Yana iya yin gwajin har zuwa ɗaruruwan samfurori a cikin sa'o'i kaɗan, saboda haka yana da sauri fiye da gwajin PCR na yau da kullun don RNA na kwayar cuta.
A farkon watan Afrilu, Birtaniya ta gano cewa babu wani kayan gwajin da ta saya da ya isa ta yi amfani da shi.
Hong Kong ta tsara wani tsari don ba da damar marasa lafiya su zauna a gida, "sashen gaggawa zai ba wa marasa lafiya bututun samfurin", za su yi ta tsotsa a ciki, su aika da shi, kuma su sami sakamakon gwajin jim kaɗan bayan haka. NHS na Burtaniya ta sanar da cewa NHS tana kan gaba wajen yin gwajin cutar a gida don kawar da haɗarin marasa lafiya su cutar da wasu idan sun zo asibiti ko kuma su kashe motar asibiti idan an yi amfani da ita. A cikin gwajin ƙasa don yanayin COVID-19, ƙwararren likitan lafiya zai ɗauki samfurin ta amfani da matakan kariya masu dacewa.
Cibiyoyin gwajin na yau da kullun sun taimaka wa Koriya ta Kudu ta yi gwaji cikin sauri da kuma fa'ida fiye da kowace ƙasa. A ranar 2 ga Maris, National Association of Statutory Health Insurance Physicians na Jamus ya ce Jamus tana da ƙarfin gwaji na kimanin 12,000 a kowace rana a cikin tsarin asibiti kuma an yi gwaji 10,700 a makon da ya gabata.
In likita ya bukaci a yi gwajin, inshorar lafiya ce take biyan kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da ƙarfin gwaji 160,000 a mako.
A ranar 19 ga Maris, an yi gwajin gwaji a wasu manyan birane.
Har zuwa 26 ga Maris 2020, ba a san adadin gwajin da aka yi a Jamus ba saboda an ba da rahoton sakamako mai kyau kawai.
Wani binciken farko na dakin gwaje-gwaje ya bayyana cewa, a duka, an gwada aƙalla samfuran 483,295 har zuwa da kuma makon 12/2020 kuma samfuran 33,491 (6.9%) sun gwada tabbatacce ga SARS-CoV-2.A Isra'ila, masu bincike a Asibitocin Technion da Rambam sun haɓaka kuma sun gwada hanyar da za su gwada samfuran daga marasa lafiya 64 a lokaci guda, ta hanyar haɗa samfuran kuma kawai su ƙara gwadawa idan an sami samfurin haɗin. A Wuhan, dakin gwaje-gwaje na gaggawa mai girman murabba'in mita 2,000 da ake kira "Huo-Yan" (Mandarin: 火眼, ko "Mata Wuta" a cikin harshen Indonesiya) an buɗe shi a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya aiwatar da samfuran sama da 10,000 a rana.
Tare da aikin da BGI mai kafa Wang Jian ya kula da shi kuma ya ɗauki kwanaki 5, yin samfurin ya nuna cewa shari'o'in da ke Hubei na iya zama kashi 47% mafi girma kuma farashin da ke tattare da sarrafa keɓewa na iya ninka idan ba a sami wannan ƙarfin gwajin ba.
Wuhan Laboratory nan da nan aka bi Huo-Yan Laboratories a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk fadin kasar Sin.
A ranar 4 ga Maris, 2020, jimlar damar gwajin ta yau da kullun ta kai 50,000 a kowace rana. Tsarin buɗe tushen mai yawa wanda Origami Assays ya saki zai iya gwada samfuran marasa lafiya 1,222 don COVID-19 ta amfani da gwaje-gwaje 93 kawai.
Har zuwa watan Maris, karancin da kuma isassun adadin maganin sun kasance cikas ga gwajin taro a Tarayyar Turai, Burtaniya, da Amurka.
Saboda haka, masu bincike sun yi ƙoƙari su bincika yarjejeniyar samar da samfurin da ta ƙunshi dumama samfurin a 98 °C (208 °F) na mintuna 5 don sakin kwayar RNA don ƙarin gwaji. A ranar 31 ga Maris, an ba da rahoton cewa Hadaddiyar Daular Larabawa ta yi gwajin coronavirus da yawa a kowane mutum fiye da kowace ƙasa, kuma tana shirye don haɓaka sikelin gwaji don isa ga yawancin jama'a.
An cimma wannan ne ta hanyar hada gwajin kwayoyin halitta da sayen manyan dakunan gwaje-gwaje masu yawa daga Group 42 da BGI (bisa ga "Huo-Yan" dakin gwaje-gwaje na gaggawa a China).
An gina shi cikin kwanaki 14, yana iya yin dubun dubatan gwaje-gwajen RT-PCR a kowace rana kuma shi ne na farko da ya yi irin wannan gwaji a wajen kasar Sin.
An kirkiro wasu nau'ikan gwajin da ke niyya ga sassan tsarin kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da takardar da Jamus ta bayar don samar da kayan gwajin da aka tura zuwa ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatun da za su samar da kansu.
An buga takardar Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta kasance ba har zuwa 28 ga Janairu wanda ya rage jinkirin gwajin da ake samu a Amurka.
Akasin haka, masana sun ce samun gwajin a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
An gina tashoshin gwaji, mafi yawa a cikin dakunan gwaje-gwaje na kamfanoni, a cikin 'yan shekaru da gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara inganta shirin gwajin a matsayin hanya mafi kyau ta rage karuwar annobar COVID-19. Babban bukatar gwajin saboda yaduwar kwayar cutar ya sa dubban daruruwan gwaje-gwaje ke jiran aiki a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da kayan shayarwa da kuma sinadarai sun zama masu wahala.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton matsalar daidaito a na'urorin gwajin su.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "aibi"; Gwamnati ta cire shingen da ke hana masu zaman kansu yin gwaji. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na China, amma ta gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya kasancewa sakamakon kasawar da aka samu wajen tattara samfurin ko kuma amfani da kayan gwajin daidai.
Ma'aikatar Spain ta ce za ta janye kayan aikin da ke ba da sakamako mara kyau, kuma za ta maye gurbinsa da wasu kayan aikin gwaji da Shenzhen Bioeasy ta samar. 80% na kayan aikin gwajin da Czech Republic ta saya daga China suna ba da sakamako mara kyau. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China waɗanda suka zama marasa daidaito.
Firayim Minista Matovič ya ba da shawarar a jefa kayan gwajin a cikin kogin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma ba sa "amfani da shi".
Gwajin, wanda ya biyo bayan keɓewar mutanen da suka gwada tabbatacce da kuma bin diddigin mutanen da suka yi hulɗa da mutanen da ke da tabbataccen SARS-CoV-2, ya ba da sakamako mai kyau.
Masu bincike da ke aiki a garin Vò na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan yawan mutane 3,400, a tsakanin kwanaki 10.
Kimanin rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma duk waɗanda aka gano sun keɓe kansu.
Ta hanyar hana mutane shiga cikin wannan al'umma, an kawar da sabon kamuwa da cuta gaba daya.
Tare da bin diddigin tuntuɓar haɗuwa, ƙuntatawa kan shigowa, gwaji, da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta haɓaka a hankali fiye da sauran ƙasashe masu tasowa duk da cewa babu takunkumi masu ƙarfi, kamar rufe gidajen abinci da kamfanonin sayar da kayayyaki.
An soke ayyuka da yawa, kuma Singapore ta shawarci mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23 ga Maris.
Wasu ƙasashe kuma sun magance annobar ta hanyar bin diddigin tuntuɓar haɗuwa, ƙuntatawa kan shigowa, gwaji, da keɓewa, amma tare da keɓewar yanki mai sauƙi, kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa ƙasashe da suka yi gwaji sosai, dangane da yawan mutuwar, suna da ƙananan ƙimar mutuwa, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano mutanen da ke da ƙananan alamun ko kuma marasa alamun.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji, da kuma dakunan gwaje-gwaje na ƙasa da ke da ƙarancin ƙwarewar COVID-19, su aika da samfuran COVID-19 masu kyau na farko biyar da samfuran mara kyau na farko goma zuwa ɗaya daga cikin dakunan gwaje-gwaje na WHO 16 don tabbatar da gwaji.
Daga cikin dakunan gwaje-gwaje 16 da aka yi amfani da su, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin ginshiƙi na gaba, shafi "% na gwajin sakamako mai kyau" ya shafi manufofin gwajin ƙasar.
Kasashen da suka gwada kawai mutanen da ke asibiti za su sami kashi mafi girma na sakamako mai kyau fiye da ƙasashen da suka gwada dukan jama'arsu, ko suna nuna alamun ko babu, tare da sauran abubuwan da suka dace.
Wanke hannu, wanda ake kira tsabtace hannu, aikin wanke hannu ne da ake yi don kawar da datti, mai, ƙwayoyin cuta, ko wasu abubuwa da ba a so.
Wanke hannuwanmu da sabulu a kai a kai a "ƙananan lokatai" na rana yana hana yaɗuwar cututtuka da yawa, kamar su diarrhea da kuma cutar kwalara, waɗanda ake yaɗawa ta hanyar ƙwayoyin cuta.
Mutane za su iya kamuwa da cututtukan numfashi, kamar su mura ko sanyi, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hancinsu, ko kuma bakinsu (watau, mucous membranes).
Abubuwa biyar masu muhimmanci na wanke hannu da sabulu a rana su ne: kafin da bayan yin fitsari, bayan wankewa da wankewa ko canza kayan wanki, kafin wankewa, kafin cin abinci da kuma kafin da kuma bayan shirya abinci ko sarrafa nama, kifi, ko kaji.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka.
Kafin, lokacin da ake dafa abinci da kuma bayan an gama.
Kafin mu kula da marasa lafiya da kuma bayan mu kula da su.
Bayan ka canja kayan wanka ko kuma ka tsabtace yaran da suka je bayan gida.
Bayan ka wanke hancinka, ka yi tari, ko kuma ka yi tari.
Bayan ka taɓa dabba ko abincin dabba ko kuma abin da dabba ta zubar.
Tsabtace hannu na asibiti yana nufin tsabtace da ke da alaƙa da hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kuma a yi magani zai iya hana ko rage yaduwar cuta.
Babban manufar likita na wanke hannu shine tsabtace hannu daga pathogens (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da haɗari ko cuta.
Wannan yana da muhimmanci musamman ga mutanen da suke kula da abinci ko kuma waɗanda suke aiki a fannin kiwon lafiya, amma yana da muhimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, ciki har da rage yaduwar mura, kwayar cutar korona, da sauran cututtuka masu yaduwa; hana cututtukan da ke haifar da zawo; rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a cikin gida.
Wani bincike da aka gudanar a shekarar 2013 ya nuna cewa ingantaccen wanke hannu na iya kara dan kadan a cikin tsayin jarirai.
A ƙasashe masu tasowa, ana iya rage mutuwar yara daga cututtuka na numfashi da na ciki ta wajen yin canje-canje a halayenmu, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage mutuwar mutane da kusan kashi 50 bisa ɗari.
Shigar da hankula a kan wanke hannu zai iya rage yawan cututtukan zawo da kashi uku; wannan za a iya yi ta hanyar samar da ruwa mai tsabta a yankunan masu karamin arziki.
Kashi 48% na raguwar cututtukan diarrhea za a iya danganta su da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da rahusa don hana diarrhea da cututtukan numfashi na gaggawa (ISPA), a matsayin halayyar da ba a sani ba da ake yi a gidaje, makarantu, da al'ummomi a duk duniya.
Ciwon huhu, wanda shi ne babban ISPA, shi ne sanadin mutuwa na farko na yara; cutar tana kashe yara kusan miliyan 1.8 a kowace shekara.
Ciwon zawo da ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
UNICEF ta ce, yin amfani da sabulu wajen wanke hannu kafin cin abinci da kuma bayan sun je bayan gida zai iya ceton rayuka fiye da allurar rigakafi ko kuma magani, kuma zai iya rage mutuwar masu ciwon tari da kusan rabi da kuma mutuwar masu kamuwa da cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana amfani da wanke hannu tare da sauran ayyukan tsabtace jiki a matsayin wani ɓangare na shirin ruwa, tsabtace jiki, da tsabta (WASH).
Wanke hannu yana kuma kāre mutum daga impetigo da ake yaɗawa ta wurin saduwa da mutane.
Wani karamin sakamako na wanke hannu shine wanke hannu sau da yawa na iya haifar da lalacewar fata daga bushewar fata.
Wani bincike da aka yi a shekara ta 2012 a Denmark ya gano cewa yawan wanke hannu yana iya haifar da yanayin fata mai itching da scaly, wanda aka sani da eczema na hannu ko kuma dermatitis na hannu, wanda yafi yawa tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa ma alama ce ta matsalar damuwa da damuwa (OCD).
Akwai lokuta masu mahimmanci guda biyar a cikin yini lokacin da wanke hannu da sabulu yana da mahimmanci don rage yaduwar cututtukan ta hanyar magunguna: kafin da bayan amfani da bayan gida (sharar gida, fitsari), bayan wankewa (canza diaper), kafin wanke yaro, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa nama, kifi, ko kaji.
Sauran lokatai da suke da muhimmanci wajen yin amfani da hanyoyin wanke hannu da suka dace don hana yaduwar cuta su ne kafin da kuma bayan kula da raunuka; bayan yin tari, tari, ko hura hanci; bayan ka taɓa dattin dabbobi ko kuma dabbobi; da kuma bayan ka taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike na 2015 game da wanke hannu a kasashe 54 ya gano cewa, a kan matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike na 2014 ya nuna cewa Saudi Arabiya ce ke da mafi girma da kashi 97 cikin dari; Amurka tana kusa da tsakiyar da kashi 77 cikin dari; da kuma China a mafi ƙasƙanci da kashi 23 cikin dari. Yanzu akwai wasu hanyoyin canza halayyar da za a iya inganta su don inganta al'adar wanke hannu da sabulu a lokuta masu mahimmanci.
Shirin Kula da Kiwon Lafiya na Farko da Ma'aikatar Ilimi ta yi a Philippines misali ne na matakan da suka dace don tallafa wa lafiyar yara da iliminsu.
Ba da maganin ɓarna sau biyu a shekara, tare da wanke hannuwanmu da sabulu kullum da kuma yin buroshin haƙora da fluoride kullum, shi ne ainihin shirinmu na kasa.
An kuma yi amfani da wannan shirin a ƙasar Indonesia.
Ana ƙara tsabtace ƙwayoyin cuta daga fata ta wajen ƙara sabulu ko kuma kayan tsabtace ruwa.
Babban aikin sabulu da na'urar wankewa shi ne rage shingen da ke hana ruwa narkewa da kuma kara narkewa.
Ruwa kaɗai ba shi da kyau wajen tsabtace fata domin kitse da kuma sunadarai, da suke cikin ƙazantar ƙwayoyin halitta, ba su narke cikin ruwa ba.
Duk da haka, isashen ruwa yana taimaka wajen kawar da kitse da kuma gina jiki.
Soap mai saurin bushewa, saboda yadda za a sake amfani da shi, yana iya ɗauke da ƙwayoyin cuta da aka samu daga amfani da su a dā.
Ƙananan nazarin da aka yi game da ƙwayar cuta da ke cikin sabulu mai guba sun kammala cewa ba zai yiwu ba domin baƙar cuta tana da yawa a cikin kumfa.
Duk da haka, CDC ta ce "safi mai narkewa da aka cire daga cikin kwano ba tare da an taɓa shi ba ya fi dacewa".
Ana tallata sabulu mai hana yin burodi a cikin al'umma mai kula da lafiyar jiki.
Har zuwa yanzu, babu tabbaci cewa amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta da aka ba da shawarar ya fi kyau ga kwayoyin da suka yi tsayayya da ƙwayoyin cuta a yanayi.
Amma, sabulu na hana ƙwayoyin cuta yana ɗauke da magungunan ƙwayoyin cuta na yau da kullum kamar triclosan, wanda ke da jerin ƙwayoyin cuta masu tsayayya.
Saboda haka, ko da yake ba a yi amfani da sabulu mai guba don yaƙi da ƙwayoyin cuta ba, amma ba zai yi tasiri sosai ba kamar yadda ake sayar da shi.
Baya ga surfactants da masu kare fata, ingantattun maganganu na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, benzoic acid a matsayin mai aiki na antimicrobial, da ƙarin mai sanyaya fata (crocodile limes, bitamin, man shanu, tsire-tsire na tsire-tsire). Wani cikakken bincike daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun yana da tasiri kamar sabulu mai ƙwayoyin cuta mai amfani da triclosan a cikin hana cututtuka da kuma tsabtace kwayoyin daga hannu.
Ruwa mai dumi da muke amfani da shi wajen wanke hannuwanmu ba ya da isashen zafi don ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 °C).
Soapy ruwan dumi ya fi ruwan sanyi tasiri wajen kawar da man da ke riƙe da ƙazanta da ƙwayoyin cuta.
Amma, ba kamar yadda mutane da yawa suka gaskata ba, nazarin kimiyya ya nuna cewa yin amfani da ruwan dumi ba ya rage ƙwayoyin cuta a hannu.
Sanitizer na hannu ko kuma maganin kashe wuka na hannu wakili ne na tsabtace jiki wanda ba ya dogara da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, an fara amfani da kayan tsabtace hannu na ruwa wanda ba shi da tushen barasa (wanda ake kira mai tsabtace hannu na giya, mai tsabtace hannu, ko kuma mai tsabtace hannu).
Yawancin waɗannan kayan aikin tsabtace suna da tushen isopropyl na giya ko ethanol wanda aka tsara tare da kayan ƙanshi kamar Carbomer (polymer na acrylic acid) zuwa gel ko tare da humektan kamar glycerin zuwa ruwa ko kumfa don sauƙin amfani da kuma rage tasirin bushewa na giya.
Ƙara hydrogen peroxide a cikin dilute yana ƙara haɓaka aikin antimicrobial. Hannun hannu wanda ke dauke da akalla 60-95% na barasa shine mai kashe ƙwayoyin cuta mai inganci.
Yin amfani da giya yana kashe ƙwayoyin cuta, ƙwayoyin cuta da suka yi tsayayya da magunguna da yawa (MRSA da VRE), ƙwayoyin cuta na tarin fuka, da ƙwayoyin cuta da yawa (har da HIV, herpes, RSV, rhinovirus, vaccinia, mura, da hepatitis), da fungi.
Rashin shan giya mai dauke da kashi 70% na kashe kashi 99.97% (rage log 3.5, kwatankwacin rage 35 decibels) na kwayoyin cuta a hannu 30 seconds bayan amfani da kuma kashi 99.99% zuwa 99.999% (rage log 4 zuwa 5) na kwayoyin cuta a hannu 1 minti bayan amfani.
Sanitizer na hannu na barasa kusan ba shi da tasiri ga kwayar cutar Norovirus (ko Norwalk), sanadin sanadin cututtukan gastroenteritis.
An shafa gaba da baya na hannaye biyu da gefuna da kuma ƙarshen dukkan yatsun hannu na kimanin dakika 30 har sai ruwan, kumfa, ko gel ya bushe.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar wanke hannu maimakon tsabtace hannu, musamman idan hannayen suna da datti.
An ƙara amfani da kayan aikin tsabtace jiki saboda sauƙin amfani da saurin kashe ayyukan microorganisms; duk da haka, kada a yi amfani da kayan aikin tsabtace jiki a matsayin maye gurbin wanke hannu daidai, sai dai idan sabulu da ruwa ba su samuwa.
Amfani da maganin shafawa na hannu na barasa na iya haifar da bushewar fata, sai dai idan an ƙara emollient da/ko moisturizer na fata zuwa ga tsari.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da/ko wasu emollients a cikin tsari.
A gwaji, maganin shafawa na hannu mai dauke da barasa wanda ke dauke da emollients yana haifar da rashin jin daɗi da bushewar fata fiye da sabulu da magungunan tsabtace ƙwayoyin cuta.
Allergic contact dermatitis, contact urticaria syndrome, ko kuma hypersensitivity ga barasa ko kuma abubuwan da ke cikin man shafawa na giya ba safai ake samu.
Ƙananan yiwuwar haifar da cututtukan fata na tuntuɓar da ke damun wannan samfurin fiye da wanke hannu da ruwa da sabulu.
Ko da yake yana da tasiri, wakili mara ruwa baya wanke hannu daga kayan ƙwayoyin cuta, amma kawai yana kashe su.
Saboda wannan dalili, mai tsabtace hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtuka da yawa domin masu cutar suna nan a hannu.
Amfanin aikin wanke hannu na rashin barasa ya dogara sosai da kayan da aka yi da shi, kuma bisa ga tarihi, wannan samfurin yana da matukar rashin inganci fiye da barasa da kuma man shafawa.
A kwanan nan, an nuna cewa maganin da ake amfani da shi da benzalkonium chloride yana da ci gaba da yin amfani da shi a matsayin maganin rigakafi bayan an yi amfani da shi, ba kamar giya ba, wanda aka nuna cewa yana rage amfani bayan an yi amfani da shi sau da yawa, wataƙila saboda ci gaba da tasirin sakamako.
Mutane da yawa a cikin ƙananan al'ummomi ba su iya sayan sabulu ba kuma suna amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙasa za su fi ruwa ƙarfi, amma ba za su fi sabulu ƙarfi ba.
Ɗaya daga cikin abubuwan da ake damuwa da su shi ne, idan aka gurɓata da ƙwayoyin cuta, ƙura ko ƙasa za su iya ƙara yaɗuwar cuta maimakon su rage.
Kamar sabulu, toka ma sanadiyar kashe ƙwayoyin cuta ce domin idan ta haɗu da ruwa, toka za ta zama ruwan ƙanshi.
Hukumar Lafiya ta Duniya ta ba da shawarar ash da yashi a matsayin madadin sabulu idan babu sabulu.
Hanyar wanke hannu daidai bisa ga shawarar Cibiyar Kula da Cututtuka ta Amurka don hana yaduwar cuta ta ƙunshi waɗannan matakan:
Ka wanke hannunka da ruwan dumi ko ruwan sanyi.
Ana ba da shawarar ruwa mai gudana domin ana iya gurɓata ɗakunan wanka da aka sanyaya, yayin da zafin ruwan bai nuna cewa yana da tasiri ba.
Ka wanke hannunka da sabulu mai yawa, har da bayan hannu, a yatsun hannu, da kuma ƙarƙashin ƙusa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna iya wanke hannayensu sosai sa'ad da suke amfani da sabulu fiye da idan suna amfani da ruwa kawai.
Ka shafe akalla dakika 20.
Yin wanka yana haifar da tashin hankali, wanda ke taimakawa wajen kawar da kwayoyin cuta daga fata, kuma yin wanka na dogon lokaci yana kawar da kwayoyin cuta da yawa.
Ka wanke shi sosai a ƙarƙashin ruwa mai gudu.
Yin wanka a cikin kwano zai iya sa hannu ya sake gurɓata.
Ka bushe da busassun ganye ko kuma ka bar su su bushe a iska.
Hannun da suka yi sanyi suna da saurin sake kamuwa da cutar. Wuraren da aka saba rasa su ne babban yatsa, wuyan hannu, tsakanin yatsun hannu, da kuma ƙusa.
Na'urar ƙusa da kuma fenti na ƙusa da aka cire suna iya adana ƙwayoyin cuta.
Ana ba da shawarar lotions masu danshi don kiyaye hannayen daga bushewa; bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za'a iya yin zaɓuɓɓuka masu tsada don sauƙaƙe wanke hannu lokacin da ba a samun ruwan famfo da/ko sabulu, misali, fitar da ruwa daga bututun mai ko kwalban da aka rataye da kuma rufewa da/ko amfani da toka, idan ya cancanta, a ƙasashe masu tasowa. A cikin yanayi inda samar da ruwa ya iyakance (kamar makarantu ko yankunan karkara a ƙasashen tasowa), akwai mafita mai amfani da ruwa, kamar "tippy-tap", da sauran zaɓuɓɓukan farashi.
Tattalin tap wani fasaha ne mai sauƙi da ke amfani da kwalban ruwa da aka rataye da igiya, da kuma wani abin da ƙafafun mutane suke amfani da shi don su zuba ruwa a hannayensu, da kuma sabulu.
Yin bushe-bushe hannu yana da muhimmanci a tsaftace hannu, amma akwai muhawara game da yadda za a bushe hannu a cikin gidan wanka.
Ƙarin bincike ya nuna cewa takarda tana da tsabta fiye da na'urar bushe hannu da ake samu a gidajen wanka da yawa.
A shekara ta 2008, wani bincike da aka gudanar da Jami'ar Westminster, London, kuma wanda masana'antar takarda ta bayar da tallafi ta European Tissue Symposium, don kwatanta tsabtar takarda, mai bushewar hannu mai iska, da kuma na'urar bushewar hannu ta zamani.
Bayan wanke hannu da bushewa da na'urar bushewa, an gano cewa adadin kwayoyin sun karu da kashi 194 cikin dari a kan littattafan hannu da kuma kashi 254 cikin dari a kan hannu.
Drying da jet iska na'urar bushewa ya haifar da wani matsakaita 42% karuwa a total adadin kwayoyin a kan na'urar bushewa na hannu da kuma 15% a kan dabino.
Bayan wanke hannu da bushewa da takarda, adadin kwayoyin sun ragu da kashi 76% a kan yatsunsu da kashi 77% a kan hannu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don tantance yiwuwar gurɓataccen gurɓataccen sauran masu amfani da gidan wanka da kuma yanayin gidan wanka saboda kowane irin hanyar bushewa.
Jirgin iska mai bushewa, wanda ke fitar da iska daga cikin na'urar a saurin da ake da'awar 180 m/s (650 km/h; 400 mph), yana iya hura kwayoyin cuta daga hannu da na'urar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar bushe hannu mai zafi yana yada kwayoyin halittar har zuwa mita 0.25 daga na'urar bushewa.
A cikin 2005, a cikin binciken da TÜV Produkt und Umwelt ya gudanar, an kimanta hanyoyin bushewa na hannu.
Bayan bushe hannu, an lura da canje-canje a yawan kwayoyin cuta:
Akwai masana'antun bushe-bushe da yawa, kuma an kwatanta bushe-bushe da bushe-bushe da takarda.
Wanke hannu ta amfani da tawul ɗin tsabtace hannu wani zaɓi ne yayin tafiya idan sabulu da ruwa ba su samuwa.
Tsabtace hannu na barasa dole ne ya ƙunshi aƙalla kashi 60% na barasa.
An ba da umarnin wanke hannu na likita tun bayan da ɗan ƙasar Hungary Ignaz Semmelweis ya gano cewa yana da tasiri (a shekara ta 1846) wajen hana cututtuka a asibitoci.
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa yawan kamuwa da cuta yana raguwa da amfani da na'urorin.
Ana wanke hannuwan likita na tsawon aƙalla dakika 15, ta amfani da sabulu da ruwa mai yawa ko gel don shafawa da goge kowane ɓangare na hannu.
Kuma a nẽmi hannãyenku daga kõwace irin nau'i na ƙura.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da goge gashi don cire shi.
Domin ƙwayoyin cuta suna iya tsira a cikin ruwa da ke hannunka, kana bukatar ka wanke hannunka sosai kuma ka bushe shi da tsabta.
Bayan an bushe, ana amfani da takarda don kashe famfo (da kuma buɗe ƙofar fita idan ya cancanta).
Wannan yana hana hannayen da aka yi amfani da su su sake gurɓata.
Manufar wanke hannu a cikin tsarin kiwon lafiya shine a kawar da kwayoyin cuta ("kuman") da kuma guje wa yaduwarsu.
The New England Journal of Medicine ta ba da rahoto cewa rashin wanke hannu har ila yana da girma sosai a yawancin wuraren kiwon lafiya, da yawancin likitoci da masu kula da jinya suna manta da wanke hannu kafin su taɓa marasa lafiya kuma suna yaɗa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu daidai da wasu ayyuka masu sauƙi na iya rage kamuwa da cututtukan jini da ke tattare da catheter da kashi 66 bisa ɗari.
Ana iya ganin ka'idodin tsabtar hannu na WHO a shafin yanar gizon ta don sharhi na jama'a.
Wani bita mai dacewa da Whitby et al.
Na'urar kasuwanci na iya auna da kuma tabbatar da tsabtar hannu idan an bukaci nuna bin ka'idoji.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" don wanke hannu:
bayan an yi masa jini/ruwa na jiki
kafin aikin aseptic, da kuma
Bayan an kula da mai haƙuri, ƙara sinadarai masu kashe ƙwayoyin cuta zuwa sabulu (sabulu "magani" ko "anti-microbial") yana kashe kayan wanke hannu.
Ana iya son wannan aikin kashewa kafin a yi tiyata ko kuma a yanayin da kwayoyin da ke da juriya ga maganin rigakafi suka zama ruwan dare. Don 'sanya' hannu kafin tiyata, ana buƙatar famfo wanda za'a iya kunnawa da kashewa ba tare da taɓa ba, mai wanke chlorhexidine ko iodine, takalmin da ba shi da tsabta don bushe hannaye bayan wanka, da goga mai tsabta don shafawa da sauran kayan aikin da ba su da tsabta don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Wannan aikin yana buƙatar wanke hannaye da ƙananan hannu har zuwa gwiwoyi, yawanci 26 minti.
Ba a bukatar dogon lokaci na yin gumi (minti 10).
Sa'ad da ake wanka, ya kamata a hana ruwa daga cikin hannu daga komawa hannunka.
Bayan an gama wanke hannu, sai a bushe hannu da kayan shafawa kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko kuma a yi amfani da maganin kashe ciwon hannu kafin da kuma bayan bi da mai ciwo.
Don kula da kamuwa da cutar staphylococcus a asibitoci, an gano cewa mafi girman fa'idar wanke hannu ya fito ne daga kashi 20% na farkon wankewar hannu, kuma cewa an sami fa'ida kaɗan lokacin da aka ƙara yawan wanke hannu sama da kashi 35%.
Wanke hannu da sabulu na yau da kullun yana haifar da sau uku na kamuwa da cuta ta hanyar abinci fiye da wankewa da sabulu mai guba. Kwatanta tsakanin wanke hannu tare da maganin barasa da wanke hannu tare da sabulu mai guba tare da matsakaicin lokaci na kowane sakan 30 ya nuna cewa wankin hannu mai tushen barasa ya rage gurɓataccen ƙwayoyin cuta 26% fiye da sabulu mai guba.
Duk da haka, sabulu da ruwa sun fi tasiri fiye da man shafawa na barasa don rage kwayar cutar H1N1 da Clostridium difficile daga hannaye.
Ana bukatar ƙarin bincike don a san abin da zai iya taimaka wa mutane a fannonin kiwon lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu an amince da shi a matsayin hanya mafi tsada da ta fi dacewa don samun lafiya da kuma cin abinci mai gina jiki.
Amma, rashin isashen ruwa, sabulu, ko kuma wuraren wanke hannu a gidajen mutane, makarantu, da kuma wuraren aiki ya sa makasudin samun ɗabi'ar wanke hannu a ko'ina ya zama ƙalubale.
Alal misali, a yawancin yankunan karkara na Afirka, ba a yawan samun famfo wajen wanke hannu kusa da gidajen wanka na jama'a ko na mutane, ko da yake akwai zaɓin wanke hannu da ba shi da tsada.
Duk da haka, rashin tsabtace hannu zai iya kasancewa saboda al'ada da aka kafa maimakon rashin sabulu ko ruwa.
Ƙarfafawa da kuma ƙarfafawa ga wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, ƙara wayar da kan jama'a game da amfanin wanke hannu, da kuma haifar da canjin halayyar jama'a na dogon lokaci.
Don ya yi aiki da kyau, ana bukatar kulawa da kuma kimantawa.
Wani nazari na tsari na nazarin 70 ya gano cewa tsarin tushen al'umma yana da tasiri wajen inganta wanke hannu a cikin LMIC, yayin da kamfen na tallace-tallace na zamantakewa bai yi tasiri ba. Daya daga cikin misalan wanke hannu a makarantu shine "Hanyar Taurari Uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi da rahusa don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran bukatun tsabta.
Lokacin da aka cimma matsakaicin matsakaicin, makarantar za ta iya motsawa daga tauraro ɗaya zuwa ƙarshe zuwa tauraro uku.
Gina wurin wanke hannu zai iya zama wani ɓangare na kamfen na inganta wanke hannu da ake yi don rage cututtuka da mutuwar yara.
Ranar Wanke Hannun Duniya wani misali ne na kamfen na wayar da kan jama'a da ke kokarin cimma burin sauya halayyar.
Wasu nazarin sun bincika tasirin jimlar farashin wanke hannu a ƙasashe masu tasowa dangane da guje wa shekara ta rai mai daidaitacce (DALY) ko kuma auna shekarun da aka rasa saboda rashin lafiya.
Wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi tsada fiye da ruwa da sauran hanyoyin tsabtace jiki.
Muhimmancin wanke hannu don lafiyar ɗan adam, musamman ga waɗanda suke cikin yanayi mai wuya, kamar uwa da ta haihu ko kuma soja da ya ji rauni a asibiti, an fara ganewa ne a tsakiyar ƙarni na 19 da majagaba biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis da ke aiki a Vienna, Austria, da Florence Nightingale, "mai kafa aikin jinya na zamani" a Ingila.
A lokacin, mutane da yawa suna da'awar cewa ana kamuwa da cuta ne ta ƙamshin ƙanshin da ake kira miasma ko kuma muguwar iska.
A shekarun 1980s, annobar da ke yaduwa ta hanyar abinci da kuma cututtukan da ke da alaƙa da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka suka ƙara ƙarfafa tsabtace hannu a matsayin muhimmin hanyar hana yaduwar kamuwa da cuta.
Barnar annobar mura ta aladu a shekara ta 2009 da kuma annobar COVID-19 a shekarar 2020 sun kara wayar da kan mutane a kasashe da dama game da muhimmancin wanke hannu da sabulu don kare kansu daga cutar.
Alal misali, ana saka allon "daidaitaccen wanke hannu" kusa da wanka a gidajen wanka na jama'a da kuma na ofisoshin gwamnati da kuma na filayen jirgin sama a Jamus.
Furucin nan "wanke hannuwansa" yana nufin cewa mutum ya ƙi ya ɗauki wani hakki ko kuma ya saka hannu a wani abu.
Wannan furcin ya fito ne daga littafin Matta sa'ad da Bilatus Babunti ya yanke shawarar gicciye Yesu Kristi, amma ya zama furci da aka yi amfani da shi sosai a ƙasar Ingila.
A Shakespeare, Macbeth, Lady Macbeth ta fara wanke hannunta a kai a kai don wanke tabo na tunanin; wani aiki da ke nuna laifinta game da laifin da ta aikata kuma saboda ta rinjayi mijinta ya yi hakan.
An kuma gano cewa, bayan tunawa ko yin tunani game da ayyukan rashin ɗabi'a, mutane suna da saurin wanke hannu kuma suna da saurin daraja kayan wanke hannu.
Bugu da ƙari, mutanen da aka ƙyale su su wanke hannayensu bayan wannan tunani sun fi saurin shiga cikin ayyukan "tsabtace" na diyya, kamar su ba da kansu.
Addini ya ba da umarnin wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, wanda ke amfani da ruwa, amma ba tare da sabulu ba don wanke hannu, wani ɓangare ne na al'adar wanke hannu a cikin addinai da yawa, ciki har da Bahá'í, Hindu, tevilah da netilat yadayim a cikin Yahudanci, Lavabo a cikin Kiristanci, da Wudhu a cikin Musulunci. Addini kuma ya ba da umarnin wanke hannu don tsabta, musamman bayan wani aiki.
Addinan Hindu, Yahudawa, da Musulmai suna bukatar a wanke hannu bayan an je wanka.
Bugu da ƙari, addinan Hindu, Buddha, Sikh, Yahudawa, da Musulmai suna bukatar a wanke hannaye kafin da kuma bayan cin abinci.
Gudanar da haɗarin aiki don COVID-19
Gudanar da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin lafiya da kiwon lafiya na aiki don kula da haɗari don rigakafin cutar coronavirus 2019 (COVID-19).
Kula da haɗari a wurin aiki ya dogara da wurin aiki da aikin da aka ba da shi, wanda ya dogara da kimantawa na tushen haɗarin fallasa, da kuma yanayin cutar a cikin al'umma, da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aiki (OSHA), ayyukan da ke da hadarin ƙarancin haɗari suna da ƙarancin hulɗa da jama'a da sauran abokan aiki; don wannan aikin, ana ba da shawarar matakan rigakafin kamuwa da cuta na asali, wanda ya haɗa da wanke hannu, ƙarfafa ma'aikata su zauna a asibiti idan an yi musu asibiti, ɗabi'ar numfashi, da yin tsabtace wuri da kuma tsabtace yanayin aiki a kai a kai.
Ayyukan da ke da haɗarin haɗari na yau da kullun sun haɗa da ayyukan da ke buƙatar kusanci ko yawan hulɗa da mutumin da ba a san ko ana zargin yana da COVID-19, amma yana iya kamuwa da cutar saboda watsawa a cikin al'umma da ke gudana ko tafiya ta duniya.
Wannan rukunin ya hada da ma'aikata da ke da alaƙa da jama'a kamar a makarantu, wuraren aiki masu yawan jama'a, da kuma manyan kayayyakin sayar da kaya.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da iska mai iska mai ƙarfi, kariya daga tari, da samar da kayan kariya na mutum idan ya haɗu da mai cutar COVID-19.
OSHA ta yi la'akari da ma'aikatan kiwon lafiya da gawawwakin da aka fallasa ga mutanen da aka sani ko ake zargi da cutar COVID-19, suna da babban haɗarin fallasa, wanda ya ƙaru zuwa babban haɗarin fallasa idan ma'aikata suka yi aikin samar da aerosol a kan, ko kuma karɓar ko sarrafa samfuran daga, mutanen da aka sani ko ake zargi da cutar COVID-19.
Kula da haɗarin da ya dace da ma'aikaci ya haɗa da kula da fasaha, kamar su ɗakunan iska masu matsin lamba, da kayan kariya na mutum wanda ya dace da aikin aiki.
Cutar COVID-19 na iya yin tasiri a wuraren aiki.
Ma'aikata suna iya ƙin zuwa aiki domin rashin lafiya, suna bukatar su kula da wasu, ko kuma suna tsoron yiwuwar haɗari.
Yanayin kasuwanci na iya canzawa, ko dai game da irin kayan da ake nema ko kuma yadda ake samun waɗannan kayan (kamar sayayya bayan sa'o'i, ta hanyar jigilar kaya, ko kuma a kan layi).
A ƙarshe, jigilar kayayyaki daga yankuna masu tasowa waɗanda ke da tasirin COVID-19 na iya zama mai rikitarwa. Za a iya amfani da shirye-shirye da shirin magance cututtukan cututtuka don jagorantar matakan kariya.
Shirin ya yi la'akari da matakan haɗari da ke tattare da wurare da ayyuka na aiki, ya haɗa da tushen fallasa, abubuwan haɗari da ke tasowa daga gida da kuma al'umma, da kuma abubuwan haɗarin ma'aikaci na mutum, kamar tsufa ko kuma yanayin rashin lafiya na kullum.
Shirin ya kuma bayyana matakan da ake bukata don magance hadarin da kuma shirin gaggawa na yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen cututtuka da tsare-tsaren su na iya zama abin da ya dace a kasa ko kuma a yankunan da ba su da lafiya.
Manufofin kamuwa da cutar sun hada da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke cikin babban hadarin cututtukan kiwon lafiya, kiyaye ayyukan kasuwanci, da rage tasirin illa ga sauran kamfanoni a cikin sarkar samar da kayayyaki.
Matsayin cutar a cikin al'ummar da kasuwancin ke ciki yana shafar matakan da ake ɗauka.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai a cikin lafiyar aiki da kiwon lafiya don rarraba kula da haɗari bisa ga tasirin su.
Idan ba za a iya kawar da haɗarin COVID-19 ba, sarrafawa mafi inganci shine sarrafa fasaha, biye da sarrafawa na gudanarwa, kuma ƙarshe kayan kariya na mutum.
Gudanar da fasaha ya ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da halayen ma'aikata ba kuma yana iya zama mafi kyawun mafita mai tsada don aiwatarwa.
Gudanar da aiki shi ne canji a cikin manufofin aiki ko hanyoyin da ke buƙatar ma'aikaci ko mai aiki ya yi aiki.
Kayan kariya na mutum (APD) an ɗauka ba su da tasiri fiye da sarrafa fasaha da gudanarwa, amma suna iya taimakawa wajen hana wasu fallasa.
Duk nau'ikan APDs dole ne a zaba bisa haɗarin da ke tattare da ma'aikata, a shigar da su yadda ya kamata (misali, masu numfashi), a saka su daidai da kuma daidai, a duba su, a kula da su, a sauya su a kai a kai, idan ya cancanta, kuma a cire su, a tsabtace su, a adana su da kyau ko a zubar da su don kauce wa gurɓatawa.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Aiki (OSHA) ta Amurka, ayyukan da ke da hadarin rashin haɗari suna da ƙarancin hulɗa da jama'a da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sun haɗa da yawan wanke hannu sosai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ɗabi'ar numfashi ta haɗa da rufe tari da tari, samar da kayan shafawa da kwandon shara, shirya aiki na nesa ko juyawa aiki tare da lokaci mai zuwa / dawowa, idan ya cancanta, gaya wa ma'aikata kada su yi amfani da kayan aiki da kayan aikin wasu, da yin tsabtace da kuma tsabtace yanayin aiki a kai a kai.
Ganowa da sauri da kuma ware mutane da ke da yiwuwar yaɗuwar cutar muhimmin mataki ne na kāre ma'aikata, abokan ciniki, baƙi, da kuma wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) na Amurka sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi na yau da kullun su zauna a gida har sai sun sami 'yanci daga zazzabi, alamun zazzabi, da sauran alamun cutar aƙalla awanni 24 ba tare da shan maganin rage zazzabi ko wasu magungunan canza alamun cutar ba, kuma cewa manufofin hutun rashin lafiya su kasance masu sassauci wanda zai ba ma'aikata damar zama a gida don kula da dangin da ke rashin lafiya, kuma cewa ma'aikata sun san wannan manufar.
A cewar OSHA, ayyukan da ke da haɗarin haɗari sun haɗa da ayyukan da ke buƙatar kusanci ko sau da yawa a tsakanin ƙafa shida (1.8 mita) tare da mutumin da ba a san ko ana zargin yana da COVID-19, amma yana iya kamuwa da SARS-CoV-2 saboda yaduwar jama'a a kusa da wurin kasuwancin, ko kuma saboda wani ya yi balaguron ƙasa da ƙasa zuwa wurin da ke da yaduwar COVID-19.
Kulawa ta gudanarwa ga waɗannan rukunin da rukunin haɗarin haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, maye gurbin haɗarin haɗuwa da haɗarin sadarwa ta kamala, sanya aikin aiki tare da lokutan isowa / dawowa a hankali, dakatar da tafiye-tafiye marasa mahimmanci zuwa wuraren da ke fuskantar cutar COVID-19, haɓaka wasu tsare-tsaren sadarwa na gaggawa don amsa damuwar ma'aikata, haɓaka ma'aikata tare da ilimin zamani da horo game da haɗarin COVID-19 da halayyar kariya, horar da ma'aikata da ke amfani da tufafi da kayan kariya game da amfani da su, samar da albarkatu da tallafawa tsabtace jiki da kuma buƙatar samun damar abokan ciniki a kai a kai, sanya takunkumi a kan fuska, sanya takunkumin rufe fuska, sanya takunkumin rufe fuska ko takunkumin rufe fuska, kiyaye abokan aiki daga COVID-19, ko dai aƙalla a haɗa su da matakan kiyayewa na yau da kullun, kiyayewa da kiyayewa na yau da kullun, kiyayewa da kiyayewa na yau da kullun, kiyayewa da kiyayewa na COVID-19 da kuma kiyayewa.
Ma'aikata da ke cikin wannan rukunin masu haɗari ba sa bukatar na'urar numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mai ciwo daga wasu mutane da nisan ƙafa 6, sanya ma'aikacin jirgin sama ɗaya don kula da mai ciwo, da kuma ba da abin rufe fuska ga mai ciwo ko kuma ya sa su rufe bakinsu da hanci da tawul lokacin da suke yin tari ko hancin.
Ma'aikatan jirgin ya kamata su sanya safofin hannu na likita na lokaci guda lokacin kula da fasinjoji marasa lafiya ko kuma taɓa ruwan jiki ko wuraren da ke da cutar kuma wataƙila wasu kayan kariya idan fasinjoji marasa lafiya suna da zazzabi, suna yin tari a kai a kai, ko kuma suna da wahalar numfashi.
Don safarar kasuwanci, gami da jiragen ruwa masu yawon shakatawa da sauran jiragen ruwa masu jigilar kaya, kula da haɗari ya haɗa da jinkirta tafiya idan ba shi da lafiya, keɓe kansa, da sanar da cibiyar kiwon lafiya a cikin jirgin nan da nan idan mutum ya sami zazzabi ko wasu alamun bayyanar yayin da yake cikin jirgin.
A mafi kyau, ana biye da lafiyar a cikin ɗakunan mutane masu keɓewa. Baya ga yaduwar a cikin al'umma, ga makarantu da wuraren kula da yara, CDC tana ba da shawarar rufewa na ɗan lokaci don tsabtace ko kuma kashe cutar idan mutumin da ke da cutar ya taɓa kasancewa a cikin ginin makaranta.
Idan akwai ƙarancin yaduwar cutar a cikin al'umma, ana iya aiwatar da dabarun hana jama'a, wanda ya haɗa da: soke ziyarar filin, tarurruka, da sauran manyan tarurruka, kamar su ilimin motsa jiki, darussan ƙungiyar mawaƙa, ko cin abinci a cafeteria, ƙara tazarar tebur, lokutan isowa da dawowa a hankali, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓun wuraren ofisoshin kiwon lafiya don yara masu alamun kama da mura.
Idan akwai yawan kamuwa da cuta a cikin al'ummar yankin, ban da dabarun hana jama'a, za a iya yin la'akari da tsawaita rufe makarantun.
An ba da shawarar cewa jami'an tilasta bin doka waɗanda ke da alaƙa da waɗanda aka tabbatar ko ake zargi da COVID-19 su bi ƙa'idodin da ake bi na masu fasahar likita na gaggawa, gami da amfani da kayan kariya na mutum.
Idan kusanci ya faru yayin kamawa, ma'aikata dole ne su tsabtace da kuma tsabtace bel da kayan aiki kafin sake amfani da su ta hanyar amfani da spray ko labule na tsabtace gida kuma su bi ka'idodin aiki na yau da kullun don sarrafawa da zubar da APD da aka yi amfani da su da kuma sarrafawa da wanke tufafi masu datti.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da kuma gawawwakin a matsayin waɗanda ke da haɗarin haɗari mai yawa ko kuma mai tsanani.
Ayyukan haɗarin haɗari sun haɗa da bayar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da ma'aikatan sufuri na likita waɗanda ke fuskantar sanannun ko waɗanda ake zargi da COVID-19.
Wannan aikin yana da haɗarin haɗari sosai idan ma'aikata suna yin aikin samar da aerosol a kan, ko kuma karɓar ko sarrafa samfuran daga, wani sanannen ko wanda ake zargi da COVID-19.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin shigar da tari, bronchoscopy, wasu hanyoyin da binciken hakori, ko kuma daukar samfurori masu yaduwa.
Ayyukan dakin gawa na haɗarin haɗari sun haɗa da ma'aikata da ke cikin shirya gawawwakin mutanen da aka sani ko ake zargi da cutar COVID-19 a lokacin mutuwa; wannan aikin ya zama mai haɗarin haɗari sosai idan ma'aikata suka yi autopsy.
Ana iya yin amfani da iska mai matsi mai ƙarfi a wasu wuraren kula da lafiya da kuma a ɗakunan gawa.
Za a kula da samfurin da matakan tsaro na Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware masu zuwa cikin dakunan jira daban-daban bisa la'akari da cewa ana zargin su da cutar COVID-19. Baya ga sauran APD, OSHA ta ba da shawarar masu aikin numfashi a cikin nisan ƙafa 6 daga marasa lafiya da aka sani ko ake zargin suna da cutar SARS-CoV-2, da kuma mutanen da ke aiwatar da hanyoyin samar da aerosol.
A Amurka, dole ne a yi amfani da rigakafin numfashi na fuska mai N95 da aka amince da NIOSH ko mafi kyau a cikin mahallin ingantaccen tsarin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo, da kuma binciken likita.
Wasu nau'ikan na'urorin numfashi na iya samar da kariya mafi girma da kuma inganta kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar rufe tufafi ko coverall saboda COVID-19 cuta ce ta numfashi ba ta hanyar ruwan jiki ba.
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska na tiyata ne kawai ga ma'aikatan bincike a wuraren shiga.
Ga mutanen da ke daukar samfurin numfashi, kula, ko kuma jigilar marasa lafiya na COVID-19 ba tare da yin amfani da hanyoyin samar da aerosol ba, WHO ta ba da shawarar sanya abin rufe fuska, tabarau masu kariya, ko makamai na fuska, riguna, da safofin hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska da na'urar numfashi ta N95 ko FFP2.
Ganin cewa wadatar APD ba ta isa a duniya, WHO ta ba da shawarar rage buƙatun APD ta hanyar sabis na kiwon lafiya na nesa, ƙuntatawa ta jiki kamar windows masu gani, tare da mutanen da ke cikin kulawa kai tsaye kawai za su iya shiga ɗakin da ke dauke da marasa lafiya na COVID-19, amfani da APD kawai da ake buƙata don takamaiman aiki, ci gaba da amfani da na'urar numfashi iri ɗaya ba tare da cire ta ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya, saka idanu da daidaita sarkar samar da APD, da kuma hana ƙarfafa amfani da abin rufe fuska ga mutanen da ba su da alamun.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
A WANNAN: Dukan ma'aikatan Gidauniyar Wikimedia
TAMBAYA: [COVID-19] Yin sauƙaƙa kaya da kuma shirya don nan gaba
RANAR SHAFI: 14 ga watan Maris na shekarar 2020, 00:24 UTC
Ba a kiyaye duk haƙƙoƙi ba
Mun tsinci kanmu cikin yanayi mai ban mamaki a wannan watan.
Cutar COVID-19 ita ce ta nuna yadda 'yan Adam suke da alaƙa da juna da kuma nawayar da muke da ita ga juna.
Ba mu taɓa fuskantar irin wannan kalubalen ba, amma mun san cewa amsarmu mafi kyau ta dogara ne da nuna juyayi, haɗin kai, da kuma gina al'umma ta duniya, wanda shine zuciyar wannan kungiya.
Abokantaka da kulawar da muka gani tsakanin dukkan abokan aikinmu ta hanyar imel, kira, da hira, tabbaci ne na musamman na mutane masu ban mamaki, waɗanda muke da sa'a sosai, don yin aiki tare da su.
Ina godiya kuma ina alfahari da ku duka don kasancewa abokan aiki.
A makon da ya gabata, wani ya nuna mini godiyarsa ga aikin da muke yi.
Sun tunatar da ni yadda muhimmancin samun damar Wikipedia yake a duniya a yau da kuma yadda wannan alama ce mai karfi da wannan muhimmin abu zai kasance a kan layi ga kowa.
Aikinku ne ya sa hakan ya yiwu, ko kun kiyaye shafin yana gudana, ko kun taimaka wajen biyan abokan aikinmu, ko kuma kun taimaka wajen kiyaye al'ummarmu lafiya.
Duniya na bukatar bayanin da Wikipedia ke bayarwa, musamman a wannan lokacin.
Wannan lokaci ne da ba wai kawai aikin da muke yi ba, amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma matsayin da kuke da shi, za mu yi wasu muhimman gyare-gyare ga yadda muke aiki tare, da za mu fara mako mai zuwa.
Yin gyara a aikinmu da kuma tsarinmu
Kamar yadda Robyn ta ambata, ƙungiyar C ta taru a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muke ganin shi ne amsar da ta dace ga ƙalubalen da muke fuskanta da kuma yadda za mu ci gaba da kasancewa da ƙungiya a wannan lokaci.
Muna son mu kawar da matsin lamba kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka rage sa'o'i a aiki, hakan zai dace.
Ga dukkan ma'aikata, 'yan kwangila, da ma'aikatan kwangila:
Aikinmu na yau da kullum zai kasance na awa hudu a rana, ko kuma awa 20 a mako, har sai mun samu karin bayani.
Ba mu sanya ranar hutu ba, idan za ku iya yin aiki fiye da yadda ya kamata, wannan aikin yana buƙatar ku.
Duk da haka, duniya ba ta da tabbas a yau, kuma ko kana bukatar ka kula da ƙaunataccenka, ka je cin kasuwa, ko kuma ka je wurin likita, lafiyarka ce fifiko a gare mu.
Ba ma lura da lokacin aikinku.
Idan kana rashin lafiya, kada ka yi aiki.
Bai kamata a ce ba, amma mun ce.
Ba a bukatar hutu na rashin lafiya ko kuma PTO, kawai ka sanar da manajanka kuma ka taimaki ƙungiyarka ta sake duba kalandarka da kuma tsarinka don ka tabbata cewa an kammala manyan ayyukan.
(Idan ka kamu da cutar COVID-19, ka sanar da Bryan a cikin T&C Ops don T&C su taimaka da tallafi da kuma tabbatar da cewa an kula da yanayinka daidai daga manajan.)
Waɗanda suke biyan kuɗi bisa ga sa'o'i za a biya su a cikakke.
Mun faɗi haka, kuma za mu sake faɗi hakan, don mu girmama alkawarinmu ga abokan aikinmu da ma'aikatanmu na sa'o'i.
Za a biya kowa daidai da lokacin da aka saba aiki.
Hakan ya haɗa da idan ka yi rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son yin aiki, muna goyon bayanka.
Mutane da yawa suna amfani da aikinsu don su saka wa duniya da ke kewaye da su matsi.
Aikinmu zai iya kawo mana gamsuwa sosai, musamman a wannan lokacin.
Bugu da ƙari, abu mafi muhimmanci shi ne ka kula da kanka.
Abin da muke so shi ne ka yi magana da manajanka domin mu san abin da za mu yi tsammani kuma mu ɗauki mataki.
Ana ɗaukan wasu ayyuka da muhimmanci.
Akwai wasu ayyuka da za a ci gaba da yi.
SRE, Ayyukan Kayan Adam, Amincewa da Tsaro, da kuma ƙungiyar Tattara Kuɗi, a tsakanin sauran su, suna yin muhimmin aiki wanda zai buƙaci ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu kuma mu mai da hankali kan tallafawa abubuwan da suka dace da aikinmu.
Akwai abubuwa da yawa da za a yi wa kowa, za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Rage lokaci a yanzu ba zai amfane mu ba a nan gaba.
Ba mu da shirin "yin aiki na dogon lokaci don mu ci gaba da kasancewa a baya" bayan annobar ta wuce.
Ba za a bukaci ka yi aiki na sa'o'i da yawa don ka cika wasu takunkumi da ba za ka iya ba.
Mun san cewa yanayin yana canjawa kuma za mu yi ƙoƙari mu kafa sababbin maƙasudai da kuma lokaci idan ya cancanta.
Yaya game da APP?
Don daidaitawa da sabon gaskiyar da kuma tsammanin lokutan aiki na yau da kullun, muna da niyyar daidaita lokacin aiwatar da Shirin Shekarar 2020-2021.
Manufarmu ita ce ta ba da shawarar tsawaita shirin 2019-2020 wanda zai ba da ƙarin lokaci don tsara kasafin kuɗi don ma'aikata su iya fifita mahimman ayyuka, kula da kansu, da kula da ƙaunatattun su yayin da suke ba da izinin waɗanda ke buƙatar ko suke son yin aiki tare da ƙaramin jadawalin a cikin makonni masu zuwa.
Ƙara wannan lokaci yana rage yawan aiki da kuma matsin lamba na tsara abubuwa a dukan ƙungiya.
Za mu gabatar da shawarwarinmu ga majalisar a mako mai zuwa kuma za mu sabunta wakilai da kuma tawagar a kan mataki na gaba da zarar mun sami tabbaci.
Na gode wa tawagar APP don jagorancinku a wannan.
Matsayi, nunawa, da kuma tsabtace ofis
A makon da ya gabata, an sanar da mu cewa wani abokin aikinmu da ke birnin SF ya kamu da cutar COVID-19.
Amma, don muna da damuwa sosai, mun yi hayar wani rukunin masu tsabtace ƙwayoyin cuta don su tsabtace dukan wuraren da ke ofishinmu a San Francisco.
Suna amfani da maganin rigakafi na asibiti don kashe kowace farfajiya, kofar shiga, ko kuma duk wani abin hawa da ke shiga bene.
Masu ginin suna aiwatar da tsarin tabbatar da lafiyarsu ta hanyar amfani da kayayyakin da ke tallafawa lafiyar masu haya.
Muna farin ciki cewa za mu sami ofishin da za mu yi amfani da shi sa'ad da muka yanke shawarar komawa.
Ofishinmu na DC yana WeWork, wanda ya raba mana da duk ma'aikatanmu na DC tsarin COVID-19.
A makon da ya gabata, ofishinmu na D.C. ya koma aiki na nesa, daidai da jagororin da aka ba San Francisco.
Kamar yadda wasu abokanmu da ke birnin New York suka sani, muna tattauna batun yin hayan wani wuri a Brooklyn.
Wannan tattaunawar tana ci gaba, amma za a iya jinkirta.
Wasu abokan aikinmu sun fara aiki daga nesa.
Abokanmu da suka daɗe suna yin aiki daga nesa sun fahimci cewa wataƙila za a yi gyara kuma suna son su ba ka shawara:
Ka ƙayyade tsawon taron sa'a ɗaya ko biyu.
Idan ana bukatar ƙarin lokaci, ka yi la'akari da raba shi zuwa kwanaki da yawa.
Ka bayyana taron da kyau, ka tsara jadawalin, kuma ka aika da karatun da za ka yi a gaba.
Sanya bidiyo a matsayin tsoho, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka naɗa shugaba don ya yi wa kowane taro ja-gora, wani ya lura da tattaunawar don tambayoyi da kuma rubuta jerin masu magana, kuma wani ya taimaka wajen yin bayanin taron (ko kuma yin rubutu a kan haɗin kai).
Aika imel zuwa tallafi na fasaha idan kana bukatar kayan kunne masu dadi.
Ka yi amfani da kuɗin da kake samu don ka sayi abinci.
Shiga cikin tashar #remoties akan Slack don tattaunawa da abokan aiki game da aikin raba
Ƙungiyar Ayyukan HR tana neman jagororin ergonomics na yanar gizo don tallafawa haɓaka aikin rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma su soke taron jama'a da Wikimedia ke tallafawa, kamar su Edit-a-thon, har sai WHO ta ce annobar ta ƙare.
Mun gaya musu cewa mun fahimci cewa bukatarmu ta sokewa da sauran takunkumi na iya hana su kammala aikin tallafin da aka amince da shi kuma ba za a hukunta kowa ba saboda jinkirta ko gyara wannan burin.
A mako mai zuwa za mu ci gaba da ƙarin jagora game da Wikimania da sauran taron al'ummomin yanki da na batutuwa.
Gabaɗaya, jin daɗin da ke cikin jama'ar duniya yana da baƙin ciki game da wannan katsewar, amma kuma yana da sauƙi game da tsabta da ikon mayar da hankali ga al'ummarsa, duka Wikimedia da sauransu.
A nan gaba, CRT tana aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma bin hanyoyin sadarwa da muke yi da su.
Ku kasance a cikin hanyar sadarwa yayin yanayin COVID-19
Za mu aika muku da gayyatar ranar Alhamis mai zuwa, da ƙarfe 2:00 UTC zuwa 7:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ɗaukar lokaci don haɗi tare.
Muna cikin wannan yanayin kuma muna so mu taimaka yadda za mu iya.
A halin yanzu, za ka iya ci gaba da samun bayanai daga wannan imel da kuma sauran muhimman bayanai game da COVID-19 a Office Wiki.
CRT za ta ci gaba da sabunta wannan shafin kuma ta tabbata cewa duk bayanan suna cikin wuri guda.
Muna kuma ƙoƙarin ci gaba da sadarwa a kai a kai da ma'aikatanmu da ke zaune a ƙasashen da aka yi wa illa sosai.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, manyan hanyoyin aiki, ko kuma matsaloli game da ɗaukar hoto, ko kuma wani abu da zai buƙaci taimako, kada ka yi jinkirin sanar da CRT kuma ka yi aiki tare da ita.
Muna nan don mu taimaka da kuma ba da tallafi idan ya cancanta.
Idan kana da wata matsala ta sirri ko kuma mai saukin ganewa, ka aika imel zuwa ga Bryan Judan, Daraktan Ayyuka na Duniya na Human Resources International.
Kada a ɗauki waɗannan canje-canjen a matsayin yin watsi da aikinmu da kuma hakkinmu.
Maimakon haka, wannan canji ya nuna cewa, a yanzu, aikinmu da kuma hakkokinmu suna bukatar a daidaita su a hanyoyi da ba mu taɓa yi ba.
Waɗannan canje-canje matakai ne da muka yi imanin suna da mahimmanci don tallafawa juna a cikin wannan yanayin don mu ci gaba da aiki, samar da tallafin da ake buƙata ga motsinmu, da kuma samar da duniya da sabis ɗin da suke dogara da shi.
Aikin da muka shirya zai kasance a wurin da zai yi mana ja-gora sa'ad da lokaci ya yi.
A yanzu, lokaci ya yi da za mu tallafa wa juna da kuma samar da sarari ga muhimman ayyuka da za su zo cikin makonni da watakila watanni masu zuwa.
Muna bukatar ku duka don yin hakan, don haka, muna son ku kula da kanku da iyalanku don ku iya yin aiki mafi kyau a lokacin da ake buƙata.
A ƙarshe, ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran membobin Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-modifying enzyme 2 (ACE2) enzyme ne wanda ke manne da waje na kwayar halitta (mambran sel) a cikin huhu, jijiyoyi, zuciya, koda, da kuma hanji.
ACE2 yana da aikin da ya saba wa enzyme mai canza angiotensin (ACE), ta hanyar rage adadin angiotensin-II da haɓaka Angiotensin (1-7), yana mai da shi wata alama mai ban sha'awa don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin hanyar shiga cikin sel don wasu coronavirus.
An kira ACE2 ɗan adam da hACE2.
Enzyme mai jujjuya angiotensin 2 shine zinc-containing metallosymmetry wanda ke kan farfajiyar endothelial da sauran ƙwayoyin halitta.
Kwayar ACE2 tana da yankin M2 na peptidase na ƙarshe-N da kuma yankin jigilar amino acid na renal na ƙarshe-C.
ACE2 shine mai amfani da membrane mai nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
An cire yankin ACE2 na waje daga yankin transmembrane ta wani enzyme, wanda aka sani da sheddase, kuma an samar da furotin mai narkewa a cikin jini kuma an cire shi a cikin fitsari.
ACE2 yana cikin yawancin gabobin: ACE2 yana manne da membrane na sel musamman nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
An kuma gano bayyanar mRNA ACE2 a cikin cerebral cortex, striatum, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine a matsayin mai daidaita ACE.
ACE tana karya hormone angiotensin I zuwa angiotensin II ta hanyar vasokonstriktion.
A ƙarshe, ACE2 ya yanke amino acid phenylalanine na carboxyl na ƙarshe daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya hydrolyze shi zuwa angiotensin (1-7) mai fadada jini (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya karya wasu peptides da suka hada da [des-Arg9] -bradikinin, apelin, neurotensin, dinorphine A, da ghrelin.
ACE2 kuma yana daidaita zirga-zirgar membrane na SLC6A19 mai ɗaukar amino acid kuma yana da hannu a cikin cutar Hartnup.
A matsayin furotin na membrane, ACE2 yana aiki a matsayin babban wurin shiga cikin sel don wasu ƙwayoyin cuta, waɗanda suka haɗa da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, ɗaure furotin S1 a kan SARS-CoV da SARS-CoV2 spikes tare da yankin enzymatic ACE2 a farfajiyar ƙwayoyin cuta yana haifar da endosytosis da kuma sauya kwayar cutar da enzyme zuwa cikin endosomes da ke cikin ƙwayoyin cuta.
Wannan shigarwar kwayar cutar kuma tana buƙatar priming na furotin S ta mai masaukin TMPRSS2, wanda hana shi a halin yanzu ana binciken shi azaman magani mai yuwuwa. Wannan ya haifar da hasashen cewa rage matakan ACE2 a cikin ƙwayoyin cuta na iya taimakawa wajen yaƙar kamuwa da cuta.
Duk da haka, yawancin ƙungiyoyi masu sana'a da hukumomi masu tsarawa suna ba da shawarar ci gaba da maganin ACE da kuma ARB na yau da kullum.
Wani nazari da kuma nazarin tsarin, wanda aka buga a ranar 11 ga Yuli, 2012, ya gano cewa "amfani da masu hana ACE ya haifar da raguwar 34% a cikin haɗarin ciwon huhu idan aka kwatanta da na kula".
Bugu da ƙari, "amfani da masu hana ACE ya kuma rage haɗarin ciwon huhu a cikin marasa lafiya da ke da haɗarin ciwon huhu, musamman marasa lafiya da ke fama da bugun jini da kuma rashin ƙarfi na zuciya.
Amfani da masu hana ACE an kuma danganta shi da rage mutuwar da ke da nasaba da ciwon huhu, ko da yake sakamakon ba shi da ƙarfi idan aka kwatanta da haɗarin ciwon huhu gaba ɗaya".
Ana sa ran ACE2 na mutum mai haɗuwa (rhACE2) ya zama sabon magani don raunin huhu na huhu, kuma ya bayyana don haɓaka haemodynamics na huhu da ƙoshin oxygen a cikin berayen da ke da cutar rashin ƙarfi na lipoplysakaride.
Rabin rayuwar rhACE2 a cikin mutum kimanin awa 10 tare da tsawon aiki na minti 30 ban da tsawon sakamako (tsawon) awa 24.
Wasu binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga marasa lafiya tare da rashin haƙuri ga masu hana tsarin ronin-angiotensin (mai hana RAS) ko kuma a cikin cututtuka tare da angiotensin II a cikin jini. An kimanta rhACE2 a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
b'Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu wanda aka tsara don taimakawa bin diddigin lamba don magance cutar coronavirus ta 2019-2020, wanda shine aiwatar da gano mutanen ("saduwa") waɗanda wataƙila sun yi hulɗa da mutane masu kamuwa da cutar.
An haɓaka ko kuma an gabatar da aikace-aikace da yawa, waɗanda ke da goyon bayan hukuma a cikin yankuna da yankuna da yawa.
An kuma samar da wasu tsare-tsare don gina aikace-aikacen bin diddigin lambobin sadarwa.
An yi tambaya game da batun sirri, musamman dangane da tsarin da ya dogara da bin diddigin wurin da mai amfani da aikace-aikacen yake.
Zaɓuɓɓuka waɗanda ba su da ɓoye ɓoye sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan don tallafawa waɗannan aikace-aikacen masu tushen Bluetooth kai tsaye cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin, tare da Alipay, sun fitar da manhajar da ke baiwa 'yan ƙasa damar duba idan sun yi hulɗa da waɗanda ke da cutar COVID-19.
Ana amfani da shi a birane fiye da 200 a kasar Sin, kuma a Singapore, ana amfani da shi a wata manhaja mai suna TraceTogether.
Wannan aikace-aikacen da al'ummar IT na gida suka haɓaka, an sake shi a matsayin mai buɗewa kuma za a ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!", aikace-aikacen Bluetooth don bin diddigin fallasa ga mutanen da ke da yiwuwar kamuwa da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da wannan manhajar.
Har zuwa 14 ga Afrilu 2020, har yanzu ana jiran amincewar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen bin diddigin lamba yana cikin ci gaba kuma zai kasance don rarrabawa a cikin 'yan makonni. Ana shirin yin irin wannan aikace-aikacen a Ireland da Faransa ("StopCovid").
Australia da New Zealand suna la'akari da aikace-aikacen da suka dogara da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geofencing ga marasa lafiyar da aka gano COVID-19 da ke zaune a Moscow; an tsara wannan aikace-aikacen don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a fannin tsaro a Jami'ar Cambridge, ya ambata wasu matsaloli na aiki da za su iya tasowa a tsarin da aka kafa ta aikace-aikace, wanda ya haɗa da yin amfani da bayanan ƙarya da kuma rashin tasiri idan aka ƙayyade bayanan da aikace-aikacen ke tattarawa ga ƙananan mutane.
Don magance damuwar yaduwar aikace-aikacen "coronavirus" masu ɓatarwa ko haɗari, Apple ya sanya iyakancewa kan nau'ikan ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, wanda ke iyakance kawai ga ƙungiyoyi "na hukuma" ko waɗanda ke da suna.
Google da Amazon suna da irin wannan takunkumi.
Masu ba da shawara kan tsare sirri sun nuna damuwarsu game da tasirin sa ido mai yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a dakatar da tsarin sa ido da aka gina don magance cutar ta coronavirus bayan barazanar ta wuce.
Kungiyar Amnesty International da fiye da wasu kungiyoyi 100 sun fitar da sanarwa da ke kira ga a hana irin wannan sa ido.
Kungiyar ta bayyana sharudda takwas ga aikin gwamnati:
sa ido dole ne ya kasance "daidai, dole, da kuma daidaitacce";
tsawaita sa ido da kuma sa ido dole ne ya kasance da sashe na faɗuwar rana;
amfani da bayanai ya zama dole a iyakance shi don COVID-19;
Tsaro da kuma asirin bayanai dole ne a kiyaye su kuma a tabbatar da cewa an kiyaye su bisa ga hujja;
sa ido na dijital dole ne ya guji ƙarin nuna bambanci da kuma marginalization;
kowane rabawa na bayanai tare da ɓangare na uku dole ne a ayyana shi a cikin doka;
dole ne a sami kariya daga cin zarafi da kuma hakkin 'yan ƙasa su amsa cin zarafi;
Ana bukatar halartar dukkan "masu ruwa da tsaki" da suka hada da masana kiwon lafiyar jama'a da kungiyoyin da ke cikin 'yan tsiraru.
Shirin Google/Apple da aka gabatar yana nufin magance matsalar sa ido ta hanyar cire tsarin bin diddigin na'urorin daga tsarin aiki bayan da ba a bukatar su.
Wasu ƙasashe suna amfani da hanyar sadarwar tushen wuri, maimakon aikace-aikace, don haka kawar da buƙatar saukar da aikace-aikace da ikon guje wa bin sawu.
A Isra'ila, an amince da bin diddigin da ake yi ta hanyar sadarwa.
Maganin cibiyar sadarwa wanda ke da damar zuwa bayanan wuri mai mahimmanci yana da matsala mai mahimmanci na sirri.
Koyaya, ba duk tsarin da ke da sabar cibiyar ke buƙatar samun damar bayanan wurin mutum ba; an ƙirƙiri wasu tsarin da ke kare sirrin sirri kuma suna amfani da sabar cibiyar kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ba na aikace-aikace ba don bin diddigin lambobin sadarwa.
Maimakon yin amfani da aikace-aikace na musamman, tsarin yana tattara bayanan sa ido daga tushe daban-daban, ya haɗa da bayanan sa ido na na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa wannan bayanin don samar da sanarwar saƙon rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu yiwuwar tuntuɓar, gwamnati ta kuma ba da bayanin wurin ga jama'a, wanda aka ba da izini ta hanyar sauye-sauye masu yawa a cikin dokokin tsare sirri na bayanai bayan yaduwar cutar MERS a ƙasar.
Ana samun wannan bayanin a cikin aikace-aikace da kuma shafukan yanar gizo. Kasashe kamar Jamus suna la'akari da amfani da tsarin da aka daidaita da kuma tsarin tsare sirri.
Har zuwa 6 ga Afrilu 2020, ba a bayyana cikakken bayani ba.
Binciken lambar sirri mai kare sirri shine ingantaccen ra'ayi, tare da babban adadin wallafe-wallafen bincike tun daga aƙalla 2013. A ranar 7 ga Afrilu 2020, sama da gungun masana goma sha biyu suna aiki kan mafita mai aminci, kamar amfani da Bluetooth Low Energy (BLE), don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT wani shiri ne na daidaitawa wanda ya ƙunshi tsarin kulawa da kulawa, ba yarjejeniya ɗaya ba. Yarjejeniyar da aka rarraba ta ƙunshi Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar Lambar L
A cikin wannan yarjejeniya, bayanan da za a iya gano su da kansu ba sa barin na'urar, kuma duk abubuwan da aka yi daidai suna faruwa a na'urar.
Ƙungiyar Sirri a MIT Media Lab ta haɓaka SafePaths, dandamali don amfani da fasahohin da ke kare sirrin yayin tattarawa da amfani da wuri ko bayanan mahaɗan hanya don bin hanyar yaduwar COVID-19.
Wannan ya dogara ne akan bincike daga farar takarda "Ayyukan da suka tafi Rogue: Kula da Sirrin Mutum a cikin annoba" wanda aka fitar a watan Maris na 2020. Wani irin wannan yunƙuri shine dandamali na SafeTrace na Enigma MPC, kamfanin da ke haɓaka fasahar tsare sirri kuma wanda aka fara kafa shi a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki mai aminci don ba masu amfani damar raba wuri da bayanan kiwon lafiya mai mahimmanci tare da sauran masu amfani da jami'ai ba tare da yin watsi da sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa Coalition na TCN na duniya ta ƙungiyoyi waɗanda ke da tsarin da ya dace kuma sun kasance sun haɗu da yarjejeniya da yawa, tare da burin rage rarrabuwa da ba da damar haɗin kai na duniya don aikace-aikacen sa ido da faɗakarwa, wanda shine babban al'amari don cimma karɓa mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta sanya yarjejeniyar BlueTrace da aikace-aikacen hukuma ta gwamnati ke amfani da ita a bude.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun ba da sanarwar wani shiri don bin diddigin lamba, wanda suke da'awar zai kare sirrin mutum, bisa la'akari da hadewar fasahar Bluetooth Low Energy da kuma tsarin boye-boye na kare sirrin mutum.
Sun kuma wallafa takamaiman fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, an yi niyyar kaddamar da tsarin ne a matakai uku:
ƙaddamar da kayan aiki don bawa gwamnati damar yin aikace-aikacen bin diddigin coronavirus na hukuma wanda ke kare sirrin mutum
Google da Apple suna shirin magance matsalar karɓar bayanai da sa ido na yau da kullun ta hanyar rarraba tsarin farko ta hanyar sabunta tsarin aiki, sannan cire shi ta hanyar da ta dace bayan barazanar ta wuce.
b'Repositioning magani (wanda ake kira sabon manufa, sabon profile, ko sabon aiki a kan magani ko juyawa zuwa magani) shine amfani da magani da aka amince dashi don sabon manufar magani, wato don cuta ko yanayin likita wanda ya bambanta da manufar farko na ci gaban magani.
Wannan hanyar ita ce hanyar binciken kimiyya da ake yi a halin yanzu don haɓaka ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma maganin jini na plasma. SARS-CoV-2 yana da wasu sunadarai 66 da za su iya zama manufa ta magani, kowannensu yana da wasu wuraren da ke ɗaure ligand.
Binciken waɗannan wuraren da ke ɗaure ligand na iya zama tushen aikin haɓaka maganin rigakafi mai tasiri ga ƙwayoyin COVID-19.
Wasu mahimman sunadarai na SARS-CoV-2 sune papain-like protease, RNA-dependent polymerase, helikase, S protein, da ADP ribophosphate.
Hussein A A, et al sun binciki wasu magungunan da ake son samarwa sannan suka inganta su kuma suka yi nazarin kamanceceniya da magungunan da aka amince da su kuma suka fi kowa a cikin su domin hanzarta samar da magungunan cutar SARS-CoV-2 da za a iya amfani da su a cikin binciken da ake yi kafin a yi shawarar su a cikin gwajin asibiti.
Chlorokuin magani ne na antimalaria wanda kuma ake amfani da shi wajen yaki da wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydrochlorquine masu alaƙa sune biyu daga cikin magunguna huɗu da za a bincika a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa za a fara gwajin chloroquine da hydrochlorquine a New York a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate bisa ga izinin Amfani da Gaggawa (EUA).
Ba a amince da shi ta hanyar gwajin gwaji na FDA ba kuma an ba da izini ne kawai a kan EUA a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya da ke cikin asibiti, amma ba za su iya karɓar magani a gwajin asibiti ba.
CDC ta ce "amfani, sashi, ko tsawon hydroxychloroquine don rigakafin ko maganin kamuwa da cutar SARS-CoV-2" ba a ƙaddara ba.
Likitoci sun ce suna amfani da shi ne sa'ad da "ba su da wani zaɓi".
Wata ƙungiyar masu bincike a Turkiyya a Istanbul suna yin ƙaramin bincike game da amfani da chlorokuin a haɗe da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da manyan bincike a jami'ar Duke da kuma jami'ar Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da gwajin lafiya da kuma inganci na maganin hana cutar hydroxychloroquine.
Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa favipiravir ya tabbatar da "bayyanannen tasiri".
Marasa lafiya 35 a Shenzhen sun gwada ba su da lafiya a matsakaicin kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kai kwanaki 11 a cikin marasa lafiya 45 da ba su karɓi maganin ba.
A wani bincike da aka yi a Wuhan a kan marasa lafiya 240 da ke da ciwon huhu, rabin marasa lafiya sun sha favipiravir, sauran rabin kuma sun sha umifenovir.
Hukumar Magunguna ta Italiya ta gargadi jama'a cewa hujjojin da ke goyon bayan maganin ba su da yawa kuma ba su da wuri.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don samarwa da kuma amfani da sojoji don isar da maganin zuwa asibitin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump tayin sayen maganin, wanda zai iya zama mai tasiri a cikin manyan cututtuka da cutar ta ninka.
Ba zai zama lafiya ba idan aka yi amfani da wannan magani ga mata masu juna biyu ko kuma mutanen da suke ƙoƙarin yin ciki.
Wani bincike na lopinavir/ritonavir (Kaletra), wanda shine haɗin maganin rigakafi na lopinavir da ritonavir, ya kammala cewa babu wani amfani da aka gani.
An tsara wannan magani ne domin hana kwayar cutar HIV ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado na ƙoƙarin gyara magunguna don gano mahaɗan da za su ɗaure da protease na SARS-CoV-2. Akwai suka a cikin al'ummar kimiyya game da tura albarkatu don sanya magungunan da aka haɓaka musamman don HIV/AIDS.
WHO ta saka lopinavir/ritonavir cikin gwajin Solidarity International.
Remdesivir an kirkireshi kuma an bunkasa shi ne ta Gilead Sciences a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg. Daga baya, Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafi a cikin vitro akan wasu fila-, pneumo-, paramikso-, da coronavirus.
Wata matsala da ke tattare da maganin rigakafi ita ce, ana iya samun ƙin kamuwa da cuta ta hanyar maye gurbin da ke iya sa a kamu da cuta kuma a ci gaba da yaduwa.
Wasu binciken farko na gwaji sun nuna cewa remdesivir na iya samun babbar takunkumi na kwayoyin halitta ga juriya. Akwai wasu gwaji na asibiti da ke gudana, gami da gwaji biyu na asibiti da asibitin Jami'ar Cleveland ke gudanarwa, daya a cikin mutane masu matsakaiciyar cuta da kuma daya a cikin mutane masu matukar cuta.
Akwai gwaje-gwaje uku na asibiti da ke gudana don bitamin C a cikin jini ga mutanen da ke kwance a asibiti da ke fama da cutar COVID-19, wato, biyu da aka sarrafa (Thailand, Kanada) da kuma guda ɗaya da ba a sarrafa ba (Italiya).
Jihar New York ta fara gwajin maganin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) tana shirin yin gwajin asibiti don Alvesco (ciclesonide) Teijin, corticosteroid na numfashi don asma, don kula da marasa lafiya da ke kamuwa da cutar coronavirus.
Don wani nau'i na enzyme mai canza angiotensin 2, ana ci gaba da gwajin Phase II tare da marasa lafiya 200 da za a karɓa daga marasa lafiya masu tsanani da ke asibiti a Denmark, Jamus, da Austria don sanin tasirin magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna binciken rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun COVID-19 masu sauƙi.
Binciken, wanda ake kira COLCORONA, ya ɗauki manya 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suka sami ƙananan alamun da ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba sa amfani da hanyoyin hana haihuwa ba su cancanci.
Ana gwada wasu maganin hana kumburi a Italiya.
Ana amfani da ƙananan ƙwayar heparin don kula da marasa lafiya wanda ya sa Hukumar Magunguna ta Italiya ta buga jagora game da amfani da shi.
An sanar da wani bincike mai yawa a cikin marasa lafiya 300 da ke nazarin amfani da sodium enoxaparin a cikin magungunan rigakafi da na magani a Italiya a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan samar da sabbin magungunan maganin cutar da aka amince da su kuma aka samar da su don bullar cutar da ta gabata, kamar su MERS, SARS, da kuma cutar West Nile.
Ribavirin: ribavirin da aka bada shawarar don maganin COVID-19 bisa ga jagororin kasar Sin na 7th edition
Umifenovir: an bada shawarar umifenovir don maganin COVID-19 bisa ga jagororin kasar Sin na 7th edition
Wasu maganin rigakafi da aka gano suna da yuwuwar zama magunguna da za a iya ba da sabon manufa don maganin COVID-19:
Tocilizumab (Anti-IL-6): An amince da shi a kasar Sin.
Bugu da ƙari, an yi gwaji a Italiya da China, duba kuma Tocilizumab#COVID-19.
b'Allurar rigakafin COVID-19 allurar rigakafin cutar coronavirus na 2019 (COVID-19) ce.
Ko da yake babu riga-kafin da ya kammala gwajin asibiti, ana ta yin ƙoƙari sosai wajen samar da irin wannan riga-kafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce, a cewar WHO, allurar rigakafin cutar SARS-CoV-2, kwayar cutar da ke haifar da cutar, ba za ta kasance cikin ƙasa da watanni 18 ba.
Ana gudanar da gwajin lafiya na kashi na biyar a watan Afrilu.
An gano COVID-19 a watan Disamba na shekarar 2019.
Babbar annobar ta bazu a duniya a shekarar 2020, wanda ya haifar da zuba jari da bincike mai yawa don samar da allurar rigakafi.
Kungiyoyi da dama suna amfani da kwayar halittar da aka wallafa don samar da allurar rigakafin cutar SARS-CoV-2.
Ƙungiyar CEPI ta ba da sanarwa a watan Afrilu cewa abubuwan da za a yi la'akari da su wajen samar da allurar rigakafi su ne saurin, ƙarfin samarwa, yaduwar da ake bukata, da kuma samun damar duniya.
A watan Afrilu, masana CEPI sun ba da rahoton cewa ana gudanar da bincike da ci gaba kan dandamali daban-daban na fasaha guda 10 a farkon 2020 don samar da rigakafin cutar COVID-19.
Manyan dandamali da aka ƙaddamar da su zuwa binciken tsaro na Phase I, sun haɗa da:
nucleic acid (DNA da RNA) (mai haɓaka Phase I da kuma ɗan takarar allurar rigakafi: Moderna, mRNA-1273)
masu kwayar cutar (masu samar da Phase I da kuma masu neman allurar rigakafi: CanSino Biologics, masu kwayar cutar adenovirus nau'in 5)
Kamar yadda masana kimiyyar CEPI suka ruwaito a watan Afrilu, jimillar masu neman rigakafi 115 suna cikin farkon matakin ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma tare da karancin bayanan jama'a (wanda ake ganin a cikin shiri ko kuma a cikin tsari).
Gwajin Phase I-II yana yin gwajin farko na aminci da rigakafi, yawanci ana yin sa a bazuwar, ana sarrafa placebo, kuma a wurare da yawa, yayin tantance mafi daidaiton sashi mai tasiri.
Gwajin Phase III yawanci yana da masu halarta da yawa, gami da rukunin kulawa, kuma yana gwada tasirin allurar rigakafi don hana cutar, yayin da yake lura da tasirin sakamako a mafi kyawun sashi.
Daga cikin masu neman rigakafin 79 da ake ci gaba da bunkasa su (wanda aka tabbatar a farkon watan Afrilu 2020), 74 daga cikinsu ba su cikin kimantawar ɗan adam (har yanzu suna cikin binciken "preclinical").
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa suna binciken yiwuwar allurar rigakafin kwayar halitta da za ta iya gyara kwayar cutar ta kwayar halitta don tayar da martani na rigakafi.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Alurar rigakafin kasa da kasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa sun fara samar da allurar rigakafi, tare da burin gwajin ɗan adam a 2021.
An sanar da aikin samar da allurar rigakafin a Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin a ranar 26 ga Janairu 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical, wanda Hanneke Schuitemaker ya jagoranta, ya sanar da cewa sun fara haɓaka allurar rigakafi.
Janssen ya hada kai da Vaxart, wani abokin aikinsa na samar da maganin da za a iya sha da baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar samarwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga takarda game da ƙirar allurar rigakafi tare da fasahar kama da fasahar da ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala hada allurar rigakafin kuma za su fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani reshen Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin rigakafin don samar da maganin peptide na Ii-Key na COVID-19.
Suna son su samar da wani maganin rigakafi da za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da aikinta na samar da rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Binciken Likitocin Sojoji da na Sojoji a Fort Detrick da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna kan bunkasa allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa suna aiki tare da Novavax Inc.
a cikin samar da rigakafi.
Bugu da ƙari, haɗin gwiwar ya sanar da shirin gwajin farko na gwaji da gwajin gwaji na Phase I a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna kan aiki kan abubuwan da aka ware guda 11, kuma ko da a kan hanya mai sauri, ci gaban allurar rigakafi zai ɗauki akalla shekara daya da rabi zuwa biyu.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere-kere a Quebec City, Quebec, ya ba da rahoton ci gaba da kwayar cutar coronavirus tare da wani bangare na kudade daga Cibiyoyin Nazarin Lafiya na Kanada.
Ana gudanar da gwajin rigakafin a cikin dakin gwaje-gwaje, tare da shirin gwajin mutum a watan Yuli ko Agusta na 2020.
A farkon makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da "'dimbin kuɗi' don samun damar yin rigakafin COVID-19" ga CureVac, wanda gwamnatin Jamus ta yi tir da shi.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin Jamus, BioNTech, don haɓaka allurar rigakafin mRNA.
A halin yanzu, wani ɗan takarar rigakafin mRNA, BNT162, yana cikin gwajin farko tare da gwajin asibiti da ake tsammanin zai fara a watan Afrilu 2020.
A ranar 17 ga Maris 2020 a Italiya, kamfanin nazarin halittu na Italiya Takis Biotech ya sanar da cewa za su sami sakamakon gwajin rigakafin a watan Afrilu 2020 kuma za a iya fara gwajin rigakafin a cikin mutane a cikin kaka.
A ranar 19 ga Maris, 2020 a Faransa, Coalition for Epidemic Preparedness Innovation (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar rigakafin COVID-19 da ta haɗa da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, tare da jimlar saka hannun jari na CEPI a cikin ci gaban allurar rigakafin COVID-19 ya kai dala miliyan 29.
Sauran abokan saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin takardun rigakafi shida a kan dabbobi.
Masu bincike na Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna kan samar da allurar rigakafin RNA da za ta iya kara karfin kanta ga COVID-19.
An samar da wani magungunan rigakafi cikin kwanaki 14 bayan an samu jerin kwayoyin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da kudade na dala miliyan 275 don gudanar da ayyukan bincike na COVID-19 guda 96, wanda ya haɗa da wasu masu neman allurar rigakafi a kamfanoni da jami'o'in Kanada, kamar su Medicago Initiative da Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da kudade na dala miliyan 192 na musamman don samar da allurar rigakafin COVID-19, tare da shirin kafa "bankunan allurar rigakafi" na kasa wanda ke dauke da sabbin alluran rigakafi da za a iya amfani da su idan akwai wata annobar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, ɗan takarar allurar rigakafin COVID-19, a cikin beraye; sun bayyana cewa "MNA da ke ba da allurar rigakafin SARS-CoV-2 S1 subunit ta haifar da amsawar takamaiman antigen [a cikin beraye] wanda ya fara bayyana makonni 2 bayan rigakafin".
A ranar 16 ga Afrilu 2020 a Kanada, Jami'ar Kwalejin Pharmaceutika ta Waterloo ta sanar da ƙirar ɗan takarar rigakafin DNA a matsayin mai yuwuwar fesa hanci.
Ta hanyar amfani da bacteriophage, an tsara DNA don yin kwafi a cikin kwayoyin halittar dan adam don samar da kwayoyin cutar da ba su da lahani, wanda zai iya motsa tsarin garkuwar jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnati, masana'antu, da jami'o'i uku na Amurka sun tara albarkatu don samun damar babban kwamfuta daga IBM, hade da albarkatun sarrafa girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako na heterologous, wanda ake kira sakamako na nonspecific.
Wannan yana nufin cewa waɗannan alluran rigakafin na iya samun amfani fiye da cutar da suke hanawa.
Wani gwaji da aka yi a Australia ya bi sawun ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar cewa allurar rigakafin da ake ci gaba da samarwa ba za ta kasance mai lafiya ko tasiri ba.
Binciken farko don kimanta tasirin allurar rigakafin ta amfani da takamaiman samfurin dabbobi na COVID-19, kamar su ACE2-transgenic mice, sauran dabbobi masu bincike, da kuma primates marasa ɗan adam, ya nuna buƙatar matakan hanawa don isa matakin tsaro na 3 a cikin magance kwayar cutar mai rai, da haɗin kai na duniya don tabbatar da daidaitattun hanyoyin aminci.
An gwada allurar rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
Har zuwa shekarar 2020, babu wani magani ko rigakafin SARS da aka tabbatar da cewa yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don magance cutar SARS na da fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya.
Lokacin da MERS ta zama ruwan dare, ana ganin binciken SARS na iya zama samfuri mai amfani don haɓaka allurar rigakafi da maganin cutar MERS-CoV.
A watan Maris na shekarar 2020, akwai rigakafin MERS guda daya (wanda ya dogara da DNA) wanda ya kammala gwajin gwaji na farko a cikin mutane, kuma wasu rigakafin guda uku suna kan aiki, dukkansu rigakafin masu dauke da kwayar cutar, biyu masu dauke da adenovirus (ChAdOx1-MERS, BVRS-GamVac), da daya mai dauke da kwayar cutar MVA (MVA-MERS-S).
Shafukan sada zumunta sun karkatar da ka'idodin maƙarƙashiya da ke da'awar cewa cutar da ke bayan COVID-19 an riga an san ta kuma cewa an riga an sami allurar rigakafi.
Takardun mallakar da aka ambata ta hanyar kafofin watsa labarun sun yi nuni da takardun mallakar da ke akwai don jerin kwayoyin halitta da kuma allurar rigakafi don wasu nau'ikan coronavirus, kamar SARS coronavirus.
b'Cutar coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ake haifarwa ta hanyar cutar coronavirus mai saurin kamuwa da cutar numfashi ta 2 (SARS-CoV-2).
Alamun da ake samu sun haɗa da zazzaɓi, tari, da kuma numfashi.
Wasu alamu za su iya haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin ƙanshin ƙanshi, da kuma ciwon ciki.
Lokaci daga bayyanar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin waɗannan cututtuka suna haifar da rashin ciwo, wasu sun zama ciwon huhu na ƙwayar cuta da kuma rashin ƙarfi.
Har zuwa 17 ga Afrilu 2020, an samu rahoton fiye da mutane miliyan 2.24 a kasashe 210 da yankuna, wanda ya yi sanadiyar mutuwar mutane fiye da 153,000.
An warkar da mutane fiye da 568,000. Ana yaduwar cutar tsakanin mutane ta wurin kusanci, sau da yawa ta hanyar tsotsa ko kuma ƙananan ɗigo da aka samar ta hanyar tari, tari, ko magana.
Ko da yake ana samun sa a lokacin numfashi, saurin sa yakan sauka a ƙasa ko kuma a saman ƙasa maimakon ya kai nesa.
Mutum zai iya kamuwa da cutar ta wurin taɓa abubuwa masu gurɓata, idanunsa, hanci, ko kuma bakinsa.
A saman, wannan cuta na iya rayuwa har tsawon sa'o'i 72.
Kwayar cutar tana da yaduwar yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma bayan matakan cutar. Hanyar ganewar asali ita ce ta hanyar amsawar sarkar polymerase transcription-reverse real-time (rRT-PCR) a cikin nasopharyngeal suap.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargin suna da cutar da kuma masu kula da su.
Shawarwari game da amfani da abin rufe fuska ga jama'a sun bambanta; wasu hukumomi suna ba da shawarar kada a yi amfani da abin rufe fuska, wasu suna ba da shawarar yin amfani da shi, wasu kuma suna buƙatar yin amfani da shi.
A halin yanzu, babu takamaiman maganin rigakafi ko maganin rigakafi na COVID-19.
An samu yaduwar cutar a kusan dukkan kasashe a yankuna shida na WHO.
Mutumin da ke da cutar zai iya zama marar alamun ko kuma ya iya jin kamar zazzabi, ya yi tari, ya gaji, kuma ya yi numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko ciwon zuciya, rikicewa, wahalar farkawa, da fuska ko lebe mai launin shuɗi; ana ba da shawarar neman magani nan da nan idan waɗannan alamun sun bayyana.
Ana iya samun alamun numfashi na sama, kamar tari, kumburi, ko ciwon makogwaro, amma ba safai ake samun su ba.
A wasu lokatai, ana iya samun ciwon ciki da ciwon ciki.
Wasu daga cikin mutanen da aka samu a kasar Sin sun fara ne da ciwon kirji da kuma bugun zuciya.
A wasu mutane, cutar za ta iya zama ciwon huhu, rashin aiki na gabobin jiki, da mutuwa.
Ana kiran wannan lokacin lokacin da ake sakawa.
Lokacin incubation na COVID-19 yawanci kwanaki biyar zuwa shida ne, amma yana iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5 na mutanen da ke da alamun cutar za su sami alamun cutar cikin kwanaki 11.5 da kamuwa da cutar.
Ba a san cikakken matsayin waɗannan masu dauke da cutar ba a cikin yaduwar cutar; duk da haka, shaidar farko ta nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
A halin yanzu, ba a san yawan mutanen da ke kamuwa da cutar ba kuma ana ci gaba da bincike, tare da Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20% na dukkan waɗanda aka tabbatar da su ba su da alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada wadanda ba su da alamun cutar a cikin adadin wadanda suka kamu da cutar a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar a ranar, mutum 130 (78%) sun nuna ba su da alamun cutar a lokacin gwajin.
Tsutsotsi da hawaye na iya ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana sa mutane su yi karin haske fiye da yadda ake yi a al'ada.
Wani bincike a Singapore ya gano cewa tari da ba a rufe ba zai iya sa saukowar ruwa ta kai tsawon mita 4.5 (15 feet).
Kodayake ba a yawan watsa kwayar ta iska, National Academy of Sciences na Amurka ya nuna cewa ana iya samun watsawar bioaerosol kuma masu tara iska da aka sanya a cikin hallway a waje da dakunan mutane sun samar da samfurin da ke da kyau ga RNA na kwayar.
Wasu hanyoyin kiwon lafiya, kamar su yin amfani da intubation da kuma yin amfani da na'urar motsa zuciya (RJP), suna iya sa a sha iska.
Duk da cewa akwai damuwa cewa kwayar cutar na iya yaduwa ta hanyar stool, an yi imanin cewa wannan haɗarin yana da ƙarancin. Kwayar cutar tana yaduwa sosai yayin da mutum ke da alamun; kodayake yaduwa na iya faruwa kafin bayyanar bayyanar, haɗarin yana da ƙarancin.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu ko uku, kuma zai iya rayuwa a kan ruwa na tsawon sa'o'i ko kwanaki.
Musamman, an gano cewa za a iya gano kwayar cutar na tsawon kwana daya a kan kwali, har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da kuma tsawon awa hudu a kan jan karfe 99%.
Amma, hakan yana iya bambanta dangane da yanayin zafi da kuma zafin jiki.
Sabulu da na'urar wanke abubuwa suna da tasiri idan aka yi amfani da su yadda ya kamata; kayan wanki suna kawar da kitsen da ke kare kwayar cutar, suna kawar da kwayar cutar, kuma suna kawar da ita daga fata da sauran wurare.
Wasu magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe cututtukan tiyata), ba su da tasiri sosai.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman nauyin kwayar cutar a gwajin rana ta biyu.
Kwayar cutar coronavirus na numfashi mai tsanani 2 (SARS-CoV-2) sabuwar kwayar cutar coronavirus ce ta numfashi mai tsanani, wacce aka fara warewa daga mutane uku da ke da ciwon huhu wanda ke da alaƙa da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin halayen SARS-CoV-2 na zamani sun kasance a cikin coronavirus da ke da alaƙa da yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke lalata kumfa mai kariya. SARS-CoV-2 yana da kusanci da SARS-CoV na farko.
Hanyoyin da COVID-19 ya fi shafa sune huhu saboda kwayar cutar tana samun damar zuwa ga kwayar mai gida ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar na huhu na nau'in II.
Kwayar cutar tana amfani da wani glycoprotein na musamman da ake kira "spike" (peplomer) don haɗawa da ACE2 kuma ya shiga cikin ƙwayoyin maraba.
An gano raunin zuciya mai tsanani a kashi 12 cikin 100 na mutanen da suka kamu da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi faruwa a cikin mummunar cuta.
Matsayin cututtukan zuciya yana da yawa saboda kasancewar amsawar kumburi na tsarin cuta da kuma lalata tsarin rigakafi yayin ci gaban cutar, amma raunin myocardial na iya kasancewa yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
Ana bayyana masu karɓar ACE2 sosai a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano yawan yawan kamuwa da cutar ta COVID-19 a ICU da kuma yawan masu kamuwa da cutar ta COVID-19 a cikin ICU, inda aka gano cewa cutar ta cutar ta COVID-19 ta haifar da rashin lafiyar jiki.
Kodayake SARS-COV-2 yana da tropism ga ƙwayoyin epithelial na numfashi waɗanda ke bayyana ACE2, marasa lafiya masu fama da COVID-19 suna da alamun cutar hyperinflammatory systemic.
Musamman, kwayoyin T masu fitar da GM-CSF masu cutar sun nuna alaƙa da daukar nauyin IL-6 masu fitar da monocytes na kumburi da cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton wani abu da ya shiga jikin mutum a lokacin da aka yi masa autopsy.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwajin misali ita ce ainihin lokacin da aka sake yin kwafin polymerase chain reaction (rRT-PCR).
Ana yin wannan gwajin ne a kan samfurin numfashi da aka samu ta hanyar tsotsa na nasopharyngeal; duk da haka, ana iya amfani da samfurin tsotsa na hanci ko sputum.
A yawancin lokaci, ana samun sakamako cikin sa'o'i da yawa zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki misalai biyu na jini a tsakanin makonni biyu don haka sakamakon yana da ƙarancin lokaci.
Masana kimiyya na kasar Sin sun sami damar ware wannan kwayar cutar ta coronavirus da kuma buga jerin kwayoyinta ta yadda dakunan gwaje-gwaje a duniya zasu iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, gwajin antibody (wanda zai iya gano kamuwa da cuta mai aiki kuma idan mutum ya riga ya kamu da cutar) yana cikin ci gaba, amma ba a yi amfani da shi sosai ba.
Kwarewar kasar Sin ta nuna cewa gwajin ya kai kashi 60 zuwa 70 cikin dari.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris, 2020 don amfani a ƙarshen watan. Jagororin ganewar asali da asibitin Zhongnan na Wuhan University ya bayar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa la'akari da yanayin asibiti da kuma hadarin annoba.
Ana samun rashin daidaiton ƙasa-gilashi na multilobar na biyu tare da rarraba kewayen, asymmetric, da na baya da yawa a farkon kamuwa da cuta.
Subpleural dominance, crazy paving (ƙwaɗawa na lobular septum tare da alveolar cikawa ya bambanta), da kuma ƙarfafawa na iya bayyana yayin ci gaban cutar.
Akwai bayanai kaɗan game da cutar ta microscopic da kuma pathophysiology na COVID-19.
Babban binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Ƙarin bayani: ciwon zuciya, ciwon zuciya, ƙuƙwalwar huhu, da kuma kumburin huhu
Za a iya lura da nau'ikan cutar huhu na kwayar cuta guda huɗu:
ciwon huhu mai sauƙi: kumburin huhu, hawan jini, babban kwayar cutar, kumburin ciki mai yawa, kumburin ciki tare da infiltration na lymphocytes, da kuma samar da kwayoyin giant da yawa
ciwon huhu mai tsanani: lalacewar alveolar difus (DAD) tare da ɓarkewar alveolar exudate.
DAD na iya saurin kamuwa da ciwon numfashi (ARDS) da kuma matsanancin rashin lafiya.
ciwon huhu a lokacin warkarwa: tsarin exudate a cikin alveolar cavity da pulmonary interstitial fibrosis
Jinin: ƙwayar cuta ta hanyar intravascular disseminated (DIC); halayen leukoerythroblastic
Matakan kariya don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da mutane suke da yawa, wanke hannuwanka da sabulu da ruwa a kai a kai na akalla sakan 20, yin amfani da tsabtace numfashi mai kyau, da kuma guje wa taɓa idanu, hanci, ko baki da hannuwa marasa wanka.
CDC ta ba da shawarar rufe baki da hanci da takarda sa'ad da kake yin tari ko hancinka kuma ta ba da shawarar amfani da takarda a cikin wuyan hannu idan ba a samun takarda ba.
Ana ƙarfafa tsaftace hannu bayan tari ko tari.
CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'anta a cikin jama'a, a wani ɓangare don rage yaduwar cutar daga mutanen da ba su da alamun cutar. Dabarun hana mutane shiga cikin jama'a suna nufin rage hulɗa da mutane da yawa, ta hanyar rufe makarantu da wuraren aiki, rage tafiye-tafiye, da soke manyan tarurruka a cikin jama'a.
Ƙuntatawa ta kuma haɗa da mutane su kasance a nesa da juna na aƙalla ƙafa 6 ko kuma ƙafa 1.8.
Babu wani magani da aka sani da zai iya hana COVID-19. Tunda ba a riga an yi hasashen cewa za a sami allurar rigakafin ba har zuwa farkon 2021, babban ɓangaren magance COVID-19 shine ƙoƙarin rage ƙaruwar annobar, wanda aka sani da "sanya layin".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa na aƙalla sakan 20, musamman bayan sun fita bayan gida ko kuma idan hannayensu sun yi datti, kafin su ci abinci, da kuma bayan sun yi hanci, sun yi tari, ko kuma sun yi tari.
Bugu da ƙari CDC ta kuma ba da shawarar yin amfani da maganin shafawa na hannu wanda ke dauke da barasa aƙalla 60%, amma kawai lokacin da sabulu da ruwa ba su samuwa. A yankunan da ba a samun maganin shafawa na hannu na kasuwanci, WHO ta ba da tsari biyu don samarwa na gida.
A cikin wannan tsari, aikin antimicrobial ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don ya taimaka wajen kawar da ƙwayoyin cuta a cikin giya; wannan "ba abu ne mai amfani ba a maganin kashe hannu".
An ƙara glycerol a matsayin humektan.
Ana kula da mutane da kulawa mai taimako, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma goyon bayan sauran gabobin da suka kamu.
CDC ta ba da shawarar cewa duk wanda ke da cutar ya sanya abin rufe fuska.
An yi amfani da maganin oxygenation na membrane na waje (ECMO) don magance matsalar rashin numfashi, amma ana ci gaba da la'akari da amfanin.
Ana ba da shawarar tsabtace jiki da salon rayuwa da kuma cin abinci mai kyau don inganta rigakafi.
Kulawa mai tallafi na iya zama da amfani ga mutanen da ke da alamun rashin lafiya a farkon kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun wallafa shawarwari don kula da marasa lafiya na COVID-19 da ke asibiti.
Masana kula da gaggawa da masu ilimin huhu a Amurka sun tattara shawarwarin kulawar daga cibiyoyi daban-daban zuwa wata hanya kyauta, IBCC.
Har zuwa watan Afrilu 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu likitoci sun fi ba da shawarar paracetamol (acetaminophen) fiye da ibuprofen don amfani na farko.
Dole ne a ɗauki matakan kariya don rage haɗarin kamuwa da kwayar cutar, musamman a cikin tsarin kiwon lafiya lokacin aiwatar da hanyoyin da zasu iya samar da aerosol, kamar su intubation ko ventilation na hannu.
Ga ma'aikatan kiwon lafiya da ke kula da masu cutar COVID-19, CDC ta ba da shawarar sanya mutumin a cikin Rukunin Keɓewar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
Kayan aikin da aka ba da shawarar su ne: rigar APD, na'urar numfashi ko abin rufe fuska, abin kare ido, da safar hannu na likita. Idan akwai, na'urar numfashi (ba abin rufe fuska) ya fi kyau.
An amince da N95 respirators don tsari na masana'antu, amma FDA ta ba da izinin amfani da wannan abin rufe fuska a ƙarƙashin izinin Amfani da Gaggawa (EUA).
An tsara N95 respirator don karewa daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da inganci ga takamaiman ƙwayoyin halitta ba don amfani da ba a ambata a kan lakabin.
Idan ba a samu abin rufe fuska ba, CDC ta ba da shawarar yin amfani da abin rufe fuska ko kuma, a matsayin na ƙarshe, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani har su bukaci yin amfani da iska mai guba ko kuma na madadin, amma wasu suna da tsanani.
Ana gudanar da bincike kan irin taimakon numfashi da za a yi wa mutanen da ke fama da rashin numfashi da ke da nasaba da COVID-19 a asibitoci, kuma akwai tabbaci cewa ana iya guje wa intubation ta hanyar amfani da babban kanula na hanci ko kuma matsin iska mai saurin motsawa.
Ba a san ko waɗannan hanyoyin biyu suna ba da irin wannan amfanin ga waɗanda ke da ciwo mai tsanani ba.
Wasu likitoci sun fi son yin amfani da iska mai guba, idan akwai, saboda wannan fasaha tana iyakance yaduwar aerosol fiye da na nasal na babban gudu.
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti na mutum ɗaya, wanda ke iyakance ƙarfin tsarin kiwon lafiya don magance tashin hankali na COVID-19 wanda ya isa ya bukaci asibiti.
Wani bincike a ƙasar Sin ya gano cewa kashi 5 cikin ɗari suna shiga sashen kula da marasa lafiya, kashi 2.3 cikin ɗari suna bukatar taimakon na'ura mai ba da iska, kuma kashi 1.4 cikin ɗari sun mutu.
A China, kusan kashi 30 cikin dari na masu cutar COVID-19 da aka kwantar a asibiti sun shiga sashen kula da marasa lafiya na musamman.
Ana samun wahalar yin iska ta hanyar inji yayin da cutar COVID-19 ke ci gaba da samun ciwon numfashi mai tsanani (ARDS) kuma oxygenation na ƙara zama da wuya.
Ana buƙatar masu iska masu ƙarfin ƙarfi da yanayin PEEP mai ƙarfi don haɓaka isar da iskar oxygen yayin rage haɗarin raunin huhu da pneumothorax da ke da alaƙa da masu iska.
Wataƙila ba a samun babban PEEP a kan tsofaffin masu sanyaya iska.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020 kuma wasu magungunan rigakafi suna cikin gwajin asibiti.
Remdesivir ya zama kamar abin da ya fi kyau.
Ko da yake ci gaban sabbin magunguna na iya ɗaukar lokaci har zuwa 2021, wasu magunguna da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwaji na ci gaba.
Ana iya gwada maganin rigakafi a kan mutane da ke da ciwo mai tsanani.
Masu ba da gudummawa da WHO ta ba da shawarar su shiga cikin gwajin inganci da amincin magani. FDA ta ba da izinin wucin gadi don plasma na warkarwa a matsayin magani na gwaji a yayin da rayuwar mutum ke cikin haɗari ko kuma nan take.
Ba a yi nazarin asibiti na plasma mai warkewa ba don tabbatar da amincinsa da kuma ingancinsa ga wannan cuta.
A watan Fabrairun 2020, kasar Sin ta kaddamar da manhajar wayar salula don magance annobar cutar.
Ana tambayar masu amfani su shigar da sunansu da lambar ID.
Wannan manhajar tana iya gano 'kusa da juna' ta amfani da bayanan sa ido don gano yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin sauran masu amfani uku.
Idan an gano yiwuwar cutar, app ɗin ba wai kawai yana ba da shawarar keɓe kai ba ne, amma kuma yana sanar da ma'aikatan kiwon lafiya na gida. Ana amfani da nazarin bayanai kan wayoyin salula, fasahar gane fuska, bin diddigin wayoyin salula, da kuma ilimin kere kere don bin diddigin mutanen da ke da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan, da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin jami'an tsaro su bi bayanan wayar salula na mutanen da ake zargin sun kamu da cutar coronavirus.
An dauki matakin ne domin sanya mutane a killace da kuma kare mutanen da suka yi mu'amala da mutanen da suka kamu da cutar.
Bugu da kari, a watan Maris na shekarar 2020, Deutsche Telekom ta raba tarin bayanan wurin waya ga hukumar gwamnatin tarayya ta Jamus, Robert Koch Institute, domin gudanar da bincike da kuma hana yaduwar cutar.
Rasha na amfani da fasahar gane fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya, Giulio Gallera, ya ce an gaya masa cewa "kashi 40 na yawan jama'a suna ci gaba da yin tafiye-tafiye".
Gwamnatin Jamus ta gudanar da wani taron satar bayanai na tsawon sa'o'i 48 da masu halarta sama da dubu 42.
Bugu da kari, Shugaban Estonia, Kersti Kaljulaid, ta yi kira ga duniya da ta samar da hanyoyin magance cutar coronavirus.
Mutane za su iya fuskantar matsi daga keɓewa, takunkumin tafiye-tafiye, illa daga magani, ko kuma tsoron kamuwa da cutar kanta.
BBC ta yi ƙaulin abin da Rory O'Connor ya ce: "Ƙaruwar ware kai, kaɗaici, rashin lafiya, damuwa, da kuma koma bayan tattalin arziki suna kawo mummunan sakamako ga lafiyar mutum da kuma lafiyarsa".
Wannan cuta na iya zama mai sauƙi tare da ƙananan ko babu alamun bayyanar, wanda yayi kama da sauran cututtukan numfashi na sama, kamar sanyi.
Masu rashin lafiya sukan warke cikin makonni biyu, yayin da masu ciwo mai tsanani ko kuma na tsanani za su iya bukatar makonni uku zuwa shida su warke.
Mata masu juna biyu na iya samun babban hadarin kamuwa da cutar COVID-19 bisa ga bayanai daga irin wadannan ƙwayoyin cuta, kamar SARS da MERS, amma akwai ƙarancin bayanai game da COVID-19. A wasu mutane, COVID-19 na iya shafar huhu kuma ya haifar da ciwon huhu.
A cikin mutanen da suka fi fama da cutar, COVID-19 na iya saurin zama cututtukan numfashi na gaggawa (ARDS) wanda ke haifar da rashin numfashi, tashin zuciya, ko rashin aiki.
Rikicin da ke tattare da COVID-19 ya hada da sepsis, rashin daidaiton jini, da lalacewar zuciya, koda, da hanta.
Rashin daidaituwar jini, musamman ƙaruwa a lokacin prothrombin, an lura da shi a cikin kashi 6% na marasa lafiya na COVID-19 da aka kwantar, yayin da aka lura da rashin aikin koda a cikin kashi 4% na wannan rukunin.
Kimanin kashi 20-30% na mutanen da ke da cutar COVID-19 sun nuna karuwar sinadarin hanta (transaminase).
A wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da kwana biyar a asibiti.
Duk da haka, marasa lafiya da aka kai ICU suna da matsakaicin kwanaki bakwai tsakanin shiga asibiti da mutuwa.
A cikin wani bincike da ya bincika cututtuka na farko, matsakaicin lokaci daga bayyanar cututtuka zuwa mutuwa kwanaki 14 ne, tare da cikakken zangon daga kwanaki shida zuwa kwanaki 41.
A wani bincike da Hukumar Lafiya ta kasa (NHC) ta kasar Sin ta yi, maza suna da kashi 2.8 cikin dari na mace-mace, yayin da mata ke da kashi 1.7 cikin dari.
Binciken da aka yi a jikin mutum ya nuna cewa an yi wa alveolar taɓawa da fibromycoid mai ƙyalli a cikin huhu biyu.
An lura da canjin kwayar cutar a cikin pneumocytes.
Hoton yana kama da cututtukan numfashi na gaggawa (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta kasar Sin ta ruwaito, an lura da lalacewar zuciya, tare da karuwar troponin ko kuma dakatar da zuciya.
A watan Maris na shekara ta 2016, an gano cewa kashi 89 cikin 100 na waɗanda suke asibiti suna da ciwo da aka haifa.
Ƙididdigar mutuwa daga yanayin ya bambanta saboda bambancin yankin, amma kuma saboda matsalolin da suka shafi tsarin.
Rashin ƙididdigar ƙananan ƙwayoyin cuta na iya haifar da ƙididdigar mutuwar da yawa.
Amma, gaskiyar cewa mutuwar ta faru ne a dā na iya nufin cewa an ƙididdige yawan mutuwar a yau da ƙanƙanta.
Masu shan sigari sun fi sau 1.4 na fuskantar mummunan bayyanar COVID-19 kuma kusan sau 2.4 sun fi buƙatar kulawa mai mahimmanci ko mutuwa fiye da waɗanda ba masu shan sigari. Akwai damuwa game da sakamakon dogon lokaci na cutar.
Hukumar Asibitocin Hong Kong ta gano cewa yawan mutanen da suka warke daga cutar ya ragu da kashi 20 zuwa 30 cikin dari, kuma binciken da aka yi a kan huhu ya nuna cewa gabobin jikin sun lalace.
Kuma yana iya sa a yi rashin lafiya bayan an warke.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata ta ba da rigakafi mai tasiri da na dogon lokaci ga mutanen da suka warke daga cutar ba.
Ana iya samun rigakafi, idan aka duba halayyar wasu ƙwayoyin cuta, amma an ba da rahoton an sami warkewar COVID-19 wanda aka biyo bayan gwajin coronavirus mai kyau 'yan kwanaki bayan haka.
An yi imanin cewa wannan cutar ta zama ta raguwa, ba ta sake kamuwa ba.
An yi imanin cewa wannan cuta ta samo asali ne daga dabbobi, ta hanyar yaduwar cuta.
Ba a san asalin asalin ba, amma a watan Disamba na 2019, yaduwar kamuwa da cuta kusan gaba ɗaya ta haifar da yaduwar mutum-zuwa-mutum.
Wani bincike na farko na 41 na COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana ranar farko da bayyanar cututtuka ya kasance 1 ga Disamba, 2019.
Ofishin WHO ya sanar da cewa cutar ta fara bayyana ne a ranar 8 ga watan Disamba na shekarar 2019.
A yawancin lokaci, ana amfani da wasu ma'auni don a ƙidaya yawan mutuwa.
Wannan adadi ya bambanta bisa ga yanki da kuma tsawon lokaci, kuma ya dogara da yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan kulawa, lokaci tun farkon barkewar cutar, da halaye na yawan jama'a kamar shekaru, jinsi, da kuma lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ta gaggawa ta ICD-10 U07.1 don mutuwar cutar ta SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar COVID-19 da aka gano a asibiti ko kuma a cikin annoba ba tare da tabbatar da dakin gwaje-gwaje don cutar ta SARS-CoV-2 ba.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga wata cuta, da kuma yawan mutanen da suka kamu da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (wanda aka gano da wanda ba a gano ba) da suka mutu daga wata cuta.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin wani takamaiman yawan jama'a daga kamuwa da cuta zuwa warwarewar shari'a.
Ko da yake ba dukan mutane da suka kamu ba ne suke samar da rigakafi, kasancewar rigakafin zai iya ba da bayani game da adadin mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani ƙaramin ƙauye da ke da mazauna 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu ne ta hanyar bikin Carnival, wanda ya yadu tsakanin matasa, wanda ya haifar da karancin mace-mace, kuma mai yiwuwa ba duk mutuwar COVID-19 ake rarraba su a matsayin mutuwar COVID-19 ba.
Bugu da ƙari, ba a shawo kan tsarin kiwon lafiya na Jamus ba.
A Netherlands, kusan kashi 3 cikin 100 na yawan jama'a suna da rigakafin, kamar yadda aka bincika daga mai ba da jini.
An tabbatar da mutuwar mutane 69 daga COVID-19 (0.004% na yawan jama'a).
Tasirin cutar da yawan mace-mace sun bambanta ga maza da mata.
Mutuwa ta fi girma a cikin maza a cikin nazarin da aka yi a China da Italiya.
Halin haɗari ga maza ya fi girma a shekarunsu na 50, kuma bambancin haɗarin tsakanin maza da mata ba ya bayyana a shekarunsu na 90.
A ƙasar Sin, adadin mutanen da suke mutuwa ya kai kashi 2.8 cikin ɗari na maza da kuma kashi 1.7 cikin ɗari na mata.
Ba a san ainihin dalilin da ya sa ake nuna bambancin jinsi ba, amma za a iya samun wasu dalilai na halitta da kuma halin kirki.
Bambancin rigakafi bisa jinsi, ƙarancin shan sigari a cikin mata, da maza da ke da yanayin haɗuwa, kamar hawan jini, a ƙarami fiye da mata na iya ba da gudummawa ga mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu 2020, gwamnatin Amurka ba ta bin diddigin bayanan da suka shafi jinsi don kamuwa da COVID-19.
Bincike ya nuna cewa cututtuka na ƙwayoyin cuta, kamar su Ebola, HIV, mura, da kuma SARS, suna shafan maza da mata dabam.
Akwai yawan mata ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, kuma suna da damar kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan cutar a hukumance shi ne "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na nufin kwayar cuta, D na nufin cuta, da kuma 19 na nufin lokacin da aka fara gano annobar: 31 ga Disamba, 2019.
An zaɓi sunan ne don kauce wa yin nuni ga takamaiman wuri na ƙasa (misali China), nau'in dabbobi, ko ƙungiyar mutane, daidai da shawarwarin ƙasa da ƙasa don suna waɗanda ke nufin hana ƙyama. An ba da sunan kwayar cutar da ke haifar da COVID-19 mai suna coronavirus mai saurin numfashi mai saurin 2 (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar COVID-19" da "kwayar da ke da alhakin COVID-19" a cikin sadarwa ta jama'a.
An kira cutar da kuma kwayar cutar "coronavirus".
A farkon barkewar cutar a Wuhan, China, an yi amfani da sunan "coronavirus" da kuma "Wuhan coronavirus" wajen kiran wannan cuta da cutar.
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCoV da cutar numfashi mai saurin 2019-nCov a matsayin sunaye na wucin gadi don ƙwayoyin cuta da cuta daidai da jagororin 2015 waɗanda ke ba da shawarar kar a yi amfani da sunayen wuri a cikin sunayen cuta da ƙwayoyin cuta.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin tsarin samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da kayan aikin iska.
A wani misali, sa'ad da asibiti na Italiya yake bukatar bawul din iska, kuma mai ba da isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen isashen.
Bayan barkewar cutar COVID-19, ka'idojin maƙarƙashiya, da bayanai marasa kyau, da kuma rashin fahimta sun bayyana game da asalin, girman, rigakafi, magani, da sauran fannoni na cutar, wanda ya bazu cikin sauri ta yanar gizo.
Mutane sun iya yada cutar zuwa wasu dabbobi.
Binciken bai sami tabbacin kwafin kwayar cutar a aladu, duck, da kaza ba.
Babu magani ko riga-kafi da aka amince da shi don magance wannan cuta.
Ana gudanar da bincike na duniya kan allurar rigakafin COVID-19 da magunguna ta kungiyoyin gwamnati, kungiyoyin ilimi, da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da gwajin "SOLIDARITY Trial" domin nazarin tasirin maganin ƙwayoyin cuta huɗu da ke da inganci.
Ba a riga an samar da rigakafi ba, amma hukumomi suna aiki sosai wajen samar da magungunan da za su yi maganin.
Binciken da aka yi a baya game da SARS-CoV ya yi amfani da shi saboda SARS-CoV da SARS-CoV-2 duk suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike a kai.
Na farko, masu bincike suna so su samar da rigakafin cutar da ba ta da lalacewa.
Amfani da wannan kwayar, ko dai kwayar da ba ta aiki ko kuma ta mutu, na nufin saurin haifar da amsawar garkuwar jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi, tana nufin samar da allurar rigakafi da za ta sa tsarin garkuwar jikin mutum ya zama mai saukin kamuwa da wasu ƙananan ƙwayoyin cuta.
A cikin SARS-CoV-2, binciken ya mai da hankali ne kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin masu karɓar enzyme ACE2.
Dabara ta uku ita ce allurar nucleic acid (DNA ko RNA, sabuwar dabara ce ta yin allurar rigakafi).
A ranar 16 ga watan Maris na shekarar 2020, an fara gwajin gwaji na farko na rigakafi tare da masu sa kai hudu a Seattle.
Allurar rigakafin ta ƙunshi lambar kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka-dangane da antibody a matsayin wata babbar ƙalubale ga ci gaban allurar rigakafin SARS-COV-2, amma wannan hanyar har yanzu tana da rikici.
Akwai gwaje-gwaje na asibiti sama da 300 da ke gudana a watan Afrilu na 2020.
Gwaje-gwaje bakwai sun kimanta maganin da aka amince da shi na zazzabin cizon sauro, sun haɗa da gwaje-gwaje huɗu na hydroxychloroquine ko chloroquine.
Sabbin magungunan rigakafi sun kasance mafi yawan binciken na kasar Sin, tare da gwajin Phase III guda tara na remdesivir a wasu kasashe tare da wa'adin bayar da rahoto a karshen watan Afrilu.
A watan Afrilu 2020, an riga an yi nazari mai ƙarfi game da ci gaban asibiti don allurar rigakafi da magungunan COVID-19. Ana kimanta wasu magungunan rigakafi da ake da su don maganin COVID-19, waɗanda suka haɗa da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir, da lopinavir/ritonavir a hade tare da interferon beta.
A watan Maris na shekarar 2020, akwai shaidar wucin gadi game da tasirin remdesivir.
An lura da ci gaban asibiti a cikin marasa lafiya da ke shan remdesivir a cikin gaggawa.
Ana gudanar da gwajin asibiti na Phase III a Amurka, China, da Italiya. An fara nazarin chlorokuin, wanda a baya ake amfani da shi wajen magance zazzabin cizon sauro, a kasar Sin a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, an yi kira ga masu bincike su sake nazarin binciken.
Hukumar kiwon lafiya ta Koriya da ta Sin sun ba da shawarar yin amfani da chlorokuin.
Koyaya, Cibiyar Virology ta Wuhan, duk da cewa tana ba da shawarar allurar gram ɗaya a kowace rana, ta lura cewa ninki biyu na cutar yana da haɗari kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa don hydroxychloroquine da chloroquine bisa ga manufofin likitocin da ke kula da marasa lafiya na COVID-19. Jagoran na 7 na kasar Sin ya kuma hada da interferon, ribavirin, ko umifenovir don amfani da su kan COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar manyan allurai na ribavirin don hana SARS-CoV-2 a cikin in vitro.
An ba da shawarar nitroxanide don ƙarin nazarin in vivo bayan nuna hana SARS-CoV-2 a ƙananan taro. Bincike ya nuna cewa farkon farawa akan furotin bulking ta hanyar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Nazarin da aka yi game da chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da manyan iyakoki wanda ya hana ƙungiyar likitanci amfani da waɗannan jiyya ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba shi da sanannen rawar da yake takawa a cikin maganin COVID-19.
Rikicin hadari na cytokine na iya faruwa a cikin COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin antistokinic. Tocilizumab an sanya shi cikin jagororin magani ta Hukumar Lafiya ta China bayan an kammala karamin bincike.
Ana gudanar da gwajin kashi na biyu a matakin kasa a Italiya bayan da ya nuna sakamako mai kyau a cikin mutane masu mummunan cuta.
An haɗa shi da gwajin jini na serum ferritin don gano guguwar cytokine, an yi nufin yaƙi da guguwar cytokine, wanda ake zargin shine dalilin mutuwar wasu mutanen da aka shafa.
A cikin 2017, FDA ta amince da mai karɓar mai karɓar interleukin-6 bisa ga nazarin yanayin baya don maganin cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Har zuwa yanzu, babu wani gwaji da aka yi a kai wanda ya nuna cewa tocilizumab magani ne mai inganci ga CRS.
Ana nazarin canja wurin rigakafin da aka tsabtace da kuma na rigakafi da aka samar da tsarin mutanen da suka warke daga COVID-19 zuwa ga mutanen da suke bukatarsa a matsayin hanyar rigakafin da ba a yi rigakafi ba.
An gwada wannan dabarar a SARS ba tare da sakamako mai kyau ba.
Rashin tasirin kwayar cutar shine tsarin aiki da ake tsammanin maganin rigakafin rigakafin zai iya daidaita kariya akan SARS-CoV-2.
Duk da haka, wasu hanyoyin, kamar su cytotoxicity na kwayoyin halitta da ke dogara da antibody da/ko phagocytosis, ma suna yiwuwa.
Wani nau'i na maganin rigakafin rigakafi, alal misali, yana amfani da rigakafin monoclonal da aka samar, yana ci gaba.
Za a iya inganta samar da maganin warkarwa, wanda shine ruwan da ke cikin jinin mai warkewa wanda ke dauke da takamaiman rigakafi ga kwayar cutar, don saurin amfani.
Cutar korona, wani rukunin cututtuka da ke da nasaba sosai
Li Wenliang, likita a asibitin Wuhan Central, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
